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Preface 
 
 
This PhD thesis described the realization and development of a new 
experimental laboratory for cardiovascular studies. Three years later, the 
Healing Research Laboratory (HeR Lab) is an approved reality, located within 
the ICEA Dept. of the University of Padua. The present paper explores the 
different aspects that have been involved on its development, and the principal 
research fields that have been touched along the doctorate program.  
It is subdivided in four parts: a first overview of the aortic district linked to 
the insertion of prosthetic devices, from physiological and engineering points of 
views. After this, the experimental activities are widely discussed. The 
experimental research was focused on the design, realization, trial-tests and 
first optimization of a mechanical-hydraulic closed circuit (called pulse 
duplicator), for the study of fluid dynamics in the systemic circulation after the 
implantation of prosthetic devices. Innovative feature of the workbench is the 
presence of a compliant silicone phantom replica of a healthy aorta, that 
permits investigations of mechanics and flow dynamics characteristics of the 
district via an experimental approach. A third section is depicted to external 
experimental projects, developed within the division of Cardiac Surgery, dept. 
of cardiac, thoracic and vascular sciences, University of Padua Medical 
School, to investigate the haemodynamic performances of a total artificial heart 
(CardioWest TAH-t); and within the UCL Cardiovascular Engineering 
Laboratory (University College London, UK), to perform in vitro assessment of 
prosthetic cardiovascular devices performances (biological aortic valves). The 
last part focuses on a numerical study based on the design of a 2D mechanical 
model for a red blood cell, and the computation of deformation-damage effects 
on the shield, due to the shear stresses induced downstream of mechanical 
aortic valves. 
The possibility to made up an experimental laboratory, and the 
development of a new-born research group, give the chance to obtain strong 
expertise along these three years in the R&D field, giving the possibility to 
actually touch all the different faces of the research, from the funding 
recruitment to the physical workbench realization or prototype testing.  
 
 
Nota riassuntiva 
 
 
Nella presente tesi di Dottorato è descritta la realizzazione e lo sviluppo di 
un nuovo laboratorio sperimentale per studi di fluidodinamica cardiovascolare. 
Il laboratorio, denominato Healing Research Laboratory (HeR Lab), a tre anni 
dalla sua creazione, è una realtà di Dipartimento consolidata; presente nel dip. 
ICEA dell’Università degli Studi di Padova. Nel proseguo dell’elaborato 
vengono indagati gli aspetti che hanno partecipato allo sviluppo del laboratorio, 
ed i principali campi di ricerca che sono stati toccati lungo il percorso di 
dottorato.  
La tesi è strutturata in quattro parti principali: la prima fornisce una 
panoramica del distretto aortico, in relazione all’inserimento di device protesici, 
sia dal punto di vista fisiologico che ingegneristico. La seconda parte è 
incentrata nella descrizione approfondita della ricerca sperimentale. Si 
focalizza nella progettazione, realizzazione e messa punto di un circuito 
meccanico-idraulico (chiamato pulse duplicator), per lo studio della fluido 
dinamica nella circolazione sistemica, a seguito dell’impianto di dispositivi 
protesici. Parte innovativa è costituta dalla presenza di un prototipo siliconico 
compliante di radice aortica ottenuta da CT-scan di paziente, per lo studio delle 
caratteristiche meccaniche del vaso e dei campi fluidodinamici locali. La terza 
sezione è costituita da progetti sperimentali sviluppati in strutture esterne 
all’HeR Lab. Il primo presso la Cardiochirurgia, dipartimento di Scienze 
Cardiache, Toraciche e Vascolari della Università degli Studi di Padova, allo 
scopo di investigare le performance emodinamiche di un cuore artificiale totale 
(CardioWest TAH-t); la seconda come membro dell’UCL Cardiovascular 
Engineering Laboratory (University College London), con l’obiettivo di indagare 
le performance di valvole aortiche biologiche per via sperimentale. La quarta 
sezione descrive uno studio numerico basato sul design di un modello 
meccanico 2D del globulo rosso, e sul calcolo di deformazioni e danni subiti 
dalla membrana, dovuti agli sforzi tangenziali indotti dal flusso effluente da 
valvole aortiche meccaniche. 
Lo sviluppo del laboratorio e del nuovo gruppo di ricerca cardiovascolare 
ha permesso di incamerare ottime competenze nell’ambito della ricerca e 
progettazione, dando la possibilità di toccare diversi aspetti dello sviluppo, 
dalla ricerca fondi alla realizzazione fisica di prototipi o banchi sperimentali. 
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Introduction 
 
 
The aim of this doctorate in hydraulic and fluid dynamic engineer was 
focused on the realization of an experimental laboratory for cardiovascular 
studies. The established Healing Research (HeR) laboratory sets itself as an 
innovative service for a productive exchange between engineering and clinical-
medicine entities, as well as other enterprises. In order to develop products, 
this gives expert advice services, and initiates a mechanism based on the 
technological transfer of knowledge that doesn’t seem to be sufficiently 
developed in the Italian environment. The HeR research group born four years 
ago under the direction of Ing. Francesca Maria Susin, who introduced myself 
to this project, with the means to start after securing a PRAT funding of 45.000 
Euro in 2012.  
In this context, the first results after these three years are certain to have 
obtained a growing interest and curiosity, in a clinical-medical working 
environment, both at a regional and national scale. Three years later, the 
laboratory is a department approved reality, located at ICEA Dept. of the 
University of Padua, and consists of two engineer researchers, one post-doc, 
two PhD students, several master’s students in thesis, alongside the important 
help of two lab technicians, working on its development. The Lab has two 
aspects: experimental and numerical, working in different projects. During this 
period, three important clinical collaborations were started: with the worldwide 
known division of Cardiac Surgery, dept. of cardiac, thoracic and vascular 
sciences, University of Padua Medical School, led by Prof. Dr. Gino Gerosa; 
with the paediatric cardiac surgery unit, University of Padua Medical School, 
through Prof. Dr. Giovanni Stellin and Dr. Massimo Padalino; and also with the 
dept. of vascular surgery, University of Padua Medical School, through Dr. 
Stefano Bonvini and Dr. Mirko Menegolo. In particular, Dr. Stefano Bonvini is 
the one that has been beloved in the Lab since its first steps and, with his great 
help, a self-funding charity sail race in Venice in June 2015 raised 10.000 Euro, 
all intended for HeR Lab. Moreover, in the engineering research field, three 
fruitful collaborations started in two years: with UCL Cardiovascular 
Engineering Laboratory (University College London, UK), leaded by Prof. 
Gaetano Burriesci, for studies about in vitro assessment of prosthetic 
cardiovascular devices performances; with the Research Unit of Biomechanics 
& Imaging in Cardiology group (University of Montreal, Canada), coordinate by 
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Damien Garcia, for studies of numerical models of aortic transvalvular pressure 
drop; and also with the Te.Si. Laboratory group (University of Padua), leaded 
by prof. Paolo F. Bariani, for the realization of silicone anatomic parts for in 
vitro tests. The idea for the near future is to also start collaborations with 
industries, trying to develop a technology transfer upon the industrial needs. 
Although these projects are in an initial phase, they highlight the growing 
relevance of the HeR Lab mission.  
 
The doctorate conducted activities have involved various aspects, both 
planning and organizational, but also management and communicative. The 
expertise obtained along these three years leads the development of the 
laboratory and the new-born research group, and gives the possibility to 
actually touch all the different faces of the research, from the funding 
recruitment to the physical workbench testing. In detail, the experimental 
research was focused on the design, realization, trial-tests and first 
optimization of a mechanical-hydraulic closed circuit (called a pulse duplicator), 
for the study of fluid dynamics in the systemic circulation after the implantation 
of prosthetic devices. A brief introduction to the fluid dynamics in the systemic 
district and to the connected engineering solution able to mimic the physiology 
will be found in Chapter 1. Particular attention was depicted to the aortic 
district, composed of aortic valve, root and arch. The design and development 
of the workbench was the main part of the doctorate and will be described in 
Chapters 2, 3, and 4. Chapter 2 examines in depth the design technique and 
the 1D numerical model developed for an initial sizing of the workbench. In 
Chapter 3, the actual pulse duplicator characteristic are provided, with a 
detailed description of mechanical and software parts, as well as an innovative 
manufacturing technique to realize a silicone aortic arch prototype. The 
detailed results about hydrodynamic performances of the system, obtained for 
different prosthesis and several heart rate and stroke volume variations, are 
described in Chapter 4. A section is depicted to an in vitro comparison, for a 
similar experimental set up, against the most used commercial mock loop 
system. The experimental activities were also conducted not only in the Dept. 
ICEA, but also in two different sites, as an external project, referenced to the 
development of the HeR Lab. They should not be seen as unconnected works, 
because they place themselves in the prosthesis assessment through 
experimental tests, following the leitmotiv of this thesis. 
The first external collaboration was focused on in vitro tests developed 
using a patient simulator machine, to assess the hydrodynamic performances 
of an artificial heart prosthetic devices for patients waiting for transplant: the 
CardioWest TAH-t and Freedom drive pumping system. The study gave the 
chance to work in close contact with the Centro V. Gallucci, within the 
Cardiovascular Surgery Operative Unit, Central State Hospital of Padova, 
allowing for fast growth in terms of expertise and the ability to work in a 
	 3	
heterogeneous team. This activity was carried out during the first year of the 
PhD, and it’s described in Chapter 5.  
A second “external” research study was developed at Cardiovascular 
Engineering Laboratory, Mechanical Engineer Dept. at UCL – University 
College London, under the supervision of Gaetano Burriesci (director of the lab 
and reader in Biomedical Engineering) and Andrea Ducci (lecturer in fluid 
mechanics), for a period of six months during the third year of the PhD. This 
research was hinged on the estimation of the hemodynamic performances 
expressed by different aortic valves and roots coupled systems. These in vitro 
tests were conducted using a commercial pulse duplicator system (ViVitro 
SuperPump System), bio-prosthetic aortic valves, and self-made silicone aortic 
roots with different shape characteristics. The detailed description and results 
of this research, that also give interesting ideas for a system capability 
comparison with regard to the hydraulic system developed in the HeR Lab, are 
described in Chapter 6. Chapter 7 keeps distance from the previous sections 
because it describes a numerical study carried out during the first and second 
year of the PhD. This in silico modelling parenthesis was based on the design 
of a 2D mechanical model for a red blood cell, and the computation of 
deformation-damage effects on the shield, due to the shear stress induced by 
the fluid downstream of the aortic valve. In particular, the total haemolysis 
index of a cloud of red blood cells in multiple passages through a prosthetic 
mechanical aortic valve was computed. To obtain this quantity, a new definition 
of incremental damage on the corpuscolate part of blood was developed.  
As the conclusion, Chapter 8 shows a brief resume of the different tasks and 
the results obtained during the PhD period, also giving some ideas on new 
possibilities for the HeR Lab, both in terms of experimental and numerical 
studies. 
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Chapter 1 
Fluid dynamics in the systemic circulation, and 
engineering solutions to mimic physiology 
 
  
1.1 Introduction 
I decided to start this chapter with the words of Lee R. Waite, professor of 
mechanical and biomedical engineering, at the Rose Hulman Institute (Indiana, 
USA). In my opinion, these are the best to introduce the argument:  
“One may question why it is important for a biomedical engineer to study 
physiology. To answer this question, we could begin by recognizing that 
cardiovascular disorders are now the leading cause of death in developed 
nations. Furthermore, to understand the pathologies or dysfunctions of the 
cardiovascular system, engineers must first begin to understand the physiology 
or proper functioning of that system. If an engineer would then like to design 
devices and procedures to remedy those cardiovascular pathologies, then 
she/he must be well acquainted with physiology.” (Waite, 2005). 
I am really convinced that this idea reflects the reality, and a multi-
disciplinary figure, such as a biomedical engineer, should have the intelligence 
to build up an open and curious mind, ever ready to understand the physics 
and the physiology of the problem. 
The next paragraphs are meant to be an engineering centred digression 
about the cardiovascular system, with a particular focus on the aortic area, 
seen as a physiologic district, but also as a possible implant site, such as for a 
prosthetic valve, an aortic stent, a ventricular assistive device, etc.  
1.2 The cardiovascular system 
The cardiovascular system is normally subdivided into heart, arteries, 
veins, capillaries, and lymphatic vessels. The main role of the cardiovascular 
system is to deliver oxygen, but it also plays other important functions such as 
temperature regulation, the delivering of nutrients, and waste removal. The 
engine of this complex system is the heart, a muscle that acts as a double 
pump: the left and the right heart. The outflow blood discharge coming to the 
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aorta (cardiac output) is dependent upon arterial pressure generated by the 
body tissues, and the heart itself. So, via the correct pressure, this double 
pump is able to generate, modify, and adjust the correct amount of blood that 
flows along the different vessels to feed all the organs. Just to have an idea of 
the work supported by the heart, it is possible to make a rough count: it beats 
70 times per minute in a rest situation, so it will beat ~100,000 times per day, 
~35 million times per year. A typical cardiac output is 70 mL of blood each 
beat, so a medium heart pumps over 7000 L, or the equivalent of 1800 gal, per 
day. Moreover, is made by a muscle with a mass of approximate 300 g (for an 
average adult man) (Waite, 2005; Ganong, 2007). 
The cardiovascular system can be further divided into three subsystems: 
the systemic, the pulmonary, and the coronary circulation. The first one is the 
subsystem that is supplied by the aorta and feeds the systemic capillaries, and 
is the one that will be most analysed by this PhD thesis, for two main reasons. 
First, it is the most stressed system in terms of flow discharge and pressure 
peak values and, as a consequence of that, the different parts (valves, flow 
tracts, etc.) tend to be the first that need a substitution. The global market plays 
an important role to direct the development of device solutions and the 
benchmarks able to test the new models in this area. In this scenario, the 
simulation systems have to fulfil international regulations that change quite 
frequently to follow the engineer -and clinical- solutions. A direct consequence 
of this is the important role played by the aortic valve and aortic arch prosthetic 
devices, and the ability to assess the real in vitro haemodynamic performance 
before the commercialization. 
 
1.2.1 Systemic circulation as a hydraulic loop 
After these preliminary considerations, let’s have a look at the systemic 
circulation physiology and its hydraulic loop parallelism. It is the principal blood 
circuit that allows the constant supply of oxygen to all organs and tissues. The 
heart acts as exchange element between two circulation systems, and it is 
subdivided in two double parts, for a total of four chambers and four mono-
direction passive valves (fig.1.1). This division helps the heart to provide a two 
stage cardiac cycle, that reflects the duality of the blood system circuit. The 
chambers are: left atrium and left ventricle, right atrium and right ventricle. The 
former two control the oxygenated blood loop, the latter two coordinate the 
cycle for the blood coming back through the inferior and superior vena cava. 
The mitral (bicuspid) and the aortic (tricuspid) valves separate the left atrium 
and the aorta from the ventricle. The tricuspid and the pulmonary valves act as 
a septum for the inflow and outflow of the right ventricle. So, using the left heart 
as a starting point for the systemic hydraulic loop, the left ventricle can be 
imagined as an in-pressure mobile chamber, with an inflow tract and an outflow 
tract. A tank and a valve make the inflow tract: the left atrium and the mitral 
valve. The aortic valve and the aortic root constitute the outflow part. The 
oxygenated blood is supplied to the left atrium from the lungs, via the 
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pulmonary vein. The cardiac cycle and the relative pressure fields (fig.1.2) can 
be explained as starting from here. The blood stored in the atrium passes 
through the mitral valve into the ventricle during the diastolic phase (about 60% 
of the time of the cardiac cycle), where the aortic valve is closed. The mitral 
valve is a bileaflet valve, with an ellipsoid shape. Its size changes a lot among 
subjects but it is normally bigger than the aortic one, and a medium man’s 
diameter could be 27-32 mm. Once the ventricle is filled, the pressure 
difference closes the mitral valve, but -for a few instants- the aortic also 
remains closed and a relevant force is imposed by the pericardium, increasing 
the pressure inside the ventricle. This short interval (about 7% of the entire 
cycle) is called iso-volumetric contraction. When the pressure inside the left 
ventricle is high enough to ensure the correct perfusion pressure to the organs, 
the blood flows through the aorta and performs the ejection (or systolic phase). 
Normally this part is about 33% of the cardiac cycle. The stroke volume 
generated from the heart can vary from 50 ml/beat up to 120 ml/beat in 
response to the function of the tissue oxygen allowing a cardiac output from 4 
l/min up to 20 l/min. The aortic valve is a trileaflet valve, with a normal size of 
about 27±4 mm for men and 24±4 mm for woman. The aorta provides the 
supply to the femoral, brachiocephalic, carotid arteries, coronaries, up to the 
capillaries; closing the circuit of oxygenated blood (and the systemic 
circulation). At the end of the systole, another diastolic phase starts and the 
aortic valve, due to a negative pressure difference between ventricle and aortic 
root, closes the leaflets allowing for the filling of the ventricle. 
 
Fig.1.1 Cross-section of the heart showing the four valves in a closed 
position. 
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Fig.1.2 A typical cardiac cycle, showing pressures waves with values for the 
main points, ventricular volume trend, electrocardiogram curve and the 
phonocardiogram measurement.  
 
1.2.2 Aortic district: valve, root and arch. Physiology and fluid 
mechanics 
The native aortic valve is anatomically identified using the physiologic name 
of tricuspid semilunar valve (fig.1.3) (Ganong, 2009). Indeed, it is composed of 
three leaflets made from connective, less vascularized tissue, with the addition 
of a variable amount of protein, and their shape remains a half-moon profile. 
The cusps are connected to a fibrous tissue ring, or valve ring, that acts as a 
physical separation between the ventricular chamber and the sinuses of 
Valsalva. A functional description of its geometry and operating principles was 
developed by Thubrikar, (Thubrikar, 1990), and, before this, a dissertation on 
the leaflets motion was written by Swanson & Clark (Swanson & Clark, 1973). 
The dynamic behaviour of the valve is quite difficult to analyse, for two 
reasons. The challenging task of observing the in vivo movement with high 
spatial resolution detail, and the complexity to replicate -in vitro- geometry and 
flow conditions. 
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In spite of these issues, since the ‘60s various researchers started to study 
dynamics of the valve leaflets and the flow patterns across the valve 
(Bellhouse, 1969; B & Talbot, 1968; Yoganathan, 2000). Of course the 
typology of the flow field (pulsatile, with non-constant profile), the 
characteristics of the fluid (non Newtonian), and the elasticity of the site, 
underline that the problem can’t be trivialized. But, using a very simple 
hydraulic parallelism, the problem could be described as a jet that passes 
through a movable orifice flowing from a cylinder to a smaller tube. In 
particular, in vivo experiments (Giddens & Yoganathan, 1998) showed that the 
valve aperture is not immediate, and expresses a specific dynamic that 
changes in function of the patient condition. Moreover, the instantaneous 
variation of the geometric area of the orifice is called GOA (Geometric Orifice 
Area), that should not be confused with EOA (Effective Orifice Area), which 
indicates the blood area (the vena contracta) that forms downstream of the 
valve. The difference between the areas and a typical EOA trend for healthy 
and pathologic conditions, are illustrated in fig.1.4 (Beauchesne et al., 2003; 
Garcia et al., 2004). Looking at the physiological trend, the opening phase is 
fast but not immediate, following different slopes since the maximum value. 
This difference is due to a common valve disease, leaflet stenosis, which 
stiffens the leaflets and hinders correct valve movement. For the healthy 
subject, it is possible to see the fluttering of the leaflets when the valve is open, 
a phenomenon due to the fast little movements that are a consequence of a 
complex geometry (the aortic root) and flow field. The complete open phase 
takes 60-70% of the cardiac cycle. The closing phase is fast, about 4% of the 
cycle, and is ruled by a high velocity gradient and vortices inside the Valsalva 
sinuses plus a physiological backflow that helps valve closure. 
 
 
Fig.1.3 Open and closed healthy aortic valve profile from the cross-section 
plane.  
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Fig.1.4 a) Schematic representation of flow through a rigid orifice plate. A1, 
Inlet cross-sectional area; EOA, effective orifice area; GOA, geometric orifice 
area (Garcia et al., 2004). b) Instantaneous effective orifice area (EOA) during 
1 ejection period for patient with severe aortic stenosis (AS) and age-/sex-
matched control patient (Beauchesne et al., 2003). 
 
The detailed flow patterns visible downstream of an aortic valve will be 
studied in Chapter 6. Some general information is summarized here, to clarify 
the physics of the problem. The aortic valve opens when the ventricular 
pressure exceeds that of the aorta (with a pressure difference across the valve, 
Δp, of about 2-3 mm Hg), and the blood is accelerated into the artery. In 
healthy individuals, it is possible to reach a velocity peak value of the jet of 
approximately 1.25 m/s just downstream of the valve. This value is slightly 
higher in children, about 1.5 m/s. For the pulmonic valve, peak velocities are 
smaller, about 0.75 m/s in adults and 0.9 m/s in children (Kilner et al., 1993; 
Weyman, 1994). The blood velocity peak is reached in the first third of systole 
(11% of the cardiac cycle). The jet shape can not be perfectly cylindrical 
because the ventricle translates and rotates (and, in accordance, the base of 
the aortic valve also varies in size, and moves), during the systole. For an 
aortic pressure range between 120 and 80 mmHg, the perimeter varies 
approximately 22%(Waite et al., 2007). Indeed, roentgenographic studies in 
patients with normal aortic valves have shown that, under resting conditions, 
the valve opens only to 40% of its maximum opening area and even during 
exercise, it only opens to about 70% (Stein et al., 1971). These studies suggest 
that the valve opens with a triangular orifice under resting conditions and 
moves toward a circular orifice under exercise conditions (Reul et al., 1979). 
Numerous experimental and mathematical analyses were performed to 
replicate and measure these velocities and characteristics. The first were 
Bellhouse and Talbot (Bellhouse & Talbot, 1969), which described steady and 
pulsatile flow studies in a model aortic flow chamber including the sinuses.  
Past the valve, the blood flows into the aortic root, and onto the aorta. The 
human aorta is the largest blood vessel and has a complex, three-dimensional 
curved geometry with multiplanar curvature (Jacob & Francone, 1974; 
Enderson, 1978). The root of the aorta is composed by three bulges (sinuses 
a) b) 
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of Valsalva) and a small straight tract (from the sinotubular junction to the 
ascending aorta) (fig.1.5). Two of the three sinuses provide blood supply to the 
heart muscles by means of the coronary arteries. Numerous studies have 
focused on the geometry and function of the aortic root, since Da Vinci (Keele, 
1952). In particular, the epitrocoidal top view profile was defined by Reul (Reul, 
1990), the attachment profile angles of the leaflets from Thubrikar (Thubrikar et 
al., 1981), and the sagittal plane of the sinuses profile from Grigioni (Grigioni et 
al., 2005). The fundamental role of the Valsalva sinuses will be described in 
detail in Chapter 6, but for now it seems enough to say that they provide less 
flow energy dispersion through the aortic root, maximizing the vena contracta, 
and also helping in the dynamics of leaflet closure. 
Fig.1.5 Aortic valve sketch with virtual and anatomical rings (Zalkind et al., 
2013). 
 
Past the valve and the Valsalva sinuses, the vessel starts to be called 
ascending aorta (and then aortic arch). Its primary plane of curvature allows 
the aorta to arch over the left pulmonary vessels and the left fork. Then, the 
aorta curves around the esophagus and the trachea in the mid-arch region, 
creating a shallow secondary curvature. In the ascending aorta a third plane of 
curvature is present, when the aorta curves around the left atrium as it rises 
from the aortic root. These curvatures express a radius-to-radius ratio of the 
about 3.8, 7.25, and 7.5, respectively (Yearwood, 1979; Yearwood & 
Chandran, 1980). In the region of the mid-arch of the aorta, three major arterial 
branches originate. A typical drawing of the arch, from a physiology book, is 
shown in fig.1.6, where it is possible to appreciate the complexity of the 
geometry. To have a rough idea of the total dimensions, the aorta from the 
aortic root to the diaphragm stays inside an A4 paper (about 210 x 300 mm). 
The descending aorta, lying close to the vertebral bodies and passing through 
the diaphragm, gives rise to more major branches that feed blood to the 
visceral organs. The descending aorta is divided into the thoracic (above the 
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diaphragm) and the abdominal segments (below the diaphragm). The 
abdominal aorta bifurcates into the two common iliac arteries at the level of the 
fourth lumbar vertebra (Anderson, 1978; Yearwood & Chandran, 1982; 
Chandran, 1993; Shipkowitz, 1995). To better optimize the flow dynamics, the 
aorta cross-section expresses an elliptical shape, with the lumen diameter 
being slightly larger in the anterior–posterior plane compared to that in the 
lateral plane, and it shrinks about 50% from the root to the descending aorta. In 
particular, Li (Li, 1987) has expressed the cross-sectional area changes in the 
aorta in an exponential form given by the relationship 
 𝐴 𝑧 = 𝐴!𝑒!!"/! 
 
where, k is the taper factor, r is the radius, z is the axial distance of the 
vessel from the aortic root, and A0 is the area at the aortic root.  
Furthermore, the aorta vessel wall movements are complex; it distends 
during the systole and contracts during the diastole. So, the flow development 
into the aorta is unsteady, passing through a vessel with an elliptical cross-
section that tapers, with a moving arterial wall boundary, curvature in multiple 
planes, and major branches in the mid-arch region as well as in the descending 
aorta. The subject of complicated flow development in the aortic arch and the 
descending aorta has attracted the attention of numerous medical scientists 
and engineers.  
 
Fig.1.6 A schematic drawing of the aortic arch from the frontal plane.  
 
One of the first studies was conducted by Rodkiewicz (Rodkiewicz, 1975) that 
studied a pulsatile flow in a 2D channel, that simulated the aortic arch with the 
three major arterial branches in the mid-arch region. The results of this model 
suggested the presence of five regions of flow stagnation and four regions of 
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boundary layer separation. Wright and Temple (Wright & Temple, 1977) 
developed research on a three-dimensional model of the human aorta, to 
visualize the flow and analyse the effect of prosthetic valves in the aortic root. 
Also Roach (Roach, 1977) used an in vitro approach to study the steady flow 
through a three dimensional model of the human aorta using flow visualization 
of dye filaments. 
In particular, Chandran (Chandran et al., 1983; Chandran et al., 1984; 
Khalighi et al., 1983; Chandran et al., 1985; Chandran, 1985) specifically 
focused on the interpretation of the flow inside the aortic root in variations of 
valve prostheses housed in the aortic annulus. They employed a three-
dimensional non-compliant model of the human aorta including the major 
branch vessels in the aortic arch. Using quantitative laser Doppler 
anemometer, they studied steady and pulsatile flow development downstream 
of different valves. The results showed that the flow development in the 
ascending aorta expresses a high dependence upon the valve design as well 
as on the orientation of the valve with respect to the root. Even in the mid-arch 
region, the velocity profiles exhibited variations depending on the valve at the 
root of the aorta. Representative flow patterns of these very informative 
studies, during the peak forward-flow phase with a tissue valve at the root of 
the aorta as well as a tilting disc valve in two different orientations, show a 
helicoidally shaped structure that forms and develops inside the vessel. An 
image extracted from Chandran (fig.1.7) shows the velocity measurements 
obtained using laser Doppler anemometry techniques at various planes in the 
aortic arch with a tilting disc mechanical valve and a porcine tissue valve. 
Fig.1.7 Velocity profiles measured in the various cross-sections in the 
model of the human aortic arch by laser Doppler anemometry technique with a 
porcine tissue valve (Roach, 1977; Chandran et al., 1984). 
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This thesis presents the case of ascending aorta and aortic arch replica, a 
project settled in collaboration with the dept. of vascular surgery of the Padua 
Hospital and the University Padua Hospital (see Chapter 3). In particular, the 
clinical need was the research of the reasons that cause a migration (or a 
malfunctioning) of the endovascular stent prosthesis placed to reduce aortic 
aneurisms. To better understand that problem, some information about the 
aortic arch aneurysms and the problems connected to the endovascular 
insertion are now provided. 
A dissertation concerning the properties of the first mechanical aorta was 
given by Dal Borgo (Dal Borgo, 1952). One of the most relevant diseases from 
the clinical perspective is the aneurism of the ascending and descending aorta. 
This local vessel expansion could cause a rupture of the aorta or a dissection 
event, both of which are very dangerous for the patient. Garcia (Garcia et al., 
2012) evaluated the aneurism severity via in vitro mechanical tests on 
biological tissues, trying to give some geometrical parameters to discriminate 
the disease level. The systemic pressure and hypertension condition are 
fundamental factors in the development of high radial forces that act on the 
aortic walls, and participate to a reshaping of the geometry of the aortic arch 
(Isnard et al. 1989; Gao et al., 2006). The wide geometric variation in terms of 
arch and aneurisms has become a problem, leading to the impossibility of 
developing a patient specific prosthesis in treating of an acute event.  
The endovascular stent is the most widely used prosthesis for the 
aneurisms treatment (fig.1.8 shows some abdominal stents). The insertion 
takes place from the femoral artery and the catheter is guided through the 
circulation towards the right position inside the aorta. Here the delivery system 
provides correct placement, and the Nitinol stent rings expand along the Teflon 
conduit, adapting to the aorta geometry (fig.1.9 shows some aortic arch stents). 
The prosthesis oversizing and correct anchoring of the necks provide a stable 
solution for aneurisms bypass (Lumsden et al., 2012). The complications 
encountered post-surgery (long-term) are normally:  
o Endoleaks (inadequate seal, sac filling, leaking through the stent, 
porous graft, endotension). 
o Migration of the necks. 
o Tightening of the nitinol structure for high curvature. 
o Rupture of the graft. 
In particular, developing an adequate replica of the anatomic district could 
provide some answers to these complications, studying the hydrodynamic 
performances in terms of pressure, velocity and stress fields. In vitro literature 
study about this topic is not so wide, for the difficulties to provide a correct 
anatomic replica or the precious physiological flow conditions for in vitro testing 
(Markl et al., 2005; Doyle et al.,2008; Sulaiman et al.,2008; Canstein et al., 
2008; Biglino et al., 2012; Biglino et al., 2013).  
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Fig.1.8 Examples of FDA-approved and currently marketed stent graft 
devices: (A) Medtronic, (B) Gore, (C) Cook Medical, and (D) Endologix. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.10 Ascending aorta endovascular stents for treatment of aneurysms. 
Left: Medtronic Talent, right: Gore Tag model. 
 
1.2.3 Prosthetic devices inserted in the aortic region	
The physiological overview, and the conducted studies on the flow 
dynamics, show how the variation of the aortic valve or the insertion of a 
prosthetic device into the aortic district could easily affect the flow pattern and 
the velocity profiles. A market device impact rank will probably put the aortic 
valve replacement in first place. Due to several societal and life factors, aortic 
valve diseases have become quite common in the north of the world, pushing 
the valve market into a constant rise from the ‘70s up to now. Moving from the 
mechanical Bjork-Shiley to the several bileaflet mechanical solutions, the 
prosthetic devices now tends to become more and more close to the native 
one, to overcome the problem of a strong anticoagulant therapy and other 
contraindications. So, since the late ‘90s, the companies have increased the 
study and the development on bioprosthetic solutions, able to guarantee an 
adequate durability, and provide an excellent flow dynamic across the valve. A 
detailed in vitro analysis of the flow patterns downstream of a porcine valve, in 
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couple with different aortic roots, can be found in Chapter 6. From 2005, new 
mini-invasive surgical solutions started to be developed: the trans-apical and 
trans-femoral accesses. These techniques use a catheter in which a valve is 
collapsed, and released in situ from the surgeons, via an expandable balloon 
system. An example of these very different prosthetic solutions is reported in 
fig.1.10. 
 
 
 
 
 
 
 
 
 
Fig.1.10	A) Mechanical valves. From left to right: Bjork-Shiley tilting disk, 
Starr-Edward caged ball, Kay-Shiley disc valve, Sorin Allcarbon bileaflet. B) 
Bioprosthetic valve. From left to right: Medtronic TAVI CoreValve, Sorin 
Perceval suterless, Edwards TAVI Sapien XT. 
 
Talking about the aortic root, the most interesting device is certainly the 
composite valve graft prosthesis. This replacement is currently the treatment of 
choice for a wide variety of lesions of the aortic root and the ascending aorta. It 
is normally made from biomaterial tissues like Dacron® or Teflon® fibres, and is 
composed of the bulges, the sinotubular junction, and a part of the ascending 
aorta. In most cases, the substitution of the aortic root is due to aneurismatic 
cavities that grow around the sinotubular region. If the first solution was 
replacement of the part, surgeons and engineers have tried to bypass this 
problem in recent years, overcoming the great issues of an open thoracic 
surgery and using an endovascular strategy. The research in this field is 
oriented to find the best geometrical pattern, for example deciding if the 
Valsalva sinuses are fundamental, in accordance with the adopted aortic valve. 
One of the last company solutions is the Mitroflow Valsalva Conduit developed 
by Sorin in 2013, that coupled the Sorin's Mitroflow aortic pericardial heart 
valve with a Mitroflow graft (fig.1.11). 
B	
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Fig.1.11 Mitroflow Valsalva Conduit with mitroflow aortic valve, developed 
and commercialized by Sorin Spa. Introduced in the USA at the end of 2012 
following FDA approval, the Mitroflow Valsalva Conduit has received CE mark 
and is commercially available in Europe from November 2013. 
The aortic arch, plus the descending aorta, is prone to aneurysms and 
dissections more than other vessel tracts. These diseases are caused by the 
remarkable stresses at the wall, and the complex flow patterns that 
characterize the double curvature part of the aorta. In particular, an aneurysm 
forms as a bulge in a section of the aorta, mainly caused by an underlying 
weakness in the aortic wall. Indeed, a dissection is classified using two 
different systems (see fig.1.12) but could be described as a tear between two 
vessel layers, which both continue to carry blood. The American College of 
Cardiology has supported and supervised several studies about aortic 
aneurysms and dissections, and a brief overview of these phenomena, the risk 
factors and the management is illustrated in fig.1.10. Moreover, the dissection 
and the aneurysm could be linked together in a more complex disease, 
increasing the risk even more for the patient. In the last decades the surgeons 
found two main operative options to treat these anomalies. The surgical 
options are the endovascular and the open repair ways. The first is based upon 
a minimally invasive insertion of a stent graft inside the vessel, released using 
a proper catheter, and expanded in situ via high pressure balloon. 
This solution is preferable in terms of impact on the body, but is not lacking 
in disadvantages, as reported in Chapter 4. The second alternative is based on 
a traditional open surgery with the replacement of the injured tract with a tube 
graft. The median sternotomy is a well know surgical procedure but presents 
some disadvantages, as it is highly invasive, and requires an external-body 
blood support machine. A sketch comparison of these techniques is shown in 
fig.1.13 (Isselbacher, 2005). 
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Fig.1.12 American College of Cardiology guidance for aortic and 
aneurysms classification. 
	
	
	
	
	
Fig.1.13 Left: repair sequence of a descending thoracic aortic aneurysm. 
Right: minimally invasive repair sequence of a descending thoracic aortic 
aneurysm using a transluminally placed endovascular stent-graft (Isselbacher, 
2005). 
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1.3 Pulse duplicators: a simulation of the nature 
The previous sections explained the characteristics of the aortic district and 
gave some ideas about the prosthetic solutions developed in the last few years 
to cure the diseases of the valve, root and aortic arch. The design, 
development, test and commercialization of all these prosthetic devices is 
impossible without continued research in optimization of materials, geometry 
and flow dynamics of the devices. To do that, different workbenches were built 
and commercialized. These devices are named mock loops (ML) or pulse 
duplicators (PD), starting from the idea of replicating the human circulation in 
terms of pressure and velocity fields through a hydro-mechanical machine. The 
main features have to be the pulsatile nature of the flow, following the 
physiological pressure trends in different areas, and a correct stroke volume 
and cardiac output, allowing the variation of the main hemodynamic 
parameters. These workbenches are normally made up with rigid and elastic 
tubes, chambers, air tanks, taps and silicone parts. From the ‘80s, the 
international regulations for the commercialization of these devices (UNI EN 
ISO 5840, last update in 2009, and FDA Draft Guidance for Industry and FDA 
Staff Heart Valves - Investigational Device Exemption (IDE) and Premarket 
Approval (PMA) Applications, last update in 2010) started to insert specific 
sections about in vitro tests and minimum performance requirements. 
 
1.3.1 First mock loops	
Cornhill designed one of the first examples of mock loops in the late 
seventies (Cornhill et al., 1977). The system used a deformable silicone sack in 
a pressurised chamber, acting as a left ventricle. The power driver was an air 
pump, able to reproduce the physiological conditions to test artificial prosthetic 
valves. The system was unable to correctly simulate the atrial systole. 
Reul provided a second example in 1974, and realized a flexible tubes 
system to simulate the flow in the aorta and inside its branches. In particular, 
he developed a specific chamber to host the tubes system, in which it was 
possible to control the compliance of the aorta and derivations. 
Scotten, in 1979, was the first that designed a PD able to evaluate both the 
mitral and the aortic valve performance. The ventricle was put in a sealed 
chamber, into which the fluid was injected by a pump. The circuit had several 
chambers and compliance systems, a deformable tract that simulated the 
aorta, and taps to replicate the vessels’ resistances. Scotten also understood 
the importance allowing optical access to the system and so he realized the ML 
with transparent polymeric materials. 
Rosenborg, in 1981, designed a specific hydraulic system able to connect 
and test the ventricular assist devices (VAD). 
Verdonck, in 1992, developed a complex system to specifically test the 
right heart valves, with two pulmonary veins and a tank to simulate the lungs. 
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There are two independent systems to regulate the internal and external 
pressure of the ML tubes. 
Probably one of the most used and known “research-made” PD was 
designed, developed and also commercialized by the University of Sheffield, 
during the ‘90s. It is known as Sheffield Pulse Duplicator (SPD), and it is 
composed of a hydraulic loop, made with plexiglass chambers, a glass aortic 
root and a servo-motor to control the flow and pressure fields inside the ML 
(fig.1.12) (AA.VV., 1989). In particular, the SPD was able to test all models of 
mechanical or stented tissue heart valves. It provides two test positions: aortic 
and mitral. A choice of aortic test sections, in four different sizes, enables the 
full range of valves to be accommodated in an appropriate model aorta. 
Various blood analogues can be used as the working fluid: saline solution or a 
saline and glycerol mix. Valve action may be photographed or filmed during a 
test, and access is provided for Laser Doppler anemometry and flow 
visualisation studies. The system is designed to perform pulsatile 
hydrodynamic testing of prosthetic heart valves following the requirements of 
ISO 5840:1989 (E) ‘Cardiovascular Implants - Cardiac Valve Prostheses’ and 
also to draft standards ISO/WD 5840 ‘Cardiac Valves’, and CEN 285 WG3 
‘Non-active Surgical Implants. Part 1: Cardiac Valves’ (March 1994). 
Looking at the mechanical parts (fig.1.12), a positive-displacement pump 
simulates left ventricular flow at a heart rate and cardiac output specified by the 
user. During simulated diastole fluid enters the mitral section from the mitral 
reservoir flowing through the mitral valve that is mounted in a chamber-to-
chamber configuration. Pressure transducers are situated upstream and 
downstream of the valve, and a flow transducer monitors forward flow and 
regurgitation. Fluid leaving the mitral section enters the model ventricle from 
where, during simulated systole, flow is directed through the aortic valve. 
Pressure transducers are mounted upstream and downstream of the aortic 
valve. A model aorta with sinuses is situated downstream of the valve. In order 
to obtain a close match between this and the test valve over the full range of 
valve sizes available, four aortae of various sizes are provided. After the 
passage through a flow probe, the flow reaches the compliance chamber, and 
then the fixed and variable system resistance, to finally flow into the mitral 
reservoir, in which the mitral valve is housed. 
 
1.3.2 ViVitro mock loop 
This session is focused on a specific mock loop, the ViVitro PD, that is 
probably the most world-wide used heart model. Indeed, all the factories that 
produce and test cardiovascular prosthetic device use this system to assess 
the hydrodynamic performance of the valve. It seems important to give some 
details (but a specific application with it will be found in Chapter 6), because 
the HeR Lab Pulse Duplicator, that will be described in the next chapters (3-4), 
is intended to be a starting point for a first alternative to this system. The 
ViVitro Systems company was founded by David Walker, and Larry Scotten, in 
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the mid-1970s. Their initial challenge was to build test equipment to evaluate a 
heart valve developed in the Cardiac Development Lab at Victoria’s Royal 
Jubilee Hospital. David and Larry’s prototype was soon able to simulate valve 
positioning and physiological compliances accurately and repeatably. Further 
development resulted in the first commercial Pulse Duplicator in 1984. The 
actual system is composed of the ViVitro model of the left heart, the 
SuperPump, that allows the correct motion at the work solution, a flow 
measuring system with two electromagnetic flow meters, and several pressure 
transducers, all controlled and adjustable by the ViViTest data acquisition 
system (fig. 1.13). As with other mock loops, the ViVitro system simulates the 
function of the heart by generating pulsatile flow through prosthetic heart 
valves placed in the Model Left Heart. The Pulse Duplicator simulates 
physiological or other complex flow variations while allowing the user to vary 
the peripheral resistance and compliance of the system. Pressure ports and 
flow measuring locations allow for data to be collected from aortic or mitral 
sites. Transparent viewpoints allow multiple viewing angles of the valve 
including inflow and outflow. The work solution is moved by a linear motor with 
high precision (controlled by software via LVDT). The pulsatile system can 
provide a cardiac output from 2 to 12 l/min, with heart beats from 30 to 140 
bpm, and a stroke volume up to 180 mL. The flow is injected in the ventricular 
chamber in which is hosted a silicone mock (that simulates the ventricle). 
Between the motor and the ventricle, a viscoelastic impedance adapter is 
inserted, which has the role of limiting the impulsivity of the fluid motion. Both 
the valve chambers can host prosthetic valve from 18 to 30 mm, and they have 
a dedicated compliance. Upstream from the valves, two probes of the 
electromagnetic flowmeters (Carolina Medical) are positioned. The ViViTest 
software control system allows the replication of physiological flow and 
pressure waves, which can be modified, collected, and analyzed. The software 
also allows the user to easily modify and customize the waveforms the pump 
follows. The ViVitro Pulse Duplicator System is used by the US Food and Drug 
Administration and is recognized by a number of other regulatory bodies 
worldwide including TÜV, BSI and the Chinese SFDA. 
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Fig.1.12 Sheffield mock loop engineer drawing (from SPD user manual). 
 
 
 
Fig.1.13 ViVitro pulse duplicator system, acquisition and control dock 
station and laptop, and the Carolina Medical Inc. electromagnetic flowmeter. 
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Chapter 2 
The 1D numerical model for workbench 
preliminarily design 
 
 
2.1 Introduction 
The thought at the base of the pulse duplicator realization was the 
production of a new experimental research reference for clinicians and 
industries, useful for start a profitable technologies transfer upon these different 
organisations. In this prospective the mock loop is the first step of the new born 
HeR Lab. One of the problems observed at the beginning of the project was 
the absence of engineer drawings, or a pre-sizing, of already developed mock 
loop systems in literature, except for the Sheffield mock loop (Barbaro et al., 
1991). The starting idea was to not make a precise copy of an existent pulse 
duplicator, but realise a system that simulate the left part of the heart and the 
human circulation, that could be easily modified following the research needs. 
For example, to study the changes due to the introduction of a compliant 
silicone vessel part instead of a rigid aortic root or creating bifurcations to 
investigate also the coronaries circulation.   
Studying this kind of hydraulic circuits, we were aware that there are some 
“fixed points” in the project, as a linear pump with a bellow for the fluid 
handling, taps as local resistance, elastic tubes or air tanks for mimic the 
compliance. But the problem was: how big have to be the different chambers, 
which is the best diameter of the pipes to have the desired pressure fields, or 
the volume of the compliance chamber and the fluid-gas ratio? To provide a 
preliminary answer these questions a numerical strategy was adopted. In this 
chapter the mathematical approach chosen for a mechanical design and 
calculation of the pulse duplicator sizing is described. The decision of study the 
problem from a fluid dynamic point of view starts from the idea that the 
Windkessel models, already developed in literature, are not sufficient physically 
based and use an electric parallelism that sometimes is trivial (Westerhof et al., 
1971).  
The mathematical strategy follows the development of a 1D model with 
concentrate parameters, able to provide pressure waves and flow behaviour for 
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a specific hydraulic system, in which the boundary flow conditions are fixed and 
the solution is computed using an equations integration scheme (Defina, 2010). 
Implementation of the code was performed using MatLab (MathWorks®). The 
discharge of the fluid is considered unsteady and periodic, with a fixed period, 
and the flow in pipes is in pressure, to have a closer condition to the 
physiological one. 
The 1D is clearly a strong simplification of the reality but, at this stage, the 
description of the flow behaviour won’t to be detailed, but provides only a 
global design guidance. To do that the model should not be too complex due to 
mathematical heavy treatise and computational cost.  
 
2.1.1 Unsteady flow in pipes 
The fluid motion for in-pressure conduits is normally studied using the 
monodimensional equations system (Ghetti): 𝜕𝐸𝜕𝑠 =  −𝛽 1𝑔 𝜕𝑣𝜕𝑡 − 𝑗	
	 𝜕(𝜌𝑄)𝜕𝑠 + 𝜕(𝜌𝐴)𝜕𝑡 = 0	
in witch E is the energy for fluid weight unit, j is the dissipation energy for 
length unit along the path s, v is the velocity, Q is the discharge, A the 
transversal area section, 𝜌 the fluid density, g the acceleration gravity, s the 
curvilinear abscissa, 𝛽 the Coriolis coefficient (assumption equal to 1) and t the 
time.  This system contains itself already a hypothesis: inside the E term, the 
effects of the spatial variation of the fluid density are neglected. In the general 
case the variables are: p, v, the density and the area of the transversal section. 
These quantities are general function of space and time. So the system is not 
close and some constitutive equations must to be used. In particular, a 
barotropic motion, that is ρ = ρ(p), and an elastic deformation of pipes, 𝐴 = 𝐴 𝑝 , could be imposed, following an “elastic treatise”. Usually is possible 
to adopt, with good approximation, the fluid density as constant in time and 
space, and also the transverse area section constant in time, adopting an 
“inelastic treatise”. Following the inelastic view the unknown variables become 
the pressure and the velocity (time and space functions), and the up-script 
second equation could be rewrite as: 
 𝜕𝑄𝜕𝑠 =  0 
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2.2 Theoretical Scheme 
2.1.1 1D Geometrical model 
To better understand the adopted theoretical scheme is necessary to define 
a simplified geometrical model that comprises the main physical characteristics 
that have to be reproduced mathematically. Fig.2.1 illustrates a sketch of the 
hydraulic loop. Following the arrows is possible to easy catch the fluid motion 
and the different circuit parts: the pump (P), the ventricular chamber (VC), the 
aortic valve (AV) –through it passes the ejection discharge Qe–, compliance 
chamber (CC), concentrate resistances (R), atrial tank (AC) –that collect and 
released the outflow Qo–, and mitral valve (MV).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.1 Hydraulic circuit plant: P) pump, VC) ventricular chamber, AV) 
aortic valve, CC) compliance chamber, AC) atrial chamber, MV) mitral valve, IN 
&) section of model flow inlet and outlet, respectively. 
 
Using this sketch, and the linearization of the part from CC and OUT, is 
possible to easily set up the adopted mathematical scheme. In particular, 
fig.2.2, concentrates on the behaviour from Qe (ejection flow) and Qo (outflow in 
diastole), reporting the same nomenclature as before. A spatial integration of 
the motion equation between sections 1 and 2, neglecting the inertia and 
dissipative terms in the airt tank and in the atrial chamber, gives: 
 𝐸! −  𝐸! =  −𝛽 𝐿𝑔 𝜕𝑣𝜕𝑡 − 𝑗𝐿 −  ∆𝐸! 
 
where, L is the pipes length between CC and SA, v the fluid velocity, j the 
energy dissipation for each space unit, and ∆𝐸! the generic concentrated 
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dissipation inserted into the system. The jL term depends on the flow 
discharge, following: 𝑗𝐿 =  𝛼𝑣 𝑣  
 
where, 𝛼 normally is a function of the geometry and roughness of the pipe, 
of the viscosity, and velocity. The most common formula adopted in practice to 
expresses the parameter is: 𝛼 =  𝑓𝐿𝑑 12𝑔 
 
with d the tube diameter, where the drop is computed. The energy drops, 
due by concentrated resistance (measured in terms of hydraulic height), are 
normally expressed by: ∆𝐸! = 𝑟 𝑉!2𝑔 
 
where, V is the mean velocity in a reference section and r a parameter that 
is a function of the geometry. 
Take as reference the initial section in fig.2.2, and neglected the kinetic 
load in the air tank: 𝐸! = 𝑧 𝑡 + !(!)!  , with p the pressure inside the air tank and 𝐸! = ℎ(𝑡). In these hypothesis is possible to rewrite the equation as: 
 ℎ 𝑡 −  𝑧 𝑡 + 𝑝(𝑡)𝛾 =  −𝛽 𝐿𝑔 𝜕𝑣𝜕𝑡 − 𝑗𝐿 −  ∆𝐸! 
 
this, has to be associated with the continuity equation at the node between 
the CC and the AC. 𝑄! = 𝑣𝐴 + 𝑣!𝐴!   𝑄! = 𝑣𝐴 + 𝑣!𝐴! 
 
Here, A is the section area of the pipe, Ac the section area of the 
compliance, As the section area of the tank, vc the velocity of the fluid inside the 
air tank, vs the velocity inside the tank, Qe the ejection flow and Qo the outgoing 
flow from the tank (SA). Using vc = dz/dt and vs=dh/dt we have: 
 𝑄! = 𝑣𝐴 + !"!" 𝐴!   𝑄! = 𝑣𝐴 − !!!" 𝐴! 
 
To close the problem another equation is needed. Is possible to include a 
relation that describes the thermodynamic transformation undergo to the gas 
inside the compliance. In general it will be a politropic transformation as: 
 𝑃!∗𝑈!! = 𝑃∗𝑈! 
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where, P* and U are the absolute pressure and the air volume in the 
compliance at a generic instant, instead P0* e U0* are referred to the initial 
instant. K for air varies from 1 to 1.4. Using zm as the highest quota of the 
compliance:  
 (𝑃! + 𝑃!"#)𝐴!(𝑧! − 𝑧!)! = (𝑃 + 𝑃!"#)𝐴!(𝑧! − 𝑧)! 
where, patm is the atmospheric pressure and z0 the initial fluid level inside 
the compliance.  
Known the flow discharge in time (Qe and Qo), the system composed by the 
up-script equations could be solved, giving the pressures and levels of the 
work solution in function of time. It also provides the flow discharge along the 
pipe between the chambers. Before compute the solution of the problem is 
better to add other information and expand the system, including the aortic 
valve behavior. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.2 Linearized scheme with quotes of the system, from the compliance 
chamber to the outlet section after the atrial tank. 
 
 
2.2.2 Transvalvular pressure drop 
The importance of introduce the valve dynamic in the mathematical 
description is relevant, so a model of the pressure drop across the valve was 
developed, using the literature studies (Garcia et al., 2000, Fiore et al., 2002; 
Garcia et al., 2005) and adding some information. To focus the valve behaviour 
is necessary to refer to a simplified geometrical model. In fig.2.3 is illustrated 
the adopted scheme, in which the ventricular chamber is identified as a portion 
of pipe at the left side of the orifice. The aortic valve is designed as a rigid 
circle orifice with a specific geometrical area that can varying in time, and the 
aortic root as rigid straight portion of pipe that connects the valve to the 
compliance chamber. From the fluid dynamic point of view, the valve imposed 
a contraction of the jet, a vena contracta (vc) section located just downstream 
the orifice, where the velocity is highest. After that, the jet reattaches the wall, 
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and the decreased velocity (re)become equal to V1. In the outlet region a 
recirculation flow is present, so a dispersion of energy has to be computed, 
following the rules of submerged jets. In particular, fig.2.3 shows a theoretical 
comportment of the jet from the left ventricle outflow tract (LVOT, section 1), to 
the separation region and vortices formation (vc to 2), and the reattach of the 
jet to the walls. Fig.2.4 illustrates the same behavior for a schematic situation, 
in which is possible to assume the jet profile as linear, and the two angles: αu 
(upstream) and αd (downstream) describe the main jet behavior. 
The presence of the restricted orifice section acts on the flow cinematic 
following the continuity equation: 
 𝜕(𝜌𝑄)𝜕𝑠 + 𝜕(𝜌𝐴)𝜕𝑡 = 0	
Where, r is the fluid density (kg/m3), Q the flow discharge (m3/s), A the 
transversal area of the jet (m2), s the coordinate along the flow (m), and t the 
time (s). In the hypothesis of uncompressible flow and un-deformable pipe the 
equation reduces to: 𝑄 = 𝐶𝑜𝑠𝑡(𝑠) 
 
The velocity and pressure behaviour along the jet path could be obtained 
from the generic equation of the energy balance between section 1 and the 
generic section s: 
 𝐸! − 𝐸! = 𝑝!𝛾 + ℎ! + 𝛼 𝑉!!2𝑔 − 𝑝!𝛾 + ℎ! + 𝛼 𝑉!!2𝑔 = 𝛽𝑔 𝜕𝑉𝜕𝑡!! 𝑑𝑠 + ∆𝐸!→! 
 
Under the condition of a non-stationary flow, and using the hypothesis of 
uniform velocity profiles (a = b = 1), h1 = h2 (because the height difference is 
negligible), and V1 = V2 (because there are not branches in the considered pipe 
portion), the energy drop across the valve corresponds with the transvalvular 
pressure drop. In formula: 
 ∆𝑃𝛾 !"# = 1𝑔 𝜕𝑉𝜕𝑡!! 𝑑𝑠 + ∆𝐸!→! 
 
The accelerated flow from 1 to vc allows to neglect the local energy losses 
phenomena. Instead, from vc to 2 the deceleration causes a vorticity region 
after the valve, so the energy lost from 1 to 2 is equal to the one lost from vc to 
2: ∆𝐸!→! = ∆𝐸!"→! = 𝑝!"−𝑝!𝛾 + 𝑉!"! − 𝑉!!2𝑔 − 1𝑔 𝜕𝑉𝜕𝑡!"! 𝑑𝑠 
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Appling the conservation of momentum along the axis s, at a specific 
volume of fluid (the rectangle 1 to 2), and after easy mathematical passages 
result: 
 ∆𝐸!"→! = (𝑉!" − 𝑉!)!2𝑔  
 
This term can be substitutes in the expression of the pressure drop. With 
the hypothesis of dA/dt ≠ 0 (and a jet geometry of a snub cone), using EAO = 
Vvc (effective orifice area) and A1=A2=A, considering the flow Q not function of 
s (Q = Q(t)), L the total length of the pipe -in particular, using the expression 
derived by Garcia for L = 2π 𝐴! − 𝐸𝑂𝐴 (Garcia et al., 2005)-, is possible to 
obtain the complete expression of the transvalvular pressure drop across the 
valve: ∆𝑝𝛾 !"# = 𝑄!2𝑔𝐸𝑂𝐴! 1 − 𝐸𝑂𝐴𝐴 ! + 1𝑔 𝑑𝑄𝑑𝑡 2π𝐸𝑂𝐴 1 − 𝐸𝑂𝐴𝐴 − 𝑄𝑔 π𝐸𝑂𝐴!.! 1 − 𝐸𝑂𝐴𝐴1 − 𝐸𝑂𝐴𝐴 𝑑𝐸𝑂𝐴𝑑𝑡  
 
where, the first part is called pure dissipative term, the second is linked to 
the temporal flow inertia and the third to the jet inertia. 
Now, there are all the theoretical ingredients to build up the model 
implementing a numerical scheme. Later will be analysed the model results to 
understand if a simplified 1D tool could provide a useful solution for a first 
sizing of the different mock loop parts. 
 
 
 
 
 
  
 
Fig.2.3 Left: sketch of the localised orifice along the conduit plus the 
recirculation regions. The grey box on the right identifies the area in which the 
conservation of momentum is applied. 
 
 
 
 
 
 
 
Fig.2.4 Schematic representation of the linearized jet, with the different 
angles for the cones. 
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2.3 Build up the numerical model 
Following the theoretical description, the model will be divided in two parts 
that are also physically separated: the first goes from the compliance to the 
atrial chamber, the second goes from the ventricular chamber to the air tank. 
This last will be analysed using a reverse strategy, for mathematical reasons 
that will be explain later. 
 
2.3.1 Compliance – Atrial chamber tract	
Referring to fig.2.2, and to the expressions for pressure, velocity, flow 
discharge, and amount of fluid in tanks, these equations could be rewrite using 
an explicit integration method (Defina, 2010). Basically the time and the 
derivate has to be discretized, using incremental steps (t = iΔt, with i = 1, 2, 
3,…n). This strategy gave: 
 𝑣!!! − 𝑣!∆𝑡 = 𝑔𝐿 𝑧 + 𝑝𝛾 − ℎ − 𝑗𝐿 − ∆𝐸! ! 
 𝑧!!! − 𝑧!∆𝑡 = 𝑄!! − 𝑣!𝐴∆𝑐  
 ℎ!!! − ℎ!∆𝑡 = 𝑣!𝐴 − 𝑄!!𝐴!  
 
and, computed zi, is possible to obtain the pressure p from the formula: 
 𝑝 = (𝑃! + 𝑃!"#)(𝑧! − 𝑧!)! 1(𝑧! − 𝑧)! 
 
The system is then completely defined adding the initial conditions for the 
specific problem. The first is the discharge, which in systole passes through the 
initial section in, and in diastole through the final section, out. The flow shape 
derives from Grigioni (Barbaro et al., 1991; AA.VV., 1989), and is a typical 
volume in time curve for a physiologic case (fig.2.5a). The proposed model has 
a linear scheme (fig.2.2), so the flow is pumped at in and extract from out, as 
having two positive physical hydraulic pumps, following the imposed curve in 
fig.2.5b. In particular, the ratio between systole and diastole is fixed (33/100), 
but the entire cycle is variable, as the flow peak.  
The pressure, tanks fluid levels and flow velocity in a quiet condition, were 
chosen as initial conditions for the model. They are: z0 in compliance, p0 in 
compliance, v0 inside the pipe. The scheme needs also the definition of 
geometrical quantities as L and d, length and diameter of the pipes, and zm, the 
tank height. To complete the model the continuous (jL) and concentrate (ΔEc) 
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dissipation parameters has to be computed. The local dissipation is described 
by a tap -R- in fig.2.2 and the mathematical relation (r) was already present in 
the previous paragraph. The iterative scheme tries to describe the obstruction 
via an incremental step definition. The initial condition is the quiet of the fluid, 
so the value of resistance has to be the one that guarantee other initial 
conditions, as for example levels of fluid in the tanks and pressure in 
compliance. The dissipation provide non zero values only if there is a flow 
through the tap, so a first step discharge Qres0 is imposed. At initial instant the 
relation becomes: 
 
𝑟! = 𝑃!𝛾 + 𝑧! − ℎ! 2𝑔𝐴!𝑄!"#!!  
 
where, all quantities have been already described (A is the area of the 
pipe). The flow through the resistance is updated at each step following the 
relation: 
 𝑄!"#!!! = 𝑣!"#$!  𝐴 
 
Where, vmean is the mean velocity in the period, computed using the velocity 
vector at the previous iteration. Using these quantities is possible to update the 
resistance coefficient, keeping constant the pressure drop across the tap. 
 
𝑟!!! = 𝑃!𝛾 + 𝑧! − ℎ! 2𝑔𝐴!𝑄!"#!!! !  
 
To obtain a convergence of the model is fundamental the presence of this 
dissipation coefficient. Indeed, the mathematical model becomes easily 
unstable in dependence of little variations of the parameters. To avoid 
divergence behaviour of the solution is important to introduce this dissipation 
factor, that helps to reach a stable condition after an initial transient phase.    
 
2.3.2 Ventricular chamber – Compliance tract	
The circuit part going from the ventricular chamber to the compliance 
(fig.2.1) could be linearized following the strategy already adopted before 
(fig.2.6). In this case the main fluid dynamic issue is the presence of a 
restriction along the pipe (aortic valve), that changes its behaviour in time. To 
describe the transvalvular pressure drop the non-stationary complete model 
described in 2.2.1 was adopted.  
In particular, given the numerical solution for the pressure trend at the base 
of the air tank (pc), through the integration implemented in 2.3.1, and applying 
the energy balance equation, is possible to obtain the pressure downstream 
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the aortic valve. Following this thought, the pressure upstream the valve is 
achievable using the non-stationary model, obtaining the flow in the outflow 
tract of the ventricular chamber. The idea is to take advantage of the pressure 
computed at a middle point in the circuit, to calculate the numerical solution 
using a different scheme in the two directions. So, backwards from compliance, 
the pressure in aortic root area could be obtained as: 
  𝑝𝐴𝑂𝛾 =  𝑝!𝛾 + ℎ! + 𝛽𝑔 𝜕𝑣𝜕𝑡 𝐿 + 𝑗𝐿 −  𝑄!2𝑔𝐴! 
 
Implementing this formula using a iterative scheme, and imposed a specific 
behaviour for terms Q(t) and EOA(t), the pressure upstream the valve (pLV) is 
immediately available: 
 𝑝𝐿𝑉𝛾 =  𝑝𝐴𝑂𝛾 + ∆𝑝𝛾 !"# 
  
 
 
 
 
 
 
 
 
 
 
 
Fig.2.5 a) Typical physiological flow in the left ventricle, b) Adopted Qe 
(blue) and Qo (red) in the mathematical model. 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.6 Linearized part from the ventricular chamber to the compliance 
chamber. 
a b 
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2.4 Preliminary sizing of the pulse duplicator 
This paragraph describes a sensitivity analysis performed using the 1D 
numerical model. The idea is to take advantage on the different output 
obtaining with different geometric input configurations, and decide which is 
better for a physic realization and implementation of the workbench. The best 
configuration is the one that provides the closer solution, in terms of pressure 
and flow, with respect to a physiological behaviour. 
 
2.4.1 Compliance and atrial chamber design	
The compliance chamber was designed as a rectangular air tank (fig.2.7), 
and the geometric variations imposed on it in the different tests are:  
 
Test  (a) (b) (c) 
Side base: b [cm] 20 20 20 
Compliance height: a [cm] 35 45 25 
Initial level: z0 [cm] 32.8 42.8 22.8 
Air pressure: p0 [mmHg] 75 68 82.5 
 
Table	2.1:	Geometric	variation	for	compliance	chamber.	
 
Here the idea is to maintain constant the air volume inside the tank. The air 
pressure is determined using a energy relation, suffered by the current flowing 
through the resistance 𝑝! = 𝛾∆𝑝!"# −  𝛾𝑧! + 𝛾ℎ! 
 
where, ∆𝑝!"# is the pressure drop across the tap, keep constant during the 
cycles. So, greater is the level of fluid in the compliance, lesser has to be the 
gas pressure in the initial condition. As is shown in fig.2.8a, the geometry 
variation has no effect on the pressure registered inside the tank, instead of a 
variation on the air volume entrapped inside the compliance (fig.2.8b). The 
values of the showed behavior were obtained for little variation of the gas 
volume (with a fixed geometry): 
 
Test  (a) (b) (c) 
Side base: b [cm] 20 20 20 
Compliance height: a [cm] 35 35 35 
Initial level: z0 [cm] 32.8 31 33.5 
Air pressure: p0 [mmHg] 75 76.3 74.4 
 
Table	2.2:	Pressure	variation	for	compliance	chamber	using	a	specific	geometric	configuration	(b).	
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Fig.2.8b shows a higher impulsive output, generated when the system 
come closer to a rigid configuration (i.e. the volume inside the compliance is 
smaller). Instead, more elastic solution is provided when a higher volume is 
available, and also the pressure range is reduced.  
 
Fig.2.7 Example of the typical engineer drawing with references, in 
particular related to compliance chamber.  
 
 
 
 
 
 
 
 
 
 
 
Fig.2.8 a) Compliance fluid pressure curves for a geometric configuration 
(see Table 2.1) and b) compliance fluid pressure curves in variation of the gas 
pressure (following Table 2.2). 
 
The different geometric quantities described were changed since the 
achievement of a comfortable set up of the model. The related optimal 
parameters are here reported, and adopted as first sizing for the pulse 
duplicator realization. 
Optimal geometric parameters: 
o Lao = 0.5 m (length of the pipe before the compliance) 
o Dao = 0.03 m (diameter of the pipe) 
o dc = 0.2 m (base side of the square compliance) 
o z0 = 0.328 m (liquid level in the compliance at time = 0 s) 
o ds = 0.4 m (base side of the square atrial chamber) 
o h0 = 0.086 m (liquid level, from the reference) 
o L = 1 m (conduit from compliance to atrial chamber) 
o dL = 0.03 m (diameter of L) 
 
 
Section	Map	
a b 
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In the initial step of the linear pump displacement, the conditions are:  
o z = z0  
o v = 0 m/s  
o p0 = 75 mmHg  
 
The boundary values are related to flow discharge values:  
o Qp = 65*10-6 m3/s (mean stroke volume) 
o Qres0 = max(Qe)/3  
o T = 0.8 s 
 
The flow shape was already showed in fig.2.5. Other references are: g = 
9810 N/m3, patm = 101325 Pa, f = 0.026 (resistance function for the continuous 
losses from Moody diagram), g = 9.81 m/s2. The pressure curves and velocity 
trend remain close in terms of shape with the presented above. 
As last observation, the concentrate resistance coefficient trend is reported, 
in fig.2.9. Could be interesting to observe how the system, after an initial 
phase, become stable and the value of the resistance converge after n≈50 
cycles. This information provides an idea of the system inertia because, also in 
a realistic case, using this settings a stable solution will probably reached after 
an adequate number of iterations, and not instantaneously. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.9 Behaviour of the resistance coefficient r along the cycles. 
 
 
2.4.2 Pressure upstream and downstream the valve	
The analysis in this case considers the variation of the length and diameter 
of the aortic tract. These are the distance between the aortic valve and the 
compliance, and the diameter of the pipe. As shows in fig.2.10, fixed the 
diameter of the conduit, the extension of the tract determines an increase in the 
pressure peaks, both positive and negative. Instead, keeping constant the 
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length, a bigger diameter has an opposite effect on the pressure behaviour. 
These possibilities are illustrated in fig.2.10a-b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.10 Compliance and aortic pressure curves for different pipe lengths 
and pipe diameter of 30 mm (a) and 35 mm (b). 
 
Computed the pressure downstream the valve, the upstream behaviour is 
obtained via integration scheme. Here the transvalvular pressure drop model 
plays an important role, with the diameter of the orifice and the value of the jet 
area in time. The maximum value of the jet area was computed using a typical 
fluid dynamic approach (Ghetti), in which different contraction coefficient (Cc) 
are adopted to determine the area of a jet passing through a rigid orifice. For 
example using a orifice diameter of 27 mm the Cc is 0.861, where 1 is the 
whole jet (vcarea = GOA·Cc). Using the obtained area as the maximum EOA 
achievable, a specific shape of EOA(t) was developed, following literature 
observation (Arsenault et al., 1998; Handke et al., 2003) (fig.2.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.11 EOA(t) along the entire cardiac cycle computed using a 27 mm 
aortic valve. 
a b
a
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Now there are all the ingredients (pAO, Q(t), EOA(t)) to compute the 
pressure upstream the aortic valve. Fig.2.12 illustrates the variation 
experienced by pLV for a variation of the valve diameter. As expected, a smaller 
valve introduces a higher dispersion of energy in the flow, and a bigger 
pressure drop.  
All these information are provided for the positive part of the flow discharge, 
for the ejection phase. When the valve close the ventricular pressure goes 
directly to the initial value around zero, and the aortic pressure become close 
to pressure inside the compliance chamber.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.11 Detailed pLV for different aortic valve sizes. 
 
2.4.3 Introduction of the closing volume	
A perfect and instantaneously closure of the aortic valve was an adopted 
condition, until now. In the reality, the last part of the ejection phase expresses 
a backward volume, due to the physical and geometric characteristics of the 
aortic valve and root. We tried to simulate this closing volume using in-vitro test 
data and extracting typical values for the closing period and for the maximum 
peak of backward flow. The adopted values were: 4% of T (T = total cycle) for 
the duration of the phenomena and 10% of Qmax for the maximum negative 
flow peak (fig.2.13).  
The parameters kept as optimal for this tract were:  
o L3 = 1.3 m (distance between valve and compliance) 
o d3 = 0.03 m (pipe diameter in L3) 
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o dv = 0.027 m (aortic valve diameter) 
 
In these conditions fig.2.14 illustrates the impact of this new flow shape on 
the pressure trends (pAO and pLV). Seems that now the behaviour of the 
pressure is closer to the physiological one especially near the closure, where 
the dicrotic notch is observed. This characteristic pressure recovery 
comportment is probably due to the obstacle encountered by the backflow in 
pass the semi-closed valve. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.13 Example of the implemented discharge curve with backflow.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.14 Pressure behaviour for aortic, ventricular and compliance districts, 
with the adoption of a backflow in the discharge curve. 
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2.5 Study abstract 
In this chapter the adopted mathematical model for a first sizing of the 
pulse duplicator was described. A new 1D strategy, in the cardiovascular fluid 
dynamic scenario, was developed to study the pressure and velocity behaviour 
inside a hydraulic circuit that simulates a Sheffield mock loop. A first 
characterization of the fluid dynamic equations for the different parts was 
described, and a translation into an iterative scheme was performed. 
In particular, the circuit was divided in two segments starting from the inflow 
section of the compliance chamber. One develops downstream, since the 
outflow section of the atrial chamber, and one upstream to the ventricular 
chamber passing through the aortic valve. For both these schemes, the 
velocity, pressure trends and liquid levels were computed. A comparative 
criterion was adopted to find the optimal parameters and a sensitivity analysis 
was performed varying the geometric characteristics of the model and the initial 
conditions of the flow, the pressure and the liquid levels (around physiological 
conditions).   
In general, both for the part downstream and upstream the compliance 
chamber, the mathematical model was able to provide interesting and useful 
results that could help to better understand different phenomena of this 
particular kind of hydraulic circuit, that works in a cyclic non-stationary flow 
conditions. 
The performance provided by the mathematical model allows also a first 
sizing of the main geometric parts of the pulse duplicator, that will used as a 
“base” for the consecutive physical development of the workbench. 
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Chapter 3 
HeR Lab Pulse Duplicator 
 
 
3.1 First step for the HeR Lab 
The PhD project has been based on the development of a mock loop 
device, from the first idea to the final implementation. This means not only 
design and project drawing but also the research of all the different 
components, correctly sized in function of their aim. The pulse duplicator is the 
first experimental tool implemented in the Healing Research Laboratory for 
Cardiovascular Studies (HeR Lab).  
The chapter organization includes: a brief overview of the literature about 
pulse duplicator examples, then move to the HeR mock loop hardware parts, in 
which are described in detail all the adopted solution on the physical realization 
of the workbench. Here it is also insert a session with the incoming updates. 
The third part deals extensively on the software programs, developed ad hoc 
for the piston fluid handling, data acquisition, and post processing. Instead, the 
next chapter will be a first comparison in terms of global performances between 
HeR device, ViVitro Superpump and typical physiologic pressure and flow 
curves.  
 
3.1.1 Brief literature overview and state of art 
Seems important to recall the literature works that helped to guide the 
development of the workbench. Some were already cited in Chapter 1, are 
here reported the most influent for precision. In particular, the Sheffield pulse 
duplicator (AA.VV., 1989) is the adopted “base” for the HeR mock loop 
development. A detailed description of hydrodynamic measures performed with 
this workbench was given by Barbaro (Barbaro et al., 1991). Before, other 
interesting systems were developed, in particular Scotten and Reul derived the 
first functional examples of hydraulic circuit to test prosthetic devices in a non-
stationary flow conditions (Scotten et al., 1979; Reul et al., 1974). 
Innovative solutions in terms of hardware and software components were 
introduced by ViVitro, and Grigioni (Grigioni et al., 2003) performed several in 
vitro tests, enhancing the important benefits of some technical solutions. In this 
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sense the state of the art is represent by the ViVitro Superpump with 
viscoelastic impedance and other design solutions (double comlpiance), that 
allows great flexibility of measure but with high costs (about 120.000 Euro). 
The last literature works concentrates the attention on various issues: 
Hildebrand and Schleicher focused on bioreactor design (Hildebrand et al., 
2003; Schleicher et al., 2010), Mouret and Tannè –Piebarot’s research group– 
developed an atrio-ventricular system similar to the ViVitro (Mouret et al., 2000; 
Tannè et al., 2010), Timms –Fraser’s research group–, Reddy and Yokoyama 
designed pulse duplicators able to test different kind of prosthetic 
cardiovascular devices (Timms et al., 2010; Reddy et al., 2010; Bazan et al., 
2011; Yokoyama et al., 2010). A vertical mock loop was also developed to 
perform studies on the aortic district via an integrated approach (Toninato: 
http://tesi.cab.unipd.it/39527/; Querzoli et al., 2014; Fortini et al., 2015).  
The here presented pulse duplicator falls into the category of systemic 
circulation simulation devices, with horizontal extension, as the Sheffield mock 
loop. It catches some solutions from the ViVitro, especially for the aortic 
section. But it also includes new solutions as the possibility to introduce a 
physiologic replica of the entire aortic root and arch. A constant attention has 
been placed on the realization of the system in according to the requirements 
requested by ISO5840:2009 and FDA guidance (ISO 5840, last update in 
2009, and FDA Draft Guidance for Industry and FDA Staff Heart Valves – 
Investigational Device Exemption (IDE) and Premarket Approval (PMA) 
Applications, last update in 2010). Of course, also the derived mathematical 
model described in Chapter 2 helped to better understand which parameters in 
the hydraulic circuit play important roles in the achievement of physiological 
curves, providing a first sizing of the parts. For example, thickness of 
ventricular chamber walls, and its dimension; best diameter and length of the 
tubes upstream and downstream the aortic valve, thickness of compliance 
chamber wall in relation to highest probably pressures, level of tap closure to 
ensure a correct medium aortic pressure, and extension of calm tank to 
interrupt the pulsatile of the flow.   
 
3.1.2 A pulse duplicator view 
The next disclosed system is a result of a step improvement strategy that 
had characterized the project along the three years. Intermediate 
configurations are reported in Di Micco and Bellio MS thesis (Di Micco: 
http://tesi.cab.unipd.it/46857/, Bellio: http://tesi.cab.unipd.it/47983/). Only the 
actual experimental configuration, that produces the best results in terms of 
hydrodynamic performances -in comparison with physiology curves and 
literature results- is here reported, to avoid confusion.  
Fig.3.1 illustrates a bird’s eye intuitive functional scheme of the workbench. 
The arrows describe the fluid direction, and the different parts are labelled to 
easily understand the subsystems functions. The work solution is handled by 
an electromagnetic linear motor, controlled via software by the operator. 
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Control and condition units provide the signals management to the system, 
also from the pulse duplicator sensors. The imposed position curve is 
transferred to the fluid via a metallic bellow, that pumps the fluid in both 
directions. An in-pressure ventricular chamber supplies the fluid in ejection and 
diastole, and it is connect with the aortic valve –passing through a flowmeter 
probe- and with the mitral district on the other side. The aortic district is 
characterised by a flowmeter chamber, a valve housing, the aortic compliance 
chamber and the aortic root. All these components are located inside the aortic 
chamber, that contains several pressure sensors. Following the scheme, the 
fluid flows through the compliance chamber, the systemic resistance and 
emerges into the atrial tank. After the calm tank, a pipe connects to the 
ventricular chamber via the atrial valve, closing the circuit. 
The whole described apparatus is illustrated in fig.3.2 and fig.3.3 with a 
lateral and bird’s eye view. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.1 Functional scheme of the pulse duplicator. 
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Fig.3.2 Her pulse duplicator lateral view: a) electromagnetic motor, b) 
ventricle chamber, c) aortic chamber, d) aortic compliance, e) heater, f) 
systemic compliance, g) atrial tank, h) resistance and mitral valve. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.3 Pulse duplicator bird’s eye view: a) electromagnetic motor, b) 
ventricle chamber, c) aortic chamber, d) aortic compliance, e) heater, f) 
systemic compliance, g) atrial tank, h) resistance and mitral valve. 
 
3.2 Mechanical parts 
3.2.1 Electromagnetic linear motor and bellow 
The linear motor moves the fluid solution using a metallic bellow. The 
whole system works as a double direction pump, reproducing the left heart 
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contractile function. This device was chosen for the constructive 
characteristics: high thermic efficiency under load conditions, absence of 
gearwheels or parts subjected to wear and tear, ability to provide a constant 
force to the fluid inside a wide range of velocities.  
The chosen electromagnetic engine is a Parker PRA3810S, illustrated in 
fig.3.4, and the current position is given by a variable tension imposed to the 
stator via software. The motor stator is fixed to an aluminium and Teflon frame, 
to avoid high vibrations and to reach the correct height of the movement axis. 
An engineer drawing is reported in fig.3.5, where the principal dimensions are 
showed. The main part is connected to the control unit via flexible cables, one 
for the energy supply and another for the position data transfer. A variable 
tension is transferred to the metallic bar that moves in both directions with a 
variable controllable velocity. Values of voltage, motion curve, and period of the 
cycle are imposed via software by the operator using a graphic interface. A 
LVDT sensor constantly monitors the current position. The PRA3810S 
provides, in absence of load and in environment temperature of 25°C, a peak 
force of 1860 N for 1 s, an absorbed current peak of 14.1 A for 1 s, a maximum 
velocity of 2.6 m/s. To hold the actuator in a fixed position 1.94 A are 
requested. For our porpoises, a continuous work condition is requested and the 
expressed force of 200 N for an operating velocity of 2 – 2.5 m/s is enough. In 
fig.3.6 the force against velocity curves are illustrated. 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.4 Detail of the Parker linear electromagnetic motor, where are visible 
the supply and control cables and the end stroke relays. 
 
A metallic movable flange connects the linear motor to the bellow (a beam 
with ball bearing connection preserve from wear), and a second -frame fixed- 
flange joints the bellow with the ventricular chamber (fig.3.7). The bellows 
expresses an internal diameter of 65.0 mm, external diameter of 90.0 mm, 
length in compression of 16.5 mm and 66.5 mm in extension. So, the useful 
stroke is about 50 mm, that corresponds to a movable fluid volume for beat of 
200 ml. Comvat Inc produces this component and an engineer drawing is 
visible in fig.3.8. 
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In couple with the LVDT sensor, for the metallic bean position monitoring, 
three microswitch relays were installed. These Cherry D45X have the task to 
control the two stroke limits and the zero position, allowing a constant signal 
reference that can be handle by the operator. The two limits are installed for 
security and, if the bar surpasses them, the motor is instantaneously stopped. 
The zero-position relay ensures a precise and reliable initial condition for 
different tests. In fig.3.9 the adopted relays configuration is showed. 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.5 Engineer drawing of the adopted motor, from the company data 
sheet. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.6 Parker PRA3810s force/velocity specifications. 
 
 
 
 
 
 
 
 
 
Fig.3.7 Linear motor and bellow connection. On the left side is easy to see 
the rail for the ball bearing and the bean connected to the bellow. 
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Fig.3.8 Engineer drawing of the bellow, from the company technical sheet. 
 
 
 
 
 
 
 
Fig.3.9 Detail of the end-stroke switches. 
 
A global vision of the linear motor, bellow, and relays system is provided in 
fig.3.10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.10 Detail of the 0-position and emergency switches, with the OK 
status led. 
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3.2.2 Control unit 
To governor the motor via remote software, the control unit LT0510 
developed by LabTrek S.r.l., represents a fundamental element for the pulse 
duplicator efficiency (3.11). Looking at the front panel, is possible to monitoring 
the correct status of the communication between the driver and the pc, via 
some red leds (power On, status Ok, Position Mode, Error, etc.). The outputs 
are cables for the motor control, for the relays monitoring, and a bus 
connection to the master-pc. 
This board manages the different signals to and from the engine, and 
guarantees a correct translation of the commands via the servo-drive system 
developed by Parker. Three principal parts characterised the control unit: the 
power supply circuit (that ensures a correct energy to all different parts), the on 
board pc and the linear motor drive (fig.3.11). The Parker SLVDN5N is a 
digital-analogue converter that provides the correct strings to the motor 
(converts a data in a specific voltage). The communication is ruled by the on 
board pc Rabbit BL2120, that received commands from LabView and traduces 
them, based on a Dynamic C language installed in a programmable flash 
memory.  
 
3.2.3 Conditioning unit 
The sensor-conditioning unit LS0609, developed by LabTrek S.r.l., is a 
device that acquires, amplifies and filters the signals coming from the sensors 
along the hydraulic circuit and adapt them for the pc elaboration (fig.3.12). The 
hardware module is composed by a supply voltage unit for the different 
integrated-circuits, and by a filtering and amplifying board (fig.3.12). The front 
panel provides information via led about the correct power supplying of the 
different circuits. The inputs are 11, divided in amplified (In0 to In5) and general 
purpose (In6 to In10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.11 Control unit box, and inside parts (left up and bottom). On the 
right: detail of the SLVD drive of the linear motor. 
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Fig.3.12 Signals conditioning unit, box and inside circuits for filtering and 
amplification. 
 
3.2.4 Ventricular chamber 
Directly connected to the bellow takes place the ventricular chamber, 
showed in fig.3.13. Represents the node of the circuit, and has two entrance 
holes, one for the bellow and one for the incoming mitral flow, and one output, 
to the aortic chamber. The chamber is made with Plexiglas panels, the base is 
a square of 0.23 m, the height is 0.23 m and the wall thickness is 15 mm. M3 
metallic screws guarantee the parts join and the cover watertight seal is 
ensured by specific silicon material. Panels engineer drawings are illustrate in 
fig.3.14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.13 Ventricular chamber from a side view.  
 
The three chamber connections are illustrated in fig.3.15-16. The bellow is 
linked via a Teflon disk (3 cm thick, 65 mm diameter) to the ventricular 
chamber, using two aluminium multi screwed flange disks and a double 
silicone O-ring to ensure the seal. PVC double T-shape part, with an internal 
variable diameter, connects the ventricular to the aortic chamber. The output 
internal diameter is 25.4 mm, for a best adaption of the flowmeter module. Two 
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pierced PVC flanges with pass through aluminium screws and silicone O-rings 
guarantee the seal. The third connection is with the mitral part, that contains 
the mitral valve: a mechanical bileaflet Sorin Allcarbon (27 mm annulus 
diameter). The mitral valve guarantees a flow to the ventricular chamber in 
diastole and a complete seal in systole. It is housed in a removable Teflon 
structure (140 mm length, 70 mm width) with a variable internal diameter (to 
house different valve sizes), made by two pieces: one internal and one external 
to the chamber, that screw one on each other ensuring a perfect watertight 
stop (fig.3.16). 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig.3.14 Engineer drawing of the ventricular chamber. In a clockwise 
orientation: chamber side to the aortic part, side from the bellow, side from the 
mitral valve, and the three last sides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.15 In clockwise orientation: connection from the ventricle chamber to 
the aortic chamber, from bellow to ventricle chamber and the three connection 
from a top and side view. 
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Fig.3.16 Detail of the mitral connection, picture and technical scheme. 
 
3.2.5 Aortic chamber 
The aortic chamber includes the most interesting and innovative parts of 
the system. It contains a small box for the flow meter sensor, a straight part 
with several pressure taps, in which the aortic valve housing and the prosthetic 
valve are placed, a dedicated compliance chamber, and in the next future a 
deformable silicone physiologic aortic arch, with the ascending arch derivations 
(fig.3.17). All these parts are housed in a rectangular 1.10 x 0.7 x 0.36 m (b x b 
x h) Plexiglas box, with wall thickness of 15 mm. 
In a operative condition the tank will be filled with fluid to replicate a correct 
transmural pressure on the aortic arch walls. A Transonic System Inc. 
ultrasonic probe model ME19PXN is positioned inside a sealed box. A shielded 
cable connects it to the control module TS410, and the signal is transferred to 
the conditioning unit. The module was programmed to work with temperature of 
20±3°C or 37±3°C. Figure 3.18 contains the flowmeter module, the probe and 
the relevant datasheet information. 
The aortic valve housing was obtained from a Plexiglas straight tube with 
internal diameter of 30 mm. The housing engineer drawing and a picture of 
used valve (OnX mechanical valve) are illustrated in fig.3.19. Valve exchange 
structure is simple and based on a double rings system (metallic and teflon) 
with multiple screws (M2.5, nylon) that acts as a sandwich, immobilizing the 
valve. This connection provides a valve housing range from 19 to 27 mm (at 
the annulus, with different adaptors). Upstream and downstream the valve are 
located several pressure taps, to allocate sensors, and measure the 
transvalvular pressure drop. The adopted transducer are PCB Piezotronics 
series 1500, with pre-amplification, double shielded cable and compensated in 
temperature. Thanks to the high sensibility (9.67 mV/mmHg), range (-20 to 500 
mmHg) and acquisition frequency (>1000 Hz), is possible to measure and see 
in live-view (via LabView software) multiple high resolution pressure curves. A 
cable connects each sensor to the conditioning unit. An engineer drawing, and 
a picture of the piezometer are reported in fig.3.20. 
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Passed the aortic valve, a T-derivation is inserted. In one direction the fluid 
flow to the aortic arch and in the other goes to the aortic compliance. That is a 
mono-directional solution that provides the correct amount of compliance at the 
aortic arch tract (that is -now- rigid). The chamber is the one that was identified 
in Chapter 2 as compliance chamber (CC), in the numerical model. The aortic 
compliance is made with a cylinder Plexiglas structure with a single in-outflow 
way at its base. Two ABS plates with O-rings guarantee the seal, and a 
pressure taps and a valve on the cover provide the adjustment and the 
monitoring of the internal gas pressure (overview of the device in fig.3.21). The 
sizing of the chamber was done following the specification given by FDA 
guidelines. In particular, the tract to make compliant was L* = 350 mm (about 
the length of the aortic arch), the choice was to reproduce a “high compliant 
chamber”. As initial conditions were used: Dc = 140 mm (compliance chamber 
diameter), Paomin = 60 mmHg, Paomax = 150 mmHg (min and max pressure 
range to reach). Using the formulas given by guidance, the final design gave a 
dh = 24.4 mm, and an exchange volume of 364 ml. The relative dimensions 
that has been implemented in the realized compliance are H = 210 mm, D = 
140 mm. After the aortic compliance, the aortic arch is inserted. In this thesis 
was not possible to include data of the fluid-dynamic performances with the 
new silicone arch, for process schedule reasons. Actually, a non-permanent 
plastic tube (30 mm inner diameter) is placed instead of it. At the end of this 
session a paragraph is dedicated to a deep description of the silicone 
physiological aortic arch design and development is provided. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.17 Global vision of aortic chamber: a) flowmeter box, b) valve 
housing, c) aortic arch, d) aortic compliance, e) pressure sensor.		
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Fig.3.18 Flowmeter unit, probe, positioning and technical data sheet. 
 
 
 
 
 
 
 
 
 
Fig.3.19 OnX bileafleat mechanical aortic prosthetic valve, valve housing 
scheme and picture (with this system, also bioprosthetic valves has been 
tested). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.20 Pressure sensor picture, positioning, technical scheme, and 
performance data.  
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3.2.6 Additional compliance chamber 
An additional compliance was inserted after the arch, outside of aortic 
chamber, just before the systemic resistance. This chamber provides two 
tasks: adding an elastic component if necessary, partitionable using a tap, and 
gives a pressure reference in a static condition, been positioned 50 cm high 
from the bench. 
Compliance sizing was performed following the FDA specification. The 
maximum compliant tract to simulate was L* = 500 mm (about the length of the 
descending aorta plus major derivation), the choice was to reproduce a “mid 
compliant chamber”. As initial conditions were used: Dc = 120 mm (compliance 
chamber diameter), Pcmin = 50 mmHg, Pcmax = 120 mmHg. Using the formulas 
given by guidance, the final design gave a max fluid increment in the chamber 
of dh = 9.8 mm, and an exchange volume of 110 ml. The realized compliance 
expresses dimensions H2 = 210 mm, D2 = 120 mm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.21 Aortic compliance chamber   Fig.3.22 Additional systemic 
compliance 
 
3.2.7 Concentrated resistances 
At the outflow tract of the compliance chamber a taps is inserted. It 
provides a fundamental pressure drop that helps to obtain the desired aortic 
pressure trend, in the cardiac cycle. The adjustment made by the operator has 
to be very fine, for this porpoise the chosen taps are BOA-control SAR 
regulation valve with smooth seal, developed by KSB (fig.3.23). These metallic 
devices provide an incremental number, from 0 to 48 that expresses the 
degree of aperture of the gate.  
Another tap with the same characteristics is inserted just upstream of the 
mitral section. In this case a current flows through the tap only in diastole 
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(moving back of the motor). An overview picture of them is observable in 
fig.3.24. 
  
 
 
 
 
 
 
 
 
 
 
 
Fig.3.23 KSB multi-rotations BOA-control SAR valve. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.24 Systemic resistances overview. 
 
3.2.8 Fluid heater 
After the resistance, a rectangular PVC isolated box is inserted (fig.3.22-
3.24). Inside of it, a metallic heater with an electronic control circuit is placed. 
The metallic tube acts as a resistance and heat up the working fluid, thanks to 
a high current across two poles positioned at its extremes. A switch, connected 
to a thermostat and a temperature sensor, creates a closed loop that permit a 
good control of the temperature of the work solution. The electric circuit is also 
composed by a diode that allows a splitting of the power. Two control steps are 
provided: 1 KW or 2 KW, to regulate the time of heating up. The electronic 
scheme of the developed circuit is showed in fig.3.25, right. The device is 
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independent from the other electronic part of the pulse duplicator and uses a 
220 V energy plug supply.  
 
 
 
 
 
 
 
 
 
 
 
Fig.3.25 Fluid heater electronic scheme. 
 
The presence of this device is important to carry the temperature up to 37 
°C, that is the physiological blood temperature, and a typical request made by 
the international regulations. Hysteresis and performance tests on temperature 
in different sections of the pulse duplicator were performed, a difference of 2-3 
°C on the far parts was obtained, with a total time to rise the temperature from 
19 to 37 °C of 90 mins. 
 
3.2.9 Atrial chamber 
The last circuit component is the atrial chamber, that is a calm tank, in 
which the fluid oscillatory behaviour is softened. This mechanism is guaranteed 
by the wide horizontal size of the tank, that is a square Plexiglas box of 0.4 x 
0.4 x 0.36 mm (b x b x h), with a wall thickness about 15 mm. It presents two 
holes for inflow and outflow, positioned on the same side, at identical height of 
all the other conduits in the circuit (about 10 cm from zero reference). A 
constant fluid level is present in the chamber, to mimic the systemic distal 
pressure reference, of about 6-7 mmHg. Picture and engineer drawing of the 
atrial chamber and are showed in fig.3.26. 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.26 Atrial chamber picture and its technical drawing. 
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3.2.10 A new component: the deformable arch 
The real innovation of the pulse duplicator developed inside the HeR Lab is 
the possibility of test several different aortic prosthetic devices, in a 
physiological replica of the anatomic district. This is possible by making 
different customized parts, and measuring the fluid dynamic performances -
global and local parameters of the flow- via advanced experimental tools. Of 
course, a reproducible moulding technique was developed, so is possible to 
adapt it in relation of the research. 
The technique that permits the creation of the final silicone product, in the 
specific case of the aortic arch is explained. It is opinion of the author that this 
procedure, that given very good results, could be generalized for different kind 
of anatomic vessel parts.  
 
CT scan images and aorta segmentation 
CT scan images of an average adult healthy patient were used to extract 
the aortic arch. An adequate number of slices n = 1000 (for a spatial resolution 
of 0.2 mm) allows the fine reconstruction of the ascending part of the aorta, 
from the aortic root, since the abdominal bifurcation. The DICOM files 
segmentation was performed using OsiriX and a single layer geometry 
definition file format was exported (wavefront .obj file). An example of these 
passages is illustrated in fig.3.27. 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.27 Osirix segmentation process: isolation of the region of interest via 
tissue thresholding and cutting tool, obtainment of a single layer healthy aortic 
arch, and a single layer –still not exported- of a aneurysmatic arch. 
 
Creation of a mesh model  
Rhinoceros and Geomegic software were used to modify and refine the 
arch geometry, to create a mesh and a surface model with specific 
characteristics. In particular, inflow and outflow customized conduits were 
inserted to perform a good adaptation on the workbench. A local remeshing of 
high curvature regions was performed and a specific smoothness of the 
surfaces was performed, obtaining a m = 20.000 rectangles mesh file (with 
vessel thickness of 0.1 mm), and a multi-surface file. To fit on a fast prototyping 
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machine, the aortic arch has been reduced to a height of 0.28 mm (the width 
was left univariate). A third stereolithographic file with all the dimensions 
increased by a specific factor, to obtain a shell of the native of 2.5 mm, was 
product. The final files are showed in fig.3.28. 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.28 Geomagic healthy aortic arch mesh file, aneurysmatic mesh aortic 
root and healthy aortic root with inflow and outflow tract for pulse duplicator 
connection. 
 
Monoaxial tests on pig’s aorta 
At the same time, axial stress-strain tests on fresh pig’s aorta tissue were 
performed. No chemical components were added at the samples, and only the 
deepest tonaca layer of the vessel was cut off to obtain the two pure 
connective – muscular layers. In particular, 7 tests were performed using a 
Bose ElectroForce® Planar Biaxial TestBench Test Instrument (fig.3.29).  
The experimental set-up was: 
o 7 tests, 3 on axial direction traction, 4 on radial direction traction 
o v = 0.5 mm/s (constant velocity of deformation)  
o T = 2 s (maximum test traction time) 
Characteristics of the samples:  
o Li = 5 mm (undeformed width) 
o w = 5 mm (width) 
o h = 2.5±0.09 mm (thickness) 
 
Observing the obtained σ−ε curves (fig.3.30), the first observation is that 
the medium elastic modulus of axial and radial orientation is quite similar. 
Typical hyperelastic behaviour is expressed by both curves, with maximum 
deformations of about 160%.  
 
Silicone choice 
The rubber that we need has to respect some restrictions: has to be 
transparent (to allow marker tracking tests and particle image velocimetry 
induction -see Chapter 8-), with the same elastic modulus and shore of the 
aortic tissue, fusion temperature has to be higher than the ABS softening 
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threshold. A low viscosity is needed for the molding process, and no 
interference with acetone, Teflon spray, and detach wax spray are 
fundamental. Now all the information to match the silicone material for the 
aortic arch are provided. Prochima Inc. C-Rubber is a commercial product that 
respects most of these characteristics. At this time are in developing accurate 
mechanical tests on silicone samples made with different thickness. This bi-
component liquid silicone was chosen as the material for the aortic arch 
replica, and expresses: 
o S = 30 (Shore, in points after 6 hours of reticulation, with sample 
depth h=6 mm) 
o D = 1.5 MPa (damage limit, h=2 mm) 
o σmax=200% (elongation limit, h=2 mm) 
o L = 5 KN/m (limit before laceration, h=2 mm) 
o rl < 0.1% (linear shrink after 7 days at 23°C) 
o t > 160°C (thermic seal) 
To make the silicone a ratio of 1:10 for the catalyser has to be used. The 
reaction starts immediately and in an environment temperature (about 23°C) it 
takes 24 h. If posed in freezer (2-4 °C) the reticulation stopped. 
 
 
 
 
 
 
 
 
 
 
Fig.3.29 Bose ElectroForce® Planar Biaxial Test Bench, mono-axial test 
image and pig’s aorta sample example. 
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Fig.3.30 Longitudinal (above) and radial (below) graph for a mono-axial 
stress-strain test on aorta pig’s tissue. 
 
Surfaces separation tests 
For the obtainment of a perfect separation between the silicone rubber and 
ABS samples, several products were tested beforehand. The surface 
treatments were compared via electronic microscopy induction. In fig.3.31 are 
showed different tests: polished ABS, polished ABS with Teflon spray, polished 
ABS with wax spray, and polished ABS with acrylic varnish spray. The 
differences are evident: the last solution provides a uniform thin layer of 
product that acts as a separator between silicone and the plate. This solution, 
with an additional layer of wax spray, permits an easy detach without damaging 
after 24 h of contact between the ABS and a thick layer of silicone. The silicone 
was not contaminated by wax and no remains on the surface were founded.  
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Fig.3.31 polished ABS, polished ABS with teflon spray, polished ABS with 
wax spray, and polished ABS with acrylic varnish spray. 
 
External and internal ABS moulds and final product 
The adopted procedure to create the final prototype is a casting on multiple 
moulds. First, with the Geomagic surface file of the artic arch (+2.5 mm uniform 
shell compared to the patient aorta), a female ABS mold was designed with 
SolidWorks software and realized with fast prototyping technique. This part 
acts as a “sarcophagus” of the real aorta. This mould has been designed in 4 
different parts to follow the double curvature of the arch, and to help the 
opening phase (fig.3.32). In fig.3.32 is also possible to see some chimneys 
used to cast the silicone, or to allow the exit of entrapped air. 
A second plate was made from the physiological .stl aorta file, via fast 
prototype technique, with an internal wall thickness of 0.1 mm, in ABS 
(fig.3.33). This is then polished, smoothed and sprayed with acrylic paint and 
wax spray. After, it is posed inside the first mould (sprayed with detach wax), 
and fixed following specific adaptors. The external 4 parts are then closed with 
screws, the junctions were sealed with Motorsil red paste, and sprayed with 
sealing silicone (fig.3.34). 
The liquid silicone was then prepared adding the components and casted, 
filling the gap between the internal thin ABS aorta and the external full ABS 
plate. Completed the fill up, all the structure was put in freezer for 24 h, to help 
a complete degasification of the entrapped air bubbles. The complete 
reticulation takes then 36 h in hoven with controlled humidity and temperature 
(40 °C). 
The final silicone aorta is showed in fig.3.34, where is possible to 
appreciate the fine internal resolution of the mold, and the physiological 
geometry obtained.  
For the fast prototype stamps creation a Stratasys Dimension 1200es 
printer was used, the adopted material was a custom ABS developed by 
a b
c d
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Stratasys Inc.. All the casting procedure and the production of the plates were 
developed with the collaboration of the Te.Si. Laboratory of the University of 
Padua. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.32 SolidWorks four parts mould file (above) and ABS forms plus 
aorta from fast prototype printer (below). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.33 ABS mold of the internal aortic arch core. 
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Fig.3.34 Sealed close mould in which the silicone has been casted, and 
the final silicone aortic arch. 
 
As last, seems important to report an observation about the aortic arch 
creation that had influenced the choice of this technique. Indeed, the first idea 
was to realize the aortic arch directly using a fast prototype printing, with rubber 
like materials. Unfortunately these materials (Stratasys Tango FLX series) are 
still not enough advanced to satisfied our requirements (especially in terms of 
biaxial resistance and transparency). This way will probably be the fastest (and 
best), when the materials will became enough resistant and similar to the real 
rubbers. 
3.3 Software parts 
The pulse duplicator control is realized through three main steps, each one 
is characterized by specific software. The low level data acquisition buffering 
from all the measure devices, pre-processing and communication between the 
linear motor and the control pc, is due using a Dynamic C program. This is 
implemented on the flash memory of the board pc, inside the control unit and 
the signals conditioning part. Live-view visualization of the measured data 
(motor displacement, pressures, flow), adjustment of the hydraulic test 
parameter (stroke volume, heart rate, motor motion curve, etc.), and the control 
of the motor, are possible through a specific LabView program, that represents 
the intermediate level. Post processing of the obtained global flow fields 
following the ISO and FDA regulations is due through a developed MatLab 
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program. The next paragraph will shortly describe these three software levels 
from a functional point of view. 
 
3.3.1 Data acquisition and transfer 
To permit a communication between the linear motor drive and the pc 
control system, an intermediary is needed. The developed Dynamic-C program 
and the Rabbit on board-pc conduct this role, governing the strings and 
commands via a serial port communication from and to the Parker PRA3810s. 
This program was developed offline, and then transferred to the control unit 
where it works in stand-alone mode. The program reads the data sent by 
LabView, and answers with the correct command to the motor drive (i.e. the 
right voltage for the displacement). It also regulates: the command timing and 
trigger from and to the linear motor, the end-stroke sensors signals and the 
velocity of the buffer transmission.  As last, it manages the different data 
packages that arrive from the motor drive and all the other sensors (pressure, 
flow, etc.), subdividing in terms of importance (i.e. information from the motor 
have the priority, to preserve a fast communication) and sending them through 
another flat cable to the LabView control program, when a specific signal asks 
for the download.  
The signal-conditioning unit acts as a bridge between the measure 
instruments and the on-board pc. It picks-up all the data, filters and amplifies 
them, in order to have the same type of data (sample frequency, same start 
acquisition instant) for all the measures. After the collection, it sends the data 
packages to the control unit at each acquisition cycle. 
 
3.3.2 LabView 
The developed LabView program is a key part for the good behaviour of 
the workbench. It is a temporized time-machine structure with different 
communication drivers that dialogs with the peripheral devices, allowing a fast 
correct downloading of the data sent by the control unit. It provides a 
translation in visual signals or numeric indicators of the data, and also the 
possibility to impose several work parameters via a user-friendly control panel 
to the pulse-duplicator (overview of it in fig.3.35). 
Different controls have been implemented in the program:  
a) Initializing panels that allow a correct set up of the system and start the 
signals and motor commands acquisition. 
b) Curve displacement: is possible to upload a custom curve for the pump 
displacement. It has to be normalized at “1”, in period and amplitude, 
for nc=100 samples. At the moment FDA (ViVitro used) displacement 
curve is implemented. This parameter gives the possibility of high-
customized studies, for example to investigate pressure and flow 
behaviour in case of non-healthy situation that reflect on a different 
volume curve. 
	 69	
c) Motor parameters control: direction, offset (from the position reference), 
heart rate (beats per minute, from 15 to 125), and amplitude (in cm, 
directly correlated to the ejected volume) that can vary from 0.1 to 3 cm 
for a corresponding maximum stroke volume of about 120 ml. These 
controls allow the modification of the hydrodynamic parameter of the 
test in a wide range of options (ISO and FDA requirements range are 
covered). 
d) Pressures and flow acquisition tool that, via different buttons and led, 
provides the downloading of the data package for the requested 
quantities. The signals are showed together at each pressing of the 
“acquisition” button.   
e) Re-zero sensor tool, that allows a re-calibration of the different sensors 
(both pressure and flow) during the initialization phase, for each 
experimental test. 
f) Saving quantities tool, that permits the saving in a user defined folder, 
of the visualized curves in a .txt file, subdivided in columns for the 
different signals. Multiple test saving could be done and the last data 
block is placed in queue, extending the .txt file. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3.35 LabView pulse duplicator front panel control. The purple box 
highlight the initializing controls, the blue one the motor controls and indicators, 
the green is depicted to pressure acquisition and data measurements, the 
orange is for re-zero of sensors. 
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Several indicators were implemented (fig.3.36-37):  
a) The graph shows both the imposed curve to the linear motor, also 
called theoretical displacement (white line) and measure data from 
LVDT sensor, called real displacement (red line). From here is possible 
to easy detach errors in the motion repeatability, in terms of shape, 
phase and peak value.   
b) The data box illustrates the different measured data, chosen for the 
visualization by the acquisition box and with a colour legend. The plot 
includes pressure and flow data, showed with two different scales, for a 
better visualization. The acquired and visualized data could be saved 
as described before; if the data is not saved it will be lost at a new data 
refresh. 
c) Some numeric indicators give back useful information for a correct 
aortic valve testing, as for example the stroke volume or the mean 
aortic pressure in the cycle. 
 
 
 
 
 
 
 
 
 
 
Fig.3.36 Examples of FDA curve and LVDT measured displacement (left), 
and typical real-time measured pressure curves for a porcine aortic valve are 
showed on the right side. 
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Fig.3.37 Example of typical pump control indicators during an experiment 
(above): bellow position offset amplitude of the displacement and heart rate. 
Below, pressure indicator as: mean aortic and ventricular pressures, pumped 
stroke volume and cardiac output. 
 
3.3.3 MatLab 
The post-processing data analysis has been carry out developing a MatLab 
program that allows the automatic calculation of all the main global flow 
parameters in according to the ISO 5840:2009. The script read the data 
collected in the test file and compute the flow parameters. Moreover, taking 
advantage of the ViVitro used test software, also the ViVitest parameters were 
computed, to help for a fast performance comparison, in case of same fluid 
dynamic tests performed with both workbenches. 
 Computed parameters divided by area of performance are now listed and 
described, and after a validation of the program through a comparison with 
ViVitro data is provided. The generic physical quantities used in the calculation 
are: T, period of the cycle, in s; HR, heart rate, in bpm; dt, time interval 
between two consecutive samples; EA, bellow area. The crossover points are 
defined as follows: P1, Beginning of Systole Positive Pressure Drop; P2, End of 
Systole Positive Pressure Drop; P3, Beginning of Diastole Positive Pressure 
Drop; P4, End of Diastole Positive Pressure Drop. I1, Beginning of systole 
Forward Flow; I2, End of systole forward flow; I3, Outflow Valve Closing, 
leakage begins; I4, End of Leakage/Cycle. All the next discussed formulas are 
computed among the mean curve of 10 acquired cycles. Fig.3.38 includes all 
these peculiar test points. 
 
Flow parameters: 
o Aortic Forward Flow Time (AFFT): this parameter indicates the 
positive flow interval, in time. 𝐴𝐹𝐹𝑇 𝑠 = 𝐼! − 𝐼! 
 
o Aortic Forward Flow Time Percent (AFFTP): percentage value of 
the positive flow duration, on the total period. 
 𝐴𝐹𝐹𝑇 % = 𝐴𝐹𝐹𝑇𝑇 100 
 
o Aortic Forward Flow (AFV): expresses, in ml, the area of the 
positive flow curve. Qi is measured in l/min. 
  𝐴𝐹𝑉 𝑚𝑙 = 𝑄! ∙ 10!60!!!! ∙ 𝑑𝑡! 
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o Cardiac Output (CO): ejected amount of fluid (net) from the left 
ventricle, for unit of time. 
 𝐶𝑂 𝐿𝑚𝑖𝑛 = 𝐻𝑅 ∙ 𝐴𝐹𝑉 − 𝐻𝑅 ∙ (𝐶𝑉 + 𝐿𝑉) 
 
o Pumped Stroke Volume (PSV): based on the motor displacement, 
allows the obtainment of the volume ejected for each cycle. S is the 
displacement variable, in mm. 
 𝑃𝑆𝑉 𝑚𝑙 = (𝑆!"# − 𝑆!"#) ∙ 𝐸𝐴 
 
o Closing Volume (CV): aortic backflow volume, in ml, computed 
using the ISO specification (flow area from I2 to the intersection 
between the x-axis and the bend point of the negative flow). 
 𝐶𝑉 𝑚𝑙 = 𝑄! ∙ 10!60!!!! ∙ 𝑑𝑡! 
 
o Regurgitant Volume (RV): flow integration between I2 and I4. It 
includes the total backflow, both closing and leakage. 
  𝑅𝑉 𝑚𝑙 = 𝑄! ∙ 10!60!!!! ∙ 𝑑𝑡! 
 
o Leakage Volume (LV): flow area includes between the bend point 
in the backflow and the starting point of a new cycle. 
 𝐿𝑉 𝑚𝑙 = 𝑅𝑉 − 𝐶𝑉 
 
o Regurgitant Fraction (RF): indicates the percentage of backflow 
related to the whole cycle. 𝑅𝐹 % = 𝐶𝑉 + 𝐿𝑉𝐴𝐹𝑉 ∙ 100 
 
o Systolic Time (ST): duration in seconds of the ejection, obtained 
through the difference between I1 and I3.  𝑆𝑇 𝑠 = 𝐼! − 𝐼! 
 
o Systolic Time Percent (STP): percentage value of the systolic time, 
on the total period. 
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 𝑆𝑇𝑃 % = 𝑆𝑇𝑇 100 
 
Most of the mentioned quantities are labelled and showed in fig.3.39. 
 
Pressure parameters (all expressed in mmHg): 
o Aortic Mean Pressure (AMP): aortic pressure over the whole cycle. 
o Aortic Max/Min Pressure (AMaP/AMiP): max/min aortic pressure. 
o Ventricular Mean Pressure (VMP): mean ventricular pressure. 
o Ventricular Max/Min Pressure (VMaP/VMiP): max/min ventricular 
pressure. 
o Gradient Pressure (GP): vector that contains the transvalvular 
aortic pressure drop computed as: 𝐺𝑃 𝑚𝑚𝐻𝑔 = 𝑃!" − 𝑃!" 
 
From this equation is possible to compute different drops, in 
relation to positive crossing points (CP) or with positive and 
negative contributions (CT). The main crossing points are the 
pressure First/Last Crossing (PCT_F/L): first/last pressure crossing 
between ventricular and aortic pressure. Using an implemented 
graphic interface the MatLab user could decide the two points on 
the averaged pressure curves and the respective pressure values 
used to compute the GPP.  
 
Mixed parameters: 
o Effective Orifice Area (EOA): important global parameter that takes 
in account both flow and pressure values. It is derived from Gorlin’s 
formula and is a fundamental performance value requested by the 
ISO and FDA guidance. If the flow Q is expressed in ml/s, the GP 
in mmHg and r in g/cm3, the computed area will be in cm2. 𝐸𝑂𝐴 𝑐𝑚! = 𝑄!"#51.6 ∙ 𝐺𝑃𝜌  
 
The automatic MatLab script, that contains these quantities, was validated 
using as control a typical ViVitro in vitro test on aortic valve. 
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Fig.3.38 Pressure and flow remarkable points during the cardiac cycle. 
 
 
 
Fig.3.39 Flow calculated areas, in according to ISO5840 regulation. 
 
Validation of the MatLab program: 
Taking as gold reference an output sheet from ViVitro test, carried out on 
an experimental test on a mechanical aortic prosthetic valve Sorin Bicarbon 25 
mm with a Sorin Allcarbon 27 mm in the mitral position, a validation of the 
implemented MatLab program was conduit. The investigation shows how, for 
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the same input data, the difference obtained between the software is extremely 
small (table 3.1), strengthen the goodness of the implemented script for the 
HeR pulse duplicator data analysis. 
In particular, the reported table shows a trial on an aortic bioprosthetic 
valve in couple with a physiological healthy three leaflets root. The boundary 
flow characteristics of the test were: 70 bpm, 37°C for the fluid temperature, 4.0 
l/min for cardiac output. The accuracy in the global performances evaluation is 
high: the min/max pressures values, flow characteristics, pumped SV, aortic 
forward flow, cardiac output are very close. The little differences concentrates 
where the value are directly dependent by the operator, as for aortic valve time 
of closure or the positive/negative crossing points, those have to be pointed by 
the user on the mean pressure curves showed on screen. This implies little 
variation especially in the volume-flow quantities as aortic RMS, or closing and 
leakeage volume data. Lots of considerations could be done (i.e. the choice to 
differentiate between what is closing and what is leakage) but seems that the 
implemented MatLab tool computes a correct algebraic sum of these quantities 
and the deviation depends on the chosen computation strategy (using different 
area integration for example). In general, the errors are behind the 3% so the 
MatLab program validation is satisfied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 Comparison between ViVitest and HeR pulse duplicator post-
processing tool outputs on global flow parameters. 
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In conclusion, the developed post-processing tool seems work with a very 
good accuracy, allowing a direct comparison between the two workbenches. In 
this sense in vitro tests similarity evaluation of valve prosthesis performance 
became very fast, with the certainty that the confronted parameters are 
computed in the same way and in accordance with international regulations, as 
it will explain in the next chapter.  
 
3.4 Study abstract 
The cardiovascular laboratory of ICEA dept. started with this project as the 
first step into bio-fluid experimental research field, to assess hydrodynamic 
performances of prosthetic devices. In this chapter a detailed description of the 
pulse duplicator was provided. The mechanical construction and software 
development were illustrated, pointing the attention on the different design 
choice and innovations against others workbenches. The hydraulic circuit is 
composed by chambers connected by conduits with an electromagnetic motor 
and a bellow that permit the fluid motion. It exhibits a horizontal distribution, in 
which is possible to simulate physiological conditions in terms of pressure and 
flow curves, changing the working conditions in a wide range of values. For 
example, the stroke volume could vary up to 200 ml/beat with a heart rate from 
25 to 120 b/min. In this context, the haemodynamic performances of prosthetic 
valves could be analysed via the implemented LabView and MatLab tools. 
As last, to product silicone components able to simulate vascular 
derivations, a dedicated technique was developed. Mechanic behaviour and 
chemical properties of biological and polymeric materials were studied to 
obtain an aortic arch prototype that is now in test on the pulse duplicator. In 
conclusion, from this first analysis seems that the pulse duplicator gives the 
possibility to expresses several fluid dynamic conditions, holding the pressure 
and flow requirements request by the international guidance with high 
accuracy. 
Seems important to remark how this work was carried out with a low 
economic investment, less than 1/3 if compared with the commercial ViVitro 
workbench. 
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Chapter 4 
HeR Pulse Duplicator in vitro performances 
 
 
4.1 Qualitative comparison against physiology 
This section focuses on a preliminary induction of the workbench ability to 
mimic the physiologic behaviour. A qualitative comparison between theoretical 
optimal trends and in vitro results is provided, to better understand which 
pressure and flow curves characteristics are fundamental to replicate.  
 
4.1.1 Mechanical valve 
In this test an aortic mechanical bileaflet OnX valve, 25 mm size, was used. 
The flow conditions were: CO = 4 l/min, HR = 70 bpm, SV about 64 ml, mean 
aortic pressure about 100 mmHg. The working fluid was physiological saline 
solution, at a temperature about 37°C. In fig.4.1 are shown the obtained 
pressure curves (mean of 10 cycle), instead below (fig.4.2) is illustrated a 
typical reference behaviour by Gayton (Gayton & Hall, 2005). The highlighted 
points referred to important phases of the cycle. From a first look, experimental 
curves and theoretical reference are correlated in terms of distribution of the 
phases length along the cycle: same duration of systole and diastole, same 
instant of opening and closing for the valve, about the same time to reach the 
maximum ventricular pressure. The mutual behaviour of the pressures is also 
significant: from valve opens to the pressure peak the ventricular pressure is 
always above aortic. Instead, during closing, the aortic start progressively to 
diverge from the ventricular since the complete closure, identified by the 
vertical fall of the upstream pressure. In diastole, the aortic pressure decreases 
progressively since its minimum, instead the ventricular remains constant to 
zero. 
In particular, referring to Gayton, the aortic valve opens normally about 75 – 
80 mmHg and closes in a range between 90 – 105 mmHg. Fig.4.1 presents the 
opening at P1 = 77.8 mmHg, and closure at P3 = 105.4 mmHg, strongly close 
to the physiological reference. Also the peak values are similar (P2 = 125.9 
mmHg) demonstrating the pulse duplicator ability to reproduce the physiology. 
The end of cycle aortic pressure value (P5) is also correct, strengthens the 
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goodness of compliant behaviour. An important effect was also reconstructed: 
the dicrotic notch. This event appears just after the closure and represents a 
hummer effect created by a pressure waves that travel in the opposite direction 
of the flow, produced by the arteries compliant phenomenon. The physiological 
range of this pressure jump is normally no more than 5 – 10 mmHg. In vitro test 
shows a pressure anomalous peak, P4, about 160 mmHg, instead a normal 
dicrotic notch. A realistic idea is that the dicrotic notch adds up to a bump 
effect, caused by the hurt of valve leaflets on the metallic annulus that is 
transferred to the rigid conduit and to the pressure sensor.   
This idea is reinforced by the evidence of a pressure peak on ventricular 
curve, just few instants late. That phenomenon seems directly correlated with 
the pressure bump suffered by the aortic pressure. The aortic-ventricular peak 
difference is about 8 mmHg, that could justify the additional presence of the 
dicrotic notch in the aortic pressure, instead of the ventricular. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.1 Ventricular, aortic pressure trends (mean of 10 cycles) and mean 
aortic pressure value are reported for a typical test with OnX aortic mechanical 
valve. Grey dots highlight the principal curve points.  
 
For the same experiment the flow curve is expressed in fig.4.3, upstream 
aortic literature behaviour is visible for comparison in fig.4.4. As for the 
pressure trends, the phase of the cycle are respected and close to the 
physiological reference given by Caro (Caro et al., 2012). Looking at in vitro 
result some points has been highlighted to facilitate the contrast. F1 
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corresponds with the aortic valve opens and for both the curves is followed by 
a rapid increase of the flow. The peak, F2, is reached about 0.25 – 0.3 s for 
both and its value depends on test stroke volume. The valve closure seems 
faster in the in vitro model compared to the reference, indeed the maximum 
regurgitation, F3, is moved up by 0.08 s. Except for this difference, the typical 
behaviour for closing, leakage and aortic valve closes flow jump (F4) is 
perfectly repeated in the experiment.  
 
In conclusion, from this curves analysis seems acceptable to say that the 
pulse duplicator is able to provide pressure and flow trends that from a semi 
quantitative point of view, and in terms of respecting of the main cardiac 
phases, mimic very well the physiological references.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.2 Physiological reference curves from Guyton, the same curve 
colours of fig.4.1 has been used, for a faster comparison. Labels highlight the 
principal cardiac cycle phases. 
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Fig.4.3 Upstream aortic valve flow trend (mean of 10 cycles), for a typical 
OnX aortic mechanical valve test. Red dots highlight the principal curve points.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.4 Physiological reference curve shape of flow upstream an aortic 
valve, from Caro. Labels highlight the principal cardiac cycle phases. 
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4.1.2 Bioprosthesis porcine valve 
A second preliminary test was carried out using an aortic porcine St.Jude 
Epic valve 25 mm size at the annulus. The aim was to investigate the presence 
of a hummer effect high as the one saw for the mechanical valve. Flow 
conditions were: CO = 4.1 l/min, HR = 70 bpm, SV about 62 ml, mean aortic 
pressure equal to 100 mmHg. The working fluid was physiological saline 
solution, at a temperature about 37°C. 
From a first look at obtained pressure curves (fig.4.5, mean of 10 cycle), 
experimental curves Guyton’s reference and the mechanical valve curves are 
strongly correlated in terms of distribution of the phase duration along the 
cycle. Pressures behaviour is also coherent across the tests, with physiological 
values and correct timing of opening and closing, as well as curves slope. In 
particular, in this case the aortic valve open at at P1 = 72 mmHg, and close at 
P3 = 120 mmHg. Peak value is P2 = 137 mmHg, and dicrotic notch stops about 
138 mmHg (P4). The end of diastole pressure is P5 = 78 mmHg. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.5 Ventricular, aortic pressure, and mean aortic pressure curves for a 
test with St.Jude Epic aortic porcine valve. Grey dots highlight the principal 
curve points.  
 
The obtained values remark the pulse duplicator ability to obtain curves 
closed to physiological references, and strengthen the hypothesis of a bump 
effect caused by the metallic structure, here mitigated by the presence of a 
more elastic tissue and Teflon valve annulus (the housing system was the 
same, also in hole dimension).  
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4.1.3 Comparison against ViVitro 
As third and last semi-quantitative comparison, the pressure and flow 
trends obtained with HeR pulse duplicator and ViVitro were compared. In these 
tests the same mechanical and biological valves were adopted (On-X 25mm at 
annulus), also equal flow conditions were imposed (see 4.1.1). Moreover, the 
aortic root in the same setup was a straight root without sinuses, to be close to 
HeR configuration. 
In fig.4.6 and fig.4.7 are reported ViVitro mean curves for 10 cycles, for 
mechanical and bioprostesis, respectively. These trends have to be compared 
to fig.4.1 and fig.4.5. In particular, referring to fig.4.1 (mechanical valve), the 
opening and closing pressures (P1 = 77.8 mmHg and P3 = 105.4 mmHg) are 
slightly different between the experiments, where the ViVitro normally shows 
similar opening but higher closing pressure (about 130 mmHg). Instead, the 
ventricular systolic peak value is analogous. In terms of global timing of the 
cardiac cycle the main phases are conserved and similar in the two 
experiments, with same percentage of systole, same point of aperture, closure 
and maximum closing volume.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.6 Mean pressures (pv, yellow line; pao, red line) and flow (upstream 
aortic valve, blue line) trends for Sorin Bi-Carbon 25 mm obtained with ViVitro 
superpump. 
 
The flow peak is a bit higher in the ViVitro (similar aortic forward volume in 
one cycle, 70 ml), but the curve shape is very close between the experiments. 
Considering the ViVitro pump as a gold standard, the absence of a so wide 
peak as the saw for the HeR curves could be explained looking at the amount 
of working fluid. The 4 l necessary to perform ViVitro tests reduces significantly 
the inertia, moreover, a less rigid system and shorter upstream and 
downstream tubes less affect pressure reflection phenomena that affect the 
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dicrotic notch. Starting from these consideration a revision of the HeR aortic 
section is in progress. 
Table 4.1 expresses a brief comparison between the two workbenches 
(referred graph are fig.4.1 and fig.4.6), in which the differences are highlighted 
in light orange. Seems clear how a more homogenous positive pressure drop, 
seen in HeR curves, produces a higher transaortic drop, that reflects in a 
smaller EOA. That difference could be ascribed at the different compliance of 
the aortic area between the experiments. Despite the already discussed aortic 
peak value, the other parameters are aligned between the two tests, except for 
the regurgitant fraction (and the relate volumes). This is probably due to the 
different valve housing, is opinion of the author that the original ViVitro housing 
due to its rigidity could sometimes improve fictitiously the regurgitant quantities. 
 
Data Description ViVitro HeR 
TransAortic press drop (mmHg) 4,57 11,08 
TransAortic max pressure (mmHg) 21,13 28,20 
Aortic mean pressure (mmHg) 98,62 100,82 
Aortic minimum pressure (mmHg) 70,75 70,81 
Aortic maximum pressure (mmHg) 129,44 168,67 
Ventricular max pressure (mmHg) 127,01 133,54 
Pumped stroke volume (ml) 105,78 104,20 
Aortic forward volume (ml) 84,17 75,43 
Aortic cardiac output (l/min) 5,01 5,01 
Aortic closing volume (ml) -4,46 -3,43 
Aortic leakage volume (ml) -8,18 -0,64 
Aortic peak flow [P] 576,04 530,45 
Aortic regurge fraction (%) 15,02 5,61 
Aortic orifice area (cm2) 3,21 2,49 
 
Table 4.1 Global hydrodynamic parameters comparison between Vivitro 
and HeR pulse duplicator for an On-X 25mm aortic valve. 
 
For porcine valve test the comparison gave very good results. Both in terms 
of pressure curves shape and also from a quantitative point of view for opening 
(P1 ≈ 70 mmHg), closing (P3 ≈ 130 mmHg), ventricular systolic peak (P2 ≈ 145 
mmHg) and aortic dicrotic notch values (fig.4.7 and fig.4.5). The main phases 
of cardiac cycle are analogous in the two experiments, with same percentage 
of systole, same instant of aperture, closure and maximum closing volume. 
Moreover, pressure and flow values are similar to physiological references, 
reinforcing the goodness of the experimental model. 
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Fig.4.7 Mean pressures (pv, yellow line; pao, red line) and flow (upstream 
aortic valve, blue line) trends for Labcor porcine 25 mm, obtained with ViVitro 
superpump. 
 
4.2 First results for flow variation 
To investigate the performance range of the mock loop, and its ability to 
provide coherent results for different parameters, a test campaign was 
developed. The boundary flow conditions were varied inside a physiological 
range, and a comparison of the hydrodynamic performances was carried out. 
Two flow parameters were varied: stroke volume and period of the cardiac 
cycle, maintaining the same ratio between systole and diastole phases.  
For all the exams, an aortic mechanical bileaflet On-X valve (25 mm) and a 
mitral mechanical bileaflet Sorin Allcarbon valve (27 mm) were used. The fluid 
was saline solution at environment temperature. Each described test (and 
referred hydrodynamic parameters) will be presented as a mean of 10 non-
consecutive cycles. 
 
4.2.1 Stroke volume changes 
The one cycle aortic forward volume was varied from 55 ml to 95 ml, 
maintaining the heart rate equal to 70 bpm. Four levels were studied (Q1 = 55 
ml, Q2 = 75 ml, Q3 = 85 ml, and Q4 = 95 m), taking Q1 as rest reference 
condition. This stroke range produces a cardiac output from 3.9 l/min to 6.5 
l/min. The waveforms were saved when mean aortic pressure reached 100 
mmHg. To obtain a more concise analysis, the differences between these 
conditions are condensate in fig.4.8 and fig.4.9, for pressure and flow 
variations, and in table 4.1 for what concerns with the hydrodynamic 
parameters.  
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Fig.4.8 shows the 4 coupled pressure curves, with a specific colour legend, 
maintained for the flow curves too. Ventricular trends are similar in shape and 
timing, with the exception of the 75 ml (yellow) that seems a bit shifted forward. 
The aperture of the valve is anticipated (in pressure) for higher stroke volume 
(from 70 to 47 mmHg, increasing the stroke), as the peak value, that increases 
for the different flow conditions (from Q1 = 135 to Q4 = 165 mmHg). The closing 
phase is extremely fast for all configurations, and hummer effect in aortic 
pressure increases proportionally to the ventricular peak.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.8 Measured pressures across the aortic valve for different flow 
conditions. Four ejected volumes are shown: Q1 = 55 ml, Q2 = 75 ml, Q3 = 85 
ml, and Q4 = 95 ml.  
 
 
Fig.4.9 expresses flow behaviour just upstream the aortic valve. Here the 
differences between the experiments are clearly evident in a proportional 
increasing of the flow peak and a semi-perfect scaling of the curves (from 437 
ml/s, 532 ml/s, 600 ml/s, up to 700 ml/s for Q4). Seems interesting to notice 
how the shift in the initial phase becomes close to zero during flow decreasing. 
A different closing volume is also observable: for 55, 75 and 85 ml they are 
very similar, instead for Q4 (95 ml forward volume) it increases a lot. That effect 
has been confirmed also by hydrodynamic parameter values. 
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Fig.4.9 Measured flows upstream the aortic valve for the described four 
conditions. 
 
Table 4.1 summarizes the hydrodynamic parameters (computed following 
ISO 5840:2009) for these experiments, carried out using the MatLab post-
processing developed program. Looking at highlighted green values seems 
acceptable to assert that the increasing of forward volume is well replicated in 
the variation of hydrodynamic quantities. This helps to affirm that the pulse 
duplicator is able to simulate with a good precision different flow conditions. In 
yellow are highlighted the closing volumes: for Q4 it is higher than the previous, 
as was seen in fig.4.9. That unusual variability will check with a larger 
measurements campaign. The well-know hummer problem has been 
highlighted in red: the non-proper physiological values underline the necessity 
to develop a more elastic housing especially for high cardiac output 
experiments that will be performed. 
 
Data Description Q1 Q2 Q3 Q4 
TransAortic press drop (mmHg) 9,94 11,08 12,06 13,80 
TransAortic max pressure (mmHg) 29,31 28,20 31,99 35,48 
Aortic mean pressure (mmHg) 101,36 100,82 99,13 99,31 
Aortic minimum pressure (mmHg) 69,34 70,81 54,20 47,35 
Aortic maximum pressure (mmHg) 158,62 168,67 179,72 190,60 
Ventricular min pressure (mmHg) -4,12 -3,98 -4,04 -4,01 
Ventricular max pressure (mmHg) 136,42 133,54 155,39 165,88 
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Pumped stroke volume (ml) 86,41 104,20 119,17 131,74 
Aortic forward volume (ml) 60,86 75,43 83,95 96,28 
Aortic cardiac output (l/min) 3,99 5,01 5,56 6,42 
Aortic closing volume (ml) -3,12 -3,43 -3,35 -5,10 
Aortic leakage volume (ml) -0,08 -0,64 -1,67 -1,12 
Aortic peak flow [P] 440,42 530,45 604,83 689,67 
Aortic regurge fraction (%) 5,12 5,61 5,99 4,79 
Aortic orifice area (cm2) 2,05 2,49 2,76 2,96 
 
Table 4.2 Global hydrodynamic parameters comparison for the stroke 
volume changes. 
 
4.2.2 Period changes 
In this second investigation the period was varied from 70 bpm to 100 bpm, 
maintaining the aortic forward volume about 75 ml. Three intensities were 
studied: T1 = 70 bpm, T2 = 85 bpm and T3 = 100 bpm, producing a CO = 5.0, 
6.2 and 7 l/min. T1 was kept as reference physiological rest condition. Also for 
this campaign, the difference pressure and flow variations were measured and 
are shown in fig.4.10 and fig.4.11, respectively. The results are shown using a 
percentage scaling, to better enhance the differences across the experiments. 
Looking at the pressure trends, the opening and closing values are in 
general correct. Rising the heart rate, the mock loop answer is not dissimilar 
across the tests in terms of minimum and maximum pressures. Instead, a re-
scaling of the x-axis values has enhanced a shift of the pressure curves, which 
tend to move forward in the cycle for high heart rate. This effects is easily 
observable at the closure, where the closing point move to the right (a 
difference of t/T=10% between T1 and T3 was measured) with a strong 
decrease of the aortic pressure, that follows the ventricular fall after the initial 
closing. A shift appears also in the flow trends, with the same gap observed for 
the pressures. This difference seems strongly connected to oscillatory 
phenomenon that characterized the high heart rate experiments. 
A flow mass oscillation seems clearly affected the pressure trends, with a 
frequency that doesn’t change across the tests but, probably due to the 
intensification of the repetitions, affects more the curves. Is still not completely 
clear which physical effect exists behind. A reasonable hypothesis could be the 
presence of a pressure vibration produced by the rigid housing system. This 
contribution appears only at valve open in ventricular and aortic trends and 
after lingers in the aortic curve, underlining its origin downstream the aortic 
valve. However, a so significant oscillatory behaviour couldn’t be explained 
only in terms of discharge. This comportment, visible in fig.4.10, doesn’t affect 
the flow upstream the valve (fig.4.11), so it could be also read as a pressure 
phenomena without a direct influence on the flow discharge. For increased 
heart rate, flows tend to become higher in terms of peak value, although the 
pumped stroke volume remains constant about 102 ml/beat. 
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An important practical consequence of the described oscillations is 
represents by the impossibility to achieve the correct hydrodynamic 
performance with high accurancy. In particular, pressure drop and effective 
orifice area, are strongly affected by this phenomena and seems now not 
suitable for a quantitative comparison with the other literature results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.10 Ventricular and aortic pressure curves for period changes. The 
trends are expressed on x-axes in percentage, for a faster comparison. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.11 Flow curves upstream the aortic valve for period changes. The 
trends are expressed on x-axes in percentage, for a faster comparison. 
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To better understand the origin of this disturb, a basic signal analysis has 
been developed. Interesting results come out: across the experiments a 
constant frequency of the oscillations was found. In particular, fig.4.12 
illustrates 75 and 100 bmp ventricular and aortic pressure waves filtered with a 
digital filter that cuts precisely only a span of frequencies between 10 and 20 
Hz. The comparison between the “raw” curves is immediately, with a strong 
decrease of the main oscillation path. Despite a digital post-processing of the 
waves seems not a scientific doable way, could help to find the physical origin 
of the problem.   
In order to better understand this, a larger comparison campaign with a 
porcine valve, is in develop. Moreover, a new elastic housing system is in 
production. That solution will surely modify the answer of the system in 
proximity of the aortic valve, where the pressure taps are inserted. 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.12 Left: filtered pressure curves with a selective bandpass filter for 
the T1 test. Right: same filtering for T3. 
4.3 HeR pro and cons 
After this first induction, seems that the mock loop expresses a good ability 
to simulate a physiological behaviour in terms of pressure curves and flow 
trends. In comparison with physiological literature curves, the pulse duplicator 
provides a correct distribution of cardiac cycle phases timing and values for 
remarkable pressure and flow points. The possibility of a wide range variation 
in terms of cardiac output is clearly an advantage in an experimental view, 
already possible in the actual configuration. Although little problems for high 
(about 100 bmp) heart rate, founded after a first experiment campaign, several 
improvements are in development. Despite that, the ability to reach 
considerable cardiac output is important and satisfied with suitable capacity. 
Another important skill is represents by the high modulability of the pulse 
duplicator, which could be modified or extended in function of the particular 
research topic (as for example the insertion of a compliant phantoms to mimic 
a vessel region). 
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 Of course, a step-by-step improvement needs a longer time compared to a 
closed commercial solution, but allows a better understanding of the design 
complexity and of the physical mechanisms that stay behind the realization. 
However, at the end of this PhD careers seems possible to affirm that the pulse 
duplicator expresses good hydrodynamic performance.  
Moreover, a custom development without private companies influence, 
except for the linear motor and the measurement instrumentations, allowed a 
strong decrease of the cost in comparison with commercial solution. An 
example comes from the ViVitro cost, that is about 100 thousand Euros, 
instead of a HeR Pulse Duplicator that is 28 thousand Euros, at this time. 
 
Also weaknesses are present in the workbench, as the considerable 
encumber of the system, the high amount of fluid solution that has to be used, 
and the high rigidity of some parts (as the valve housing). In this way, the new 
silicon aortic arch will give a benefit in terms of pressure fields and workbench 
elasticity. As last, the signal processing and post-processing tools are good but 
still not “perfect”, as the ViVitro software analysis. Despite that the main fluid 
dynamic parameters requested by the international regulation could be 
computed and the pulse duplicator can be steers in live-view mode.   
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Chapter 5 
In vitro analysis of CardioWest™ TAH-t 
hydrodynamic performance: Freedom® portable 
driver behaviour 
 
 
5.1 Introduction to heart transplant and Total Artificial 
Heart prosthesis, overview and statistic data 
The present chapter, and the described research, is focused on the 
determination of in vitro fluid dynamic response of a temporary total artificial 
heart substitute, the CardioWest™ (CW), using physiological parameters 
values for pressure range and Cardiac Output (CO). The role of artificial heart 
devices become relevant in clinical field about 15 years ago, due to a constant 
grow of heart failure and serious heart pathologies. As extreme but not rare 
chance, the substitution of an ill heart imposed the insertion of a mechanical 
double-pump, one for each ventricle, which normally is powered by an external 
drive. This solution is normally temporary and installed as a bridge to 
transplantation device. Of course if the location of the power console is outside 
the body -as for CW-, from one side allows limiting the weight inside the body, 
but from the other creates problem of a direct-wired connection from inside to 
outside of the patient. The deducible complexity in the design and realization of 
a TAH-t figure out how the market’s solutions are restricted to two: the 
AbioCor™ and CardioWest™ total artificial hearts (Cohn et al., 2015). Devices 
like the CW are necessary in case of acute heart failure (HF), underling the 
importance of a constant development and performance assessment of more 
and more reliable devices that could be implanted in easy way and that have to 
operate in a such complex environment. 
 The characteristics of the CW coupled with a portable drive unit, the 
Freedom® driver (FD), was analysed in this experimental work. The principal 
aim was to determine if the CW simulator is a reliable workbench to test the 
coupled system, able to enhance the best and diminish the weak points of the 
driver, in order to give some suggestions to the clinicians and the device 
designer. The investigation was performed using a parallel approach. Several 
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in vitro tests, to estimate the performance of the FD using a specific mock loop 
as patient simulator, were performed, and in vivo tracking of a very long-term 
implantation was done.  
The experimental investigation presented in this chapter was promoted by 
a clinical need, referred on a specific case, registered in the Centro V. Gallucci, 
within the Cardiovascular Surgery Operative Unit, Central State Hospital of 
Padova (Tarzia et al., 2015). In particular, the patient was subjected to 
implantation of CardioWest™ in December 2007 (first Italian CW implant). The 
heart transplant was performed after 1374 days, so the patient was linked to 
the TAH-t for longer than anyone had been previously in the world. During that 
period, different external consoles were adopted (BigBlue, Companion®, and 
then portable Berlin-heart Excor®) and several CPET baseline tests were 
performed. In December 2010 the patient was moved to the Freedom® portable 
driver, and other CPET exams were carried out at a fixed time gap, to monitor 
the patient’s condition. A couple of months after the last driver change, the 
patient showed a dyspnea with pulmonary edema: these symptoms had not 
been previously expressed. In particular, due to an observed reduction in 
maximum power output and a lower peak of VO2 in Freedom CPET (10.1 
mL/Kg/min, 34% predicted) compared to the Baseline, the patient was listed for 
an urgent heart transplant. These evidences stimulated the surgeons to 
investigate the problem from a bioengineering point of view, bringing the 
clinical need to our attention. 
To better understand the technical purpose of this work, and the thought at 
the base, seems essential a fast introduction focused on the prosthetic 
solution, for patient waiting for heart transplant, based on the most relevant 
literature data.  
 
5.1.1 The scarcity of donors and increment of heart failure 
Recently, the National Health and Nutrition Examination Survey (NHANES) 
indicates that more than 23 million people in the world are affected by diseases 
related to HF. Of these, 7 million are located in Europe, and 7.5 million in North 
America (about 5 million people in USA ≥20 years of age) (Westaby, 2013; Go 
et al., 2013). This review-data put the HF at the top of the medical issues 
impact ranking, in terms of human and economic resources. It is evaluated 
that, for the US, the direct and indirect costs for adult treatment were greater 
than $34 billion in 2008, and predicted to be $44.9 billion in 2015, rising to $70 
billion in 2030 (Guruprasad et al., 2012). It is also estimated that heart disease 
has high incidence in the population over 65 years of age, and the occurrence 
of HF is about 10 per 1000 people (Go et al., 2013). Patients affected by HF 
are split into four increasing severity classes, in accordance with the common 
classification method released by the New York Heart Association (NYHA) 
(McMurrey et al., 2012). From the National Heart Lung and Blood Institute 
(NHLBI) data, around 35% of the patients fall into Class I, the same proportion 
into Class II, 25% into Class III, and the remaining 5% into Class IV. The main 
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treatments for HF are: medical drugs, heart resynchronization (CRT), heart 
transplant (HT), or, in specific cases, the uses of mechanical prosthetic 
assistance circulation devices, like Total Artificial Heart (TAH) or Ventricular 
Assist Device (VAD) (Guruprasad et al., 2012). From the latest studies, only 
8% of the treated patients were alive at a two year follow-up. Furthermore, the 
patients treated with drug therapy or CRT, displayed a one year mortality equal 
to 15% and 28%, for Classes III and IV respectively (Westaby, 2013; 
Guruprasad et al. 2012; Kemp, 2012). In this introduction, and for the 
discussed study, we will focus on the highest risk class, i.e. on the patients who 
are unable to perform any physical activity without pain. For this case, the 
mostly common treatment is replacing the heart (Westaby, 2013). From the 
Organ Procurement and Transplantation Network (OPTN) data, there are 
about 3555 people waiting for HT, updated on 6 September 2013, considerably 
greater than the number of donors in 2012, which was 24516 (ref. OPTN). This 
gap, and the steady increase of people affected by HF, emphasizes the key 
role of prosthetic devices, like TAH, to provide cardiovascular functionality for 
people waiting for HT.  
 
5.1.2 The prosthetic solutions: AbioCor™ and CardioWest™ 
These prosthetic devices express a high mechanical complexity, but at the 
same time they must guarantee a high reliability and a long-life at fatigue for all 
the components. The AbioCor™ is designed to sustain the body's circulatory 
system and to extend the lives of patients who would otherwise die of heart 
failure. Its unique design allows it to be totally implanted within the body. The 
patients are not tethered to air-pumping console nor do they have wires or 
tubes piercing their skin. As the CardioWest™, it is intended for use in end-
stage heart failure patients whose hearts have irreversible left and right 
ventricular failure and for whom surgery or medical therapy is inadequate. 
The thoracic unit consists of the artificial ventricles, which contain their 
corresponding valves, and a motor-driven hydraulic pumping system. The 
hydraulic pumping system uses pressure to shuttle blood from side to side—in 
this case, from the artificial right ventricle to the lungs or from the artificial left 
ventricle to the rest of the body. To create this pressure, the pump's motor 
rotates at 4000 to 8000 revolutions per minute. An internal emergency 
rechargeable battery is continually charged by the external power source. The 
internal battery can provide up to 20 minutes of operation while disconnected 
from the main battery pack. The AbioCor is normally powered by an external 
console or battery packs. The internal battery will power the pump only when 
the external power supply is disconnected. Power to the AbioCor is achieved 
with an energy-transfer device called a transcutaneous energy transmission 
(TET) system. The TET system consists of internal and external coils that are 
used to transmit power across the skin. Because tubes or wires do not pierce 
the skin, the chances of developing an infection are decreased. External 
battery packs can power the AbioCor for 4 hours. 
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The AbioCor competitor, and the most used TAH-t in the world, is the 
CardioWest TAH-t. The technical characteristics of the CW will be discussed in 
detail in the next section, here the attention is focused on a fast literature 
review about the implanted outcome and the international certifications 
obtained by SynCardia. 
In 2004, the SynCardia Systems, Inc. received FDA endorsement for the 
commercialization of the CardioWest™ temporary Total Artificial Heart (CW), 
and the approval from Centers for Medicare & Medicaid Service 
reimbursement, in 2008 (PMA FDA). This device is specified as a temporary 
total artificial heart and the clinical designation is a Bridge To Transplantation 
(BTT) device in patients with imminent risk of death (Class IV). These patients 
normally suffer from total aortic dysfunction and multi-organ failure, so the 
TAH-t could be the best solution, as it allows an organ to recover from a 
previously imposed high cardiac output. In particular, the CardioWest™ is the 
first TAH approved by FDA for use as a BTT device and, since 2004, has had 
more than 1200 installations (over 335 patients per year) (Slepian et al., 2013; 
Torregrossa et al., 2013). In 2012, the TAH received the FDA designation as a 
Humanitarian Use Device (HUD) for use in U.S. patients with critical condition 
who are not eligible for heart transplant. This is a step towards clinical use, as 
an alternative to HT, i.e. for ‘‘destination therapy” (FDA HUD). This topic is still 
in full development and will become increasingly followed (Torregrossa et al., 
2013). It is quite easy to find clinical case studies for the BTT CW in the 
literature, due to a large data set collected over 20 years of use by US and 
Europe principal medical centres (Copeland et al., 2004-2; Copeland et al., 
2004; Copeland et al., 2012; El-Banayosy et al., 2005; Leprince et al., 2002). 
All these studies show the great difficulties to point out the real performances 
of the CW in repeatable and non patient specific conditions. In particular, it 
becomes clear that it is necessary to carry out several in vitro tests, to explain 
the performance of the “stand-alone” device, in reliable physiological 
conditions. Specifically in this context, in vitro experiments are preferred to in 
vivo analysis because they allow the free control and fine adjustment of all the 
physiological parameters of the system (e.g. pressure range, cardiac output, 
etc.). In this study we show how this goal can be reached using a customized 
mock loop developed for in vitro tests for the CW TAH-t: the CardioWest 
Simulator (CWS). Only one scientific study was performed using the CWS 
(Spurlock et al., 2012), to test the performance of a new design of pump for a 
temporary extra-corporeal device. In literature, few in vitro works try to point out 
the performance of continuous flow TAH (Fukamachi et al., 2010), or pulsatile 
bioprostetic TAH (Jansen et al., 2012), or, even, to evaluate the in vitro 
response to preload and afterload of the MagScrew TAH (Weber et al., 2002), 
using other pulse duplicator systems. Another work tried to estimate, via a non-
invasive method, the mean parameters in the Jarvik-7, using the Donovan 
mock loop. (Vonesh et al., 1991). Other mock loops were developed to 
estimate the in vitro performance of electrical TAH (Zapanta et al., 2005), or 
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the CFTAH performance used as pulsatile devices (Khalil et al., 2010). All 
these in vitro studies underline the importance of an experimental methodology 
applied to the cardiovascular device, in order to improve understanding of their 
behavior. 
In the present study, the CW behavior was tested in a simulation of post-
hospitalization therapy, using the only portable drive unit developed by 
SynCardia: the Freedom® one (Jaroszewski et al., 2011; Friedline & Hassinger, 
2012). The in vitro tests performed provide the hydrodynamic characterization 
of the system, and a first estimation of the drive behavior. The controlled 
change of the main physiological parameters (cardiac output and pressures), 
for different levels of blood circuit resistance, allowed the understanding of the 
stand-alone behavior of the drive, giving possible suggestions for a specific 
clinical case. 
5.2 CardioWest TAH-t, drive systems and patient 
simulator mock loop 
In this section are described the most relevant instruments used to perform 
the in vitro tests; starting from a functional description of the TAH-t, then 
moving to the workbench specifically designed to housing the prosthetic 
artificial heart, and finally focusing on the different external pumps used to 
provide the correct power to the system. The last section describes the direct 
measured quantities during the tests and the estimated physiological 
parameters. 
 
5.2.1 CardioWest TAH-t 
The SynCardia CardioWest™ (CW) TAH evolved from the early design of 
Kolff, Olsen and Jarviks during the ‘70s. The actual CW is made of two 
independent ventricles, which are implanted intra-thoracically in the orthotopic 
position, (fig.5.1a). The implantable ventricles are connected to an external 
driver system, a pneumatic compressor, allowing co-ordinated ventricle 
activation with independent parameters for each ventricle, through two 
percutaneous drivelines (fig.5.1b). The two artificial ventricles are subdivided, 
via a movable diaphragm, into a blood chamber and a gas section. Each 
chamber is housed in an external case fabricated with polyurethane solution 
(SPUS), over laid with a DacronTM  mesh, to which are connected a PVC 
driveline, and a superior part that contains both the inflow and outflow zone 
made with SPUS graft and isoPlastTM (thermo plastic polyurethane) 
connections. Two mechanical monoleafleat Medtronic-Hall™ heart valves (25 
and 27 mm, for outflow and inflow) are here placed. The diaphragm is 
comprised of a multilayer SPUS matrix, with the four layers providing resilience 
and toughness to the membrane, which must undergo more than 5107 
cycles/year. CW is usually implanted in orthotopic position after the complete 
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replacement of patient’s native ventricles. It is designed to provide conditions 
closest to the physiological range, i.e. 50 ml for stroke volume (SV) and 6 l/min 
for the cardiac output (Shah et al., 2011; Slepian et al., 2013). However, the 
SynCardia™ Inc. ensures proper functioning up to 70 ml and 9.5 l/min 
respectively (SynCardia Systems, Inc., Summary of Safety and Effectiveness, 
CardioWest TAH-t FDA Premarket Approval Application). Indeed, the designed 
work conditions include a partial filling and total emptying of the ventricles; in 
this way, the device provides a CO reserve (10-20 ml) for an increased 
requirement of oxygenated blood during physical activities, or allows an 
increment in the venous return. 
Understood the design complexity of the prosthesis, is important to remind 
that also the usual work conditions are quite hard. Indeed, most of the parts are 
in continuative contact with blood and physiological fluids. This topic opens the 
important issue of the biocompatibility of the adopted materials, which involved 
lots of limitations and additional attention. In these studies we completely don’t 
take in account biocompatibility problems, using desalined water as work 
solution. 
 
5.2.2 External Drivers 
The extra-corporeal drivers, named Companion® and Freedom®, are today 
the most common driving units used for giving the correct power to the TAH-t 
(fig.5.1c). The Companion® is uniquely designed for hospitalized patients; it is 
quite cumbersome, but provides a great flexibility of use, allowing many 
variants of working parameters (Slepian et al., 2011; Slepian et al., 2013), see 
performances in Table 1.  
The state-of-the-art Companion 2 (C2) hospital driver supports patients 
from implant of the SynCardia temporary Total Artificial Heart until their 
condition becomes stable and they can be switched to the Freedom® portable 
driver. The C2 driver provides pneumatic pressure for the Total Artificial Heart 
using one of two air sources. The primary source is hospital air, which provides 
quieter operation. The secondary source is two internal, redundant 
compressors to provide increased patient safety and reliability. The C2 also 
supplies independent vacuum for the left and right ventricles to provide 
optimum performance for each patient based on their individual needs. For the 
operating room and initial stages of patient recovery, the C2 driver is docked in 
the Companion Hospital Cart, which features sturdy support handles and 
locking casters to provide robust, reliable support. Once the patient is out of 
bed and ambulatory, the C2 driver can be docked in the Companion Caddy to 
provide the patient with greater mobility in the hospital. The Caddy supports 
patient recovery by making it easier for patients to move and exercise, which 
helps them to rebuild their strength and improve their health. The C2 user 
interface features a full-color touch screen. This screen displays alarm and 
power status, and on-screen adjustable parameters including pressure, flow 
and cardiac output. The C2 can operate in three different modes: 
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− Operating Room (OR) Mode – a password is required to enter OR 
Mode, which provides full menu access, including system check and 
muted alarms. 
− Intensive Care Unit (ICU) Mode – a password is required to enter ICU 
Mode from Ambulatory Mode, and requires double confirmation for any 
changes. 
− Ambulatory Mode – no changes are permitted, and graph and settings 
data can be minimized. 
 
	
	
	
	
	
	
	
	
	
	
	
	
	
Fig.5.1 The CardioWest TAH-t implanted site and positioning (1a). The 
device connection to the external drive through two percutaneous cables (1b). 
The extra-corporeal drivers, Companion® Hospital cart and Freedom® 
portable driver are the most common driving units used to ensure the correct 
power to the TAH-t (1c). 
When eligible patients become stable, they can be switched from the C2 
hospital driver to the Freedom® portable driver, which provides the patient with 
greater mobility. Patients who meet discharge criteria can then leave the 
hospital to wait for a matching donor heart at home and in their communities. 
The FD, provides a simpler user interface, portability and lightness even 
outside a hospital environment (7 Kg in a backpack size). The latter is 
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unquestionably the best solution for non-hospitalized patients. Because of its 
lightness and functionality, this device improves the quality of life to unthinkable 
standards only a few years ago. The pump is powered by two lithium-ion 
batteries that are re-charged using a standard electrical outlet or the cigarette 
lighter adaptor in a car. This allows patients to recharge their batteries while 
traveling and at night while they are sleeping. The Freedom drive is strictly 
embedded, with the regulation of only one parameter possible: the change of 
the work frequency (125±15 bpm), alterable only by qualified staff during 
hospital visits (SynCardia Systems, Inc., driver Freedom® user guide), see 
Table 1 for details.  
 
5.2.3 Patient Simulator 
The CardioWest Simulator (CWS) (fig.5.2) is the patient simulator used in 
the in vitro tests described in this chapter. Its developed and authorized by 
SynCardia Inc. for staff training or pre-implantation tests of the CW (SynCardia 
Systems, Inc.,Temporary Total Artificial Heart – Patient Simulator and Training 
Center - MOCK CIRCULATION TANK user’s manual). Basically, it is a 
hydraulic system for cardiovascular device performance estimation, and it is a 
modified version of the most common Donovan mock loop (Donovan, 1975). It 
is capable of simulating the cardiovascular system and it reproduces typical 
human resistance, compliance and pressure range. The normal use of this 
device is for trial and clinical application. It reduces high costs and the risk of in 
vivo trials during the clinical investigation, and it is also used in the test protocol 
to verify the CW performance, just before surgical implantation into the patient. 
Let’s have a fast look at the CWS construction, helped by fig.5.2. It is made of 
a plexiglass structure with a total size of around 23 l; the external dimensions 
are h=40.7, l=64.0 and d=20.4 cm. It is divided into four main chambers, to 
reproduce the four physiological pressures of the cardiovascular system: Aortic 
artery chamber (AoP), Pulmonary Artery chamber (PAP), Left Atrial chamber 
(LAP) and Right Atrial chamber (RAP). A toggle valve is placed at the top of 
each block, which allows for the adjustment of individual compliance levels, 
according to the proportional behaviour, P·V=k (P=pressure, V=volume, 
k=constant), i.e. air volume increases results in increased compliance (Hicks, 
1990). 
The TAH-t is normally connected to the mock loop using two suitable 
elastic pipes. The right ventricle of the TAH is connected to the RAP chamber, 
through the right inflow tube, and to the PAP chamber using the right outflow 
tube. In a similar way for the left ventricle, even if here LAP is the inflow 
chamber and AoP is the outflow chamber. The CWS is also able to simulate 
the human vascular resistance: a gate valve placed at the connection between 
the AoP and RAP chambers allows for regulation of the systemic vascular 
resistance (SVR). Similarly, the tract between PAP and LAP represents the 
pulmonary circulation, where the gate acts as a pulmonary vascular resistance 
(PVR). The AoP (and similarly PAP) chamber contains a bellow filled with 
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water, connected to the valve gate and to a height adjustable reservoir. As the 
reservoir is raised, the static pressure into the bellow increases, causing the 
bellow to expand. The result is an increase of the flow resistance, SVR (PVR), 
from one chamber to the other one. 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
	
	
	
	
	
	
	
	
	
Fig.5.2 The CardioWest patient simulator in a front view, where are visible 
the different parts: a) aortic chamber, b) pulmonary artery chamber, c) right 
atrial chamber, d) left atrial chamber and f) is the tested CardioWest TAH-t. In 
the right up angle the CWS dimension are showed, in cm. e) Shows the 
ultrasound flowmeter placed at the outflow tract from the aortic chamber. 
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All the tests performed were related to a specific setting of the vascular 
resistance (seven levels) and fluid dynamics condition for the patient simulator. 
In this way, a linear increment of the human vascular resistance was simulated, 
within a physiological range. Specifically, level 1 corresponds to the minimum 
vascular resistance, and level 7 to the maximum. This setup allows for 49 
combinations of SVR and PVR. For each test, the level of resistance, the 
Freedom® work parameters, and the fluid-gas volumes ratio in the chambers 
were set (see Table 1). The work fluid used in the study was desalinized water 
at 20°C, with a viscosity of 1.001 cP, and a kinematic viscosity of 834.17·10-
6m2/s. 
 
5.2.4 Measured quantities in in vitro tests 
The measurements performed in the study are: the Left Atrial Pressure 
(PLA), the pressure range in the Aortic root (PAO), the Right Atrial Pressure 
(PRA) and the Pulmonary Artery Pressure (PAP). The cardiac output from the 
left ventricle (COL) and the left Ventricular Fill (VFL) were detected from 
Freedom’s LCD display. Moreover, a posteriori pulmonary and systemic 
resistances (Rp and Rs) were calculated, and compared to the set on the CW 
patient simulator. The pressure in the different districts with measured using 
analog piezometers. The sites for measuring the pressure of PAO and PAP 
were located immediately downstream of the ventricles, while the PLA and 
PRA pressure sites are placed just upstream of the left and right ventricles. 
The fig.5.3 shows a static calibration example of the PAO piezometer following 
the SynCardia reference static pressure value (0.835 mH2O), with the reported 
setup configuration. Starting from the reference value (AoP labeled arrow), the 
work solution was added and the chamber fluid height (pcalc = δ*10/13.56) 
was compared to the measured value by the piezometer (pmeas). The 
correlation value between them is quite high (r2≈1), and confirms the reliability 
of the obtained measures. The piezometers are designed to only provide the 
mean value of the pressure in the cycle; moreover five different tests have 
been performed for each configuration, to provide reliability for the obtained 
values.  
Each set of measurements is composed of the four pressures, the CO and 
the VF. From the direct measurement of pressures, the pulmonary and 
systemic pressure drops in the pulmonary circulation derived:  ∆P! = P!" −  P!" , ∆P! = P!" −  P!" . 
Knowing the previous parameters, the pulmonary and systemic resistances 
were computed, as:  R! = ∆!!!"! , R! = ∆!!!"! , where CO! = CO! − (CO! ∙ 0.05) 
The cardiac output from the right ventricle (COR), not shown on the display, 
was calculated via the guidelines of SynCardia Inc., as COR = HR  VFr. These 
quantities help us to better understand the reliability of the system in simulating 
the human circulation, and to confirm that the physiological output parameters 
are acceptable. 
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Fig.5.3 A static calibration example for the PAO piezometer, where: IN is 
the outflow tract downstream the CardioWest left ventricle, at the same high of 
the measuring site (white dot), d  is the distance between the probe site and 
the free surface (in m of water, or pcalc in mmHg), pmeas the piezometer 
pressure measured values.  
 
5.3 Hydrodynamic performances of CW and Freedom 
drive 
The performed in vitro tests with the CWS and FD, allow the collection of 
hydro-dynamic data to assess the performance of the coupled system (Table 
2).  
 
5.3.1 Workbench sensitivity test 
As first examination, a sensitivity analysis was performed in order to verify 
the correct behaviour of the workbench. In fig.5.4, the incremental trend of left 
atrial pressure (PLA) versus the systemic and pulmonary resistance (SVR and 
PVR) is shown. The relationship between PLA and PVR is linear, with a 
regression coefficient equal to k=-0.48, and PLA decreasing by 1 mmHg at 
each increment of pulmonary resistance. Moreover, the PLA remains constant 
for different steps of SVR. As can be seen in the inset of fig.5.4, the aortic 
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pressure was stable, as expected, around a constant value (102+-2.5 mmHg), 
for all the different steps of PVR. The waveforms behavior confirm that the 
coupled system CWS-FD reproduces physiological behavior with good 
likeness.  
To improve the accuracy of the experimental model, and to verify the 
correspondence between the stepping workbench resistance and the 
computed pulmonary resistance (Rp, in Wood units), a posteriori investigation 
was performed. The results are summarized in fig.5.5, where the trend 
between Rp and steps of PVR is expressed, for 5 repeated experiments. For 
each pulmonary resistance step (PVR), the systemic resistance was altered, 
and 7 different measurements were obtained and plotted on a graph (Rs1 – 
Rs7). The CWS reproduces both a marked hypo-physiological pulmonary 
resistance (0-1 WU), and a full physiological range of pulmonary resistance (<3 
WU), in particular from 1.0 to 2.7 WU. After an initial linear trend, the Rp tends 
to a plateau, and the curve shapes deviates markedly from the previous semi-
linear increment, a sign of an upper limit on the expressible CWS performance. 
The curve of best fit (black line in fig.5.5), expresses how from the fourth to the 
seventh step of pulmonary resistance, the Rp falls into the physiological range. 
However, from the first to third step of PVR, the Rp reflects a resistance 
behaviour that is hypo-physiological. This behaviour underlines the need to test 
the TAH-t in a wide range of conditions, both physiological and non-
physiological. 
 
5.3.2 Freedom Drive performance 
One of the most important results of the study is the proven ability to test 
the FD in physiological conditions, to measure the PAO and PAP pressure 
range and the SVR and PVR resistances, using an in vitro workbench normally 
designed only for simple device calibration. It is out of doubt that the CW 
device, in couple with the FD, provides the best actual choice for class IV (or 
over) patients waiting donors for HT surgery. After adequate training, the 
hospitalized patient can be transferred to a home recovery, greatly improving 
life quality. Moreover, the idea for the implanted CW is now shifting from a 
temporary BTT device to a destination therapy device. In this perspective, the 
portability and lightness of the device become key in supporting an extra-
hospital environment, increasing patient mobility, and their ability of a faster 
cardiopulmonary rehabilitation. Last but not least, this solution helps to strongly 
decrease hospital costs.  
Looking at the disadvantages of the Freedom Drive, it is not easy to find 
good statistical or engineering data in literature. In particular, some clinical 
problems could be related to use of a CW in couple with the Freedom® portable 
device (Shah et al., 2013; Jaroszewski et al., 2011). Other tests were 
performed to study the relationship between in vitro measured pulmonary 
artery pressure and estimated Rp in greater detail.  
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Fig.5.4 Behavior of the left atrial pressure (PLA) versus the systemic and 
pulmonary resistance (SVR and PVR) changing by steps. The PLApul express 
a strong decreases instead the PLAsys stays quite constant for every 
resistance steps. In the inset is present the observed semi-constant PAO trend 
in changing of PVR by steps. 
	
	
	
	
	
	
	
	
	
Fig.5.5 A-posteriori calculated pulmonary resistance (Rp) versus steps of 
pulmonary vascular resistance (PVR). Each mark corresponds to a specific 
step of systemic vascular resistance. The black line follows the mean value of 
Rp through the 7 different systemic resistance increments.  
PLApul 
	 108	
In fig.5.6, the results of the relationship between the measured PAP and 
the a-posteriori obtained Rp are proposed. As illustrated, after an initial slow 
increase, where the Rp is in a hypo-physiological resistance range, the 
relationship becomes linear, with k=0.191. This behaviour can be seen when 
Rp varies from 0.6 to 1.4 WU, which is associated to a physiological pulmonary 
pressure, ranging from 18.0 to 25.0 mmHg. For Rp>1.4 WU, the PAP grows up 
and exceeds the clinical warning threshold, which applies to half of the total 
measuring range. This trend seems to support the idea that, in a normal Rp 
range and under constant flow rate condition, the Freedom Drive could 
produce unsafe values of PAP. This could generate a potential dysfunction 
within the human body. It is also easy to observe from fig.5.6 how the 
pulmonary pressure increases from about 25.0 to 33.0 mmHg, and the 
imposed Rp increases from 1.4 to 2.6. This result seems significant, because –
clinically- the pulmonary hypertension is established if the mean PAP is greater 
than 25 mmHg (Galiè, 2009).  
 
 
 
 
	
	
	
	
	
	
	
 
Fig.5.6 Relationship between in-vitro measured pulmonary artery pressure 
and estimated Rp. The graph is divided in physiological and warning pressure 
values (>25mmHg), and in hypo or normo pulmonary resistance (threshold at 1 
WU). The seven white dots correspond to the seven chosen steps for Rp. In the 
inset is shows the behavior of the cardiac output during the tests, for all the 
PVR steps. 
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In conclusion, fig.5.6 allows for detailed observation of how the FD could 
operate in specific physiological conditions, inducing a non-adjustable high PAP, 
which could produce pulmonary edema in a human body. Moreover, seems 
important to be reminded that the Freedom Drive keeps the CO constant, 
imposing a high driving pressure, in order to compensate for a potential 
increase of the Rp, thus increasing the PAP over the warning threshold, 
including when the increase of the resistance remains within the physiological 
limit. All of these remarks seem to explain the clinical case discussed by Tarzia 
(Tarzia et al., 2015). 
 
5.4 A patient reported case 
As reported in the Chapter introduction, the research performed in this 
section was supported and justified by an important reference clinical case. In 
particular, a clinical research work described in-hospital rehabilitative and 
evaluative interventions (CPET methodology), from the beginning to the 1215th 
day of treatment (Tarzia et al., 2015). Next paragraphs are centred on the 
clinical view –and solution- to the encountered problems, and on the engineer 
answer that we tried to delineate through this research. 
 
5.4.1 The clinical answer 
Looking at the patient’s condition according to the result of examinations, 
the medical equipe identified the cause of deterioration in the patient’s clinical 
state was due to the lower increase of the cardiac output as a result of using 
the Freedom, compared to the Baseline CPETs. The surgeons supported the 
idea that the dyspnea (and worsening CO with exercise) could be explained by 
the sudden increase of pulmonary arterial pressure, due to switching from 
EXCOR to the Freedom driver, in a patient where pulmonary vascular 
resistances had likely decreased over time (under EXCOR support) (Tarzia et 
al., 2015). This scenario seems to be clear despite of the fact that the 
Freedom® showed a satisfactory flow of 8 l/min, according to output data. In 
literature, the clinical complication related to use of CW was largely 
investigated, but only few cases of pulmonary edema were collected (Copeland 
et al., 2004; Copeland et al., 2012, H.Copeland & J.Copeland, 2012). In all 
these clinical studies, the utilized driver was the “Big Blue” or the Companion®. 
Previously, this topic was studied by Vonesh (Vonesh et al., 1991) who 
underlined the absence of an accurate determination and close regulation of 
the pressure-flow relationship in the pulmonary vasculature using the TAH, and 
observed that high incidence of hypertension, edema and respiratory diseases 
in the pulmonary districts was encountered in TAH recipients (Griffith, 1989; 
DeVries et al., 1984).  
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5.4.2 The engineer point of view 
From the engineering perspective, some information on that issue can now 
be added. In particular, the FD is designed to provide a constant flow rate 
(CO=7-8 l/min), regardless of the boundary body conditions. In vitro literature 
experiments, performed using a CardioWest™ simulator and a portable 
Freedom® drive unit under several fluid dynamics conditions, showed a 
noticeable increase of pulmonary arterial pressure although the pulmonary 
resistance remains in the physiological range (<3 WU) (Galiè, 2009; Chen, 
1997). 
In the present in vitro study a mean pulmonary artery pressure of about 27.5 
mmHg, for pulmonary resistance between 1 and 2.6 WU, was observed. In that 
condition, no output warning was provided by the FD. The high medium 
pulmonary pressure could be a consequence of the high Freedom’s left and 
right constant drive pressures (205 mmHg and 110 mmHg, respectively). 
These evidences could open a parenthesis on Freedom’s alarm system, and in 
general on the difficult task of a private company to provide, to unspecialized 
individuals, a medical device adequately to the high reliability/performance 
requested and, at the same time, that guarantees the complete safety for the 
patient. In this context the FD, compared to the Companion drive, seems to be 
a great step forward in terms of portability and patient quality life, but at the 
other hand the strong embedded functionalities don’t allow a modification that 
could improve, in certain conditions, the patient outcome.  
As an operative example, the obtained PAP values during the tests 
suggests that it could be useful to provide a controlled access of the drive 
settings in a home environment to make fine proper adjustments. Moreover, 
implementing a more sophisticated electronic closed loop control system on 
the machine, by reasonably lowering the pressure of the right actuator, or the 
CO. Furthermore, the idea of keeping the CO and the right drive pressure 
unchangeable to facilitate a long term organ recovery, but also maintaining 
high vascular resistance, seems to be in contrast with the obtained in vitro and 
in vivo results, that show high PAP in the case of patient physiological RP. 
 
Table 1 
Parameter	 Freedom		 Companion		
Left	drive	pressure	-	LDP	 205	mmHg	 120	-280	mmHg	
Right	drive	pressure	–	RDP	 110	mmHg	 40	–	150	mmHg	
left	vacuum	–	LV	 -10	mmHg	 0	–	-30	mmHg	
Right	vacuum	–	RV	 -10	mmHg	 0	–	-30	mmHg	
%	Systole	 50%	 40	–	60	%	
Heart	rate	–	HR	 125±15	bpm	 40	–	150	bpm	
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Table 2 
Param
eter	
Hi	
LAP	
(mm
Hg)	
σ	Hi	
LAP	
(mm
Hg)	
Hi	
AoP	
(mm
Hg)	
σ	Hi	
AoP	
(mm
Hg)	
Hi	
PAP	
(mm
Hg)	
σ	Hi	
PAP	
(mm
Hg)	
COsx	
(l/m
in)	
σ	
COsx	
(mm
Hg)	
Rpolm	
(mmHg/
min/l)	
σ	Rpolm	
(mmHg/
min/l)	
s_1	 17.06	 0.76	
103.3
4	 5.59	 18.13	 0.60	 7.66	 0.23	 0.14	 0.05	
s_2	 15.54	 0.58	
105.5
0	 6.58	 18.54	 0.48	 7.97	 0.29	 0.38	 0.02	
s_3	 14.54	 1.29	
104.0
9	 8.13	 20.14	 0.61	 8.10	 0.36	 0.69	 0.10	
s_4	 13.69	 0.33	
104.0
4	 6.95	 22.98	 0.19	 8.33	 0.05	 1.12	 0.03	
s_5	 13.02	 0.42	
102.5
9	 6.09	 27.30	 0.31	 8.14	 0.08	 1.75	 0.08	
s_6	 11.60	 0.14	
101.1
9	 7.96	 33.04	 0.55	 8.29	 0.07	 2.59	 0.09	
s_7	 11.24	 0.32	 98.66	 7.76	 32.58	 1.05	 8.47	 0.13	 2.52	 0.17	
	 	 	 	 	 	 	 	 	 	 	
1_p	 13.65	 2.06	 93.67	 2.96	 24.66	 6.93	 8.24	 0.19	
	 	
2_p	 13.62	 1.83	 96.51	 2.67	 24.31	 6.36	 8.19	 0.33	
	 	
3_p	 13.29	 1.79	 98.29	 3.23	 24.25	 6.17	 8.23	 0.28	
	 	
4_p	 13.62	 1.99	
102.7
3	 2.38	 24.48	 6.33	 8.17	 0.23	
	 	
5_p	 13.98	 2.22	
106.6
6	 2.47	 25.06	 6.61	 8.11	 0.25	
	 	
6_p	 14.31	 2.69	
109.3
2	 2.08	 25.02	 6.34	 8.00	 0.41	
	 	
7_p	 14.21	 2.38	
112.2
2	 2.13	 24.96	 5.92	 8.01	 0.48	
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5.5 Study abstract 
The gold standard therapy for people affected by advanced heart failure is 
heart transplant. The gap between donors and patients in waiting lists has 
promoted the development of circulatory support devices, such as Total 
Artificial Heart (TAH). This study was focused on the in vitro performance of a 
specific device: the temporary CardioWest™TAH, driven by the SynCardia 
Freedom® portable pump. The aim was to evaluate the ability of drive to adapt 
to changes of physiological parameters, using an ad-hoc developed hydraulic 
circuit as a patient simulator, and to provide possible interpretation for specific 
clinical cases. In vitro tests were performed using an hydraulic closed loop 
acting as patient simulator, developed by SynCardia Company. Several 
hydrodynamic parameters were obtained, as: cardiac output, the filling of the 
ventricles, pressures in the atria, and ventricles. The aorta and pulmonary 
artery pressures were measured at different values of vascular resistance, that 
were simulated in the range of systemic (SVR) and pulmonary physiological 
resistances (PVR).  
The realized measuring campaign, and the measured quantities, highlights 
the ability of the coupled system to provide behaviour close to the 
physiological. This answer allows the thought that the used mock loop could 
provide interesting non-patient biased results in terms of haemodynamic 
performances of artificial heart devices and drive pumps. 
Despite good results in terms of physiological quantities simulation, the 
Freedom drive expressed also some weak points. In particular, the mean 
pulmonary artery pressure (PAP) increases above 30 mmHg, also in the range 
of physiological PVR (2.6 WU), with a CO of 8.29 l/min. This appened 
although, after increasing the PVR, the left atrial pressure decreases, 
according to the expected physiological trend, whilst aortic pressure remains 
almost stable. A large increase of PAP is probably associated with the preset 
settings of the FD. This could correlate with the clinical course of a patient who 
was supported by the CardioWest™TAH and experienced complications after 
being switched to the new FD, highlighted by the occurrence of dyspnea and 
pulmonary edema despite a high cardiac index.  
In conclusion, this study provides a new way to perform a sensitivity 
analysis of the performance of CardioWest patient Simulator and the 
CardioWest™ TAH-t coupling system, powered by the Freedom Drive. To 
improve understanding of the behavior of the drive, including in clinical cases, 
the system was analysed in terms of fluid dynamics and primary cardiovascular 
parameters. In particular, the CardioWest workbench was used as a real 
patient simulator, not delimiting its operative field as a pre-operation test 
device, showing its suitability for being used in in vitro investigations over a 
wide range of physiological conditions. 
The results of the tests suggest that the Freedom drive is an extremely useful 
device, which could increase the quality of life of the patient, and help in the 
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way of a long-term implantation device. On the other hand, its rigid work 
dynamic behavior could not induce the correct response of the organ under 
certain specific conditions. The results obtained can also help to justify, with 
good accuracy, detection of some symptoms in clinical cases, and to entail a 
prospective design for the device. 
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Chapter 6 
Physiological vortices in the Valsalva sinuses: an in 
vitro answer for bio-prosthetic valves 
 
 
6.1  Introduction: haemodynamic performances of aortic 
valves 
The principal aim of this study was to try to give an answer at the different 
flow patterns founded in literature, describing the vertical structure downstream 
an aortic prosthetic heart valve. In this context, the present chapter and the 
described research adopted an in vitro strategy, to determine the 
hemodynamic performances expressed by different aortic valve plus root 
coupled system. In particular, the estimation of the vortices in the Valsalva 
sinuses, for bioprosthetic heart valves, was performed designing different 
silicone mock roots and testing them in a pulse duplicator through a particle 
image velocimetry technique. The measurement of the global parameters of 
the flow (ΔP, EOA, energy loss) and local parameters of the flow (velocity 
maps, streamlines), allowed to better understanding how a valve and root 
coupled system form a unique environment.  
Before going in deep on the workbench and instruments description, and 
on the experimental campaign results, the next session is depicted to a short 
introduction to the well-known literature issue of the vorticity structure in the 
Valsalva sinuses. 
 
6.1.1 Vortices in the Valsalva sinuses 
The presence of vortices within the Valsalva sinuses has been a known 
phenomenon since the 1960s, stimulated by the development of the first heart 
valve replacement. Although accepted by the scientific community, other 
studies gave conflicting views of the role of the sinuses on the valve leaflet 
dynamics (Keele, 1952; Bellhouse & Reid, 1969; Bellhouse & Bellhouse, 1968; 
Van Steenhoven & Van Dongen, 1979). It now seems to be well accepted that 
the sinuses of Valsalva not only improve the dynamic behaviour of the valve in 
the leaflet dynamics, but also play an important role in the washing out of the 
sinuses, and blood supply of the coronaries (Van Steenhoven & Van Dongen, 
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1979; Peskin, 1982; Peacock, 1990; Rubenstein et al., 2012; Caro et al., 2012; 
Ducci et al., 2013).  However, the specific contributions of the sinus 
architecture upon the hemodynamic are still unclear, and often contradictory. 
Defining a positive vortex as in the description in fig.6.1, the mechanism 
proposed by Bellhouse, suggests the formation of an entrapped positive vortex 
(ω) in the sinus (Bellhouse & Bellhouse, 1968). This vortex is generated at the 
exit of the leaflets during early systole, and expands into the sinus, where it 
remains trapped. This vortex persists into early diastole, promoting leaflet 
closure (Ming et al., 1986; Swanson & Clark 1973; De Hart, 1997; De Hart et 
al., 1997; De Hart et al., 2003; Korakianitis et al., 2006; Katayama et al., 2008). 
Later studies report an alternative mechanism, where the initial eddie 
produced during early systole at the leaflets edge, does not expand into the 
Valsalva sinus, but migrates far from the valve along the root, generating a 
slower negative vortex in the sinus. This negative vortex is a counter vortex in 
the sinus, working in an opposite direction to that of the sinus vortex in the 
previous studies. This vortex seems to help the closure of the leaflets, whilst 
the original positive vortex is located in an area that is the ideal continuation of 
the leaflet profile into the flow. In particular, observing this issue from an 
experimental in vitro point of view, it is possible to follow this mindset in several 
works (Ducci et al., 2013; Leo et al., 2005; Leo et al., 2006; Dasi et al., 2009; 
Saikrishnan et al., 2012). 
Alternative mechanisms for the vortices in the root were obtained by 
numerical studies, tending towards the positive vortex mode, although some 
conclude the presence of multiple vortices within the sinus (Fukui et al., 2013). 
Recently, newly available high intensity MRI images with a specific tracer in the 
blood have allowed in vivo flow visualisation (Yang et al., 1998; Markl et al., 
2005; Escobar et al., 2004; Ranga et al., 2006; Markl et al., 2011). These 
studies tend to suggest the presence of a positive vortex, stable within the 
sinus. However, due to the difficulty of differentiating fast and slow vortical 
structures within the main jet using this technique, the potential error in the 
computed particle tracking is significant. Therefore, current in vivo studies 
mainly provide a global indication of the flow behaviour in the aorta, and are 
not sufficient to provide a conclusive answer on the local fluid motion inside the 
sinuses. 
This study aims to provide a clearer and more generalised view of the flows 
in the aortic root, with specific attention on an idealised healthy situation. A 
number of in vitro experiments were performed, using a pulse duplicator to 
mimic the physiological pressure curves, and a 2D particle image velocimetry 
(PIV) system to measure the local flow field parameters. Various aortic root 
geometries were combined with prosthetic valves of different sizes. Particular 
attention was placed on how the size of the sinuses of Valsalva affects their 
function and the downstream flow of the aortic valve. Healthy and idealised 
operating conditions were considered, whilst the geometric ratios of the inflow, 
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outflow, and sino-tubular junction diameters are preserved across the various 
roots, mimicking the different literature valve housing set-up. 
 In a short summary this study tends to provide a new insight in the 
physiological function of Valsalva sinuses, and on the effect of anatomical 
variations upon the function of the native and prosthetic valves.  
 
 
 
 
 
 
 
 
 
 
 
Fig.6.1 Definition of a positive vortex ω. Y is the main jet flow direction, x is 
the span-wise direction. In the experimental set-up the positive vortex could be 
seen as an un-counter vortex in the left sinus. 
 
 
6.2 Set-up for the experimental campaign 
In this paragraph are described the different instruments utilized in the 
experiments, starting from the workbench and the laser-PIV instrumentation, 
moving to the silicone mock roots design and then describing the global and 
local measured quantities, that will be show in the result section.  
 
6.2.1 Testing workbench: ViVitro Superpump 
All the experiments were carried out using a hydro-mechanical commercial 
pulse duplicator system (Vivitro Superpump System SP3891, ViVitro Labs Inc., 
Canada). The system simulates the heart function by generating a pulsatile 
flow through mock heart chambers, with variable systemic resistance, and 
variable aortic, systemic and ventricular compliances (fig.6.2a).  Millar Mikro-
Tip® high resolution pressure catheters were used to collect the pressure fields 
upstream and downstream of the aortic valve. An electromagnetic flowmeter 
(Carolina Medical Model FM501) with a 28 mm flow probe (Model EP688) was 
used, located just upstream of the aortic valve, allowing quantification of the 
forward, closing and leakage flows through the aortic valve. All these global 
flow fields were collected using the ViViTest software control system. All the 
tests were performed according to the requirements of the standard ISO 
5840:2009, using a physiological flow rate of 4 l/min, a heart rate of 70 bpm, 
and a mean aortic pressure of 100 mmHg.  
ejected	flow
root	axis
root	wall
positive	vortexpositive	vortex
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6.2.2 Particle Image Velocimetry technique 
The local fluid dynamic fields were determined using 2D PIV (TSI Inc.). This 
non-intrusive optical technique provides the measurements of the 
instantaneous velocity vector field of an investigated area, by seeding the 
analysed volume with reflective particles, which become illuminated when a 
laser sheet is passed over them. The images from two controllably spaced 
laser pulses are recorded via a high speed camera, and computer software 
calculates which particles in the first image correlate in the second image, and 
produces a velocity map from the resultant displacement. In this study the 
region of interest was the aortic root cross section (sagittal plane) downstream 
the aortic valve.  The neutrally buoyant, low lag, and passive tracer particles 
used for all these tests were hollow glass particles (Dantec Dynamics HGS-10, 
nominal diameter 10 µm). A high-powered laser light sheet (YAG PIV laser with 
dual cavities, 70mJ (x2) at 15 Hz, 532 nm, 1.5 mm maximum laser thickness) 
was used to selectively illuminate the seeded solution. The PIV system was 
synchronised with the ViVitro pulse duplicator through a timing box, to trigger 
the camera at the desired time instant of the cardiac cycle (see fig.6.2,b) and 
collect a pair of images. A photo and equivalent diagram of the experiment are 
shown in fig.6.2,a, alongside the 5 valve and root setups. 
6.2.3 Adopted work solution 
Due to the number of experiments required in this investigation, and 
concerned with the effect of glycerine upon tissue leaflets, was preferred to use 
a non-glycerine solution, within international regulations (Fisher et al., 1988). 
The work solution was a mix of deionised water and potassium iodide (KI), with 
a hydro-dynamically insignificant quantity of sodium thiophosphate, to remove 
colour from the liquid. The resultant clear colourless solution has the same 
dynamic viscosity of saline water at 37 °C (η=1·10-3 Pa·s) and minimum 
refractive index mismatch with the mock aortic roots and valve leaflets (n = 
1.40) was used. Refractive index (RI) matching was verified by analysing the 
distortion of a grid produced when viewed through a silicone root in the testing 
solution (fig.6.2c).  
 
 
6.2.4 Aortic valves and mock roots 
Porcine valves were preferred due to their similarity with healthy human 
aortic valves in terms of shape, thickness and material (Thubrikar, 1990). The 
valves used for the tests were two stented aortic Labcore TLPB supra-annular 
porcine surgical prostheses, with diameters of 25 and 29 mm. The 29 mm 
valve was selected because its inner diameter (i.e. the leaflets diameter) is 
about 25 mm and therefore, when coupled with a 25 mm mock root, better 
describes the healthy physiological geometry of a 25 mm root. The valves were 
placed in the optimal surgical supra annular position unless specified 
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differently, to mimic the physiological ratio between leaflet and sinus. The 
valves were inserted into a series of mock roots of different design: a straight 
root of 25 mm diameter with no sinuses; two physiological roots, with a 25 and 
29 mm diameter at the annulus and at the sinotubular junction, with three equal 
sinuses; and a 25 mm diameter aortic root identical to the one previously 
described but designed to host the stent of the 29 mm valve, mimicking a 
stentless-like configuration with physiological leaflets. Sinuses were based on 
the geometric proportions described by Swanson & Clark (Swanson & Clark, 
1973), the epitrocoidal top view profile defined by Reul (Reul, 1990), the angles 
of attachment of the leaflets from Thubrikar (Thubrikar et al., 1981), and the 
saggital plane sinus profile from Grigioni (Grigioni et al., 2005). The chosen 
designs reflect the idea of the hugest span of possibilities, going from the total 
absence of sinuses (similar to a Dacron aortic root replacement), to a 
expanded aderly-root, to a physiological healthy root configuration. All roots 
were made of optically clear, solvent free, low viscosity silicone elastomer 
(MED-6015, NuSil Technology, Carpinteria, CA, USA, refractive index n = 1.4). 
The tested roots had negligible compliance.  
 
6.2.5 Global and local measurement fields 
The global hydrodynamic performances of the valves were determined by 
measuring the transvalvular pressure drop (Δp), and flow (Q), of the cardiac 
cycle, over 20 cycles with an acquisition frequency (fc) of 300 Hz (256 samples 
per cycle). The effective orifice area (EOA), and the total energy loss (Eloss) 
were based on Gorlin’s formula (ISO 5840:2009). The local flow field studied 
through image velocimetry gave 2D images of selected instant in the cardiac 
cycle. The instants for imaging (in the results section) were selected to best 
characterise the flow features during the cardiac cycle (see fig.6.2b).  
These five instants are: maximum increase of flow (1), maximum flow (2), 
the maximum decrease of flow (3), the first plateau of decreasing flow (4), and 
the flowrate equal to zero (5). For each instant, two consecutive laser pulse 
beams were triggered, with an adjustable Δt rising from 50 to 400 µs, to 
capture the hydrodynamic behaviour in both the relatively fast and slow regions 
of the flow field. The images were processed using Insight4G (TSI Inc.), with a 
spatial calibration ranging from 20 - 25 µm/pixel. The vector velocity maps 
generated were averaged in Tecplot, which also computed and plotted the 
streamlines. For each test the refractive index matching and the dynamic 
viscosity of the solution were monitored and kept constant.  Finally, the local 
flow fields were computed from 200 phase resolved images for each instant; 
this quantity of images was found from preliminary investigations to be the start 
of a quality plateau. 
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Fig.6.2 a) Picture of the typical experiment set-up: LA = left atrium, M = 
mitral valve, A = aortic valve, AD = aortic district, SC = systemic compliance, 
AC = aortic compliance, R = resistance, C = high speed camera, L = laser, T = 
trigger. b) Typical flow behaviour upstream the aortic valve and the chosen 
time instants through the cycle. c) Refractive index matching for the stentless 
root, using a reference grid. d) Illustration of the different mock roots. 
6.3 Results: velocity vector maps and global 
performances following the ISO 5840:2009 
Contour maps of the average magnitude of velocity and streamlines in the 
plane are presented. The hydrodynamic performance of the different systems 
were also assessed in terms of mean systolic transvalvular pressure drop (ΔP); 
Gorlin’s effective orifice area (EOA), regurgitative volumes (forward and 
closing), and total energy loss components. The leakage volume in each setup 
is mainly due to the paravalvular leak between the prosthesis and the hosting 
holders, which would be negligible for surgical bioprostheses correctly 
implanted in patients, and so has been omitted from this report. 
 
6.3.1 Straight mock root 
To identify the main function of the sinuses in the development of vortical 
structures downstream of the valve, an extreme reference case was studied by 
removing the Valsalva chambers.  The 25 mm external diameter porcine valve 
was placed and tested in a straight tube of 25 mm diameter. The most 
descriptive images from the PIV study are represented in fig6.3. During systole, 
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positive vortex rings are generated at the exit of the opening leaflet, in close 
proximity to the aortic wall (fig.6.3,a) and, finding no physical space within 
which to be constrained, escape quickly away from the valve, driven by the 
ejected flow (fig.6.3,a-b). This mechanism, evident during maximum forward 
flow (fig.6.3,b), narrows the cross-section of the main jet. The vortex escape 
phenomenon repeats several times during the ejection phase so that, later in 
systole, a series of positive vortices interfere with the shape of the main jet, 
and is still significant in late systole, with the deceleration of the flow (fig.6.3, c-
d), and disappears only after the valve is fully closed (flowrate equal to 0 l/min, 
fig.6.3,e). Another positive vortex is detected above the commissure, on the 
right side in fig.6.3,a; which remains in this region during the whole systolic 
phase. For this configuration, the maximum velocity, detected as the fastest 
particle flowing in the investigated region, is 3.0 m/s. From the PIV images at 
the maximum averaged velocity, the fast forward jet width results equal to 1.4 
cm. In terms of hydrodynamic performances, the valve produces a ΔP of 10.98 
mmHg, alongside a computed EOA of 1.57 cm2. This corresponds to 32% of 
the root cross section, and about 45% of the internal stent diameter. The 
energy loss was equal to 137.27 mJ, and the closing volume regurgitation is 
0.7 ml (Table 1 and fig.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6.3 Velocity maps and streamlines for sinusless configuration.	
6.3.2 Physiological 25mm mock root 
In a second experiment, the same valve was tested on an idealized 
physiological aortic root including Valsalva sinuses, having an identical 
diameter (25 mm) at the sino-tubular junction as the previous straight root, and 
using the same 25mm porcine valve. The velocity maps in fig.6.4 describe the 
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behaviour of the flow across a sagittally symmetrical plane for this analysis. A 
positive vortex develops at the leaflet exit at the beginning of systole, but this 
time remains entrapped into the sinus (fig.6.4, a-b). The vortex remains 
confined in the Valsalva sinuses whilst fully developing, from the instant of flow 
peak, (fig.6.4, b) until the end of the closing phase (fig.6.4, c-d), as founded in 
previous research. The forward main jet has a conical spreading shape on the 
right side, but is impinged by a vortical ring that develops on top of the stent. 
This forms at the beginning of the systolic phase, and expands towards the 
centre of the root during late systole (fig.6.4, a-b-c-d). In fig.6.4, e; the vortex in 
the sinus loses some energy, leaving a weak recirculation with predominant 
backflow from the sinus to the commissure. Velocity analysis indicates a 
maximum jet velocity around 2.9 m/s, and a fast forward jet width of 1.7 cm. In 
terms of hydrodynamic performances, the valve produces a ΔP = 8.63 mmHg, 
whilst the computed EOA is equal to 1.65 cm2, corresponding to 38% of the 
root cross section, and about 48% of the internal stent diameter. The total 
energy loss is equal to 79.66 mJ, and the closing regurgitation volume is 0.45 
ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6.4 Velocity maps and streamlines for ideal-surgical configuration. 
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6.3.3 Physiological 29mm mock root 
The experiment performed in section 6.3.2 was repeated using the same 
25 mm porcine valve, but positioned in a scaled up aortic root of identical 
shape, characterised by a diameter at the sino-tubular junction equal to 29mm. 
The most descriptive PIV images for this configuration are represented in 
fig.6.5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6.5 Velocity maps and streamlines for valve-mismatch configuration. 
In the early phase of systole – maximum increasing flow (fig.6.5, a) - a 
positive vortex forms inside the sinus, and a spread main jet develops just over 
the leaflets. At maximum ejection, the positive vortex escapes from the sinus, 
with a similar mechanism as that observed for the straight root. The vortex 
relocation confines the main jet profile, narrowing the high speed region 
(fig.6.5, b-c). This geometrical mismatch also produced a vortical structures not 
observed before. In particular, towards the end of the systole a positive vortical 
ring, recovering energy from the main forward flow, becomes stronger and 
stable in proximity of the sinotubular junction (fig.6.5, c-d). This generates a 
fully developed lower velocity counter-vortex inside the sinus (fig.6.5, d). The 
fig.6.5, e; represents the instant of the inversion of the flow, in which the valve 
has already begun the closing stage. As in previous cases, a positive vortex 
forms on top of the commissures (fig.6.5, a-b-c-d). This structure moves over 
during systole, becoming stable with the vortex centre about 2 cm above valve 
stent at the maximum negative gradient instant. A maximum forward jet 
velocity of 2.8 m/s (with a width around 1.62 cm) was detected just before the 
peak of the flow. In terms of hydrodynamic performances, the valve produces a 
ΔP of 9.29 mmHg, and an EOA of 1.53 cm2, corresponding to 23% of the root 
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cross section and about 44% of the internal stent diameter. The total energy 
loss is equal to 118.70 mJ, and the closing regurgitation volume 3.27 ml. 
 
6.3.4 Physiological 25mm mock root, low valve 
In order to verify the effect of an inaccurate valve positioning, a 25 mm 
porcine valve was moved 8.5 mm lower than the usual ideal supra-annular 
surgical height. This standard geometric valve housing was reported in 
previous studies, and is the default position for the valve housing in the Vivitro 
pulse duplicator (33 34 35). The processed PIV images for this configuration 
are represented in fig.6.6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6.6 Velocity maps and streamlines for low-valve configuration. 
A positive vortical ring starts developing at the base of the sinus at the 
beginning of the systolic phase (fig.6.6, a). In the interval between the valve 
opening and the flow peak through the valve, this positive vortex increases in 
size, and eventually leaves the sinus. Hence, at the flow peak the vortex 
moves up in proximity of the sino-tubular junction (fig.6.6, b). During the closing 
phase, a second vortex generates at the sinus base, and develops inside the 
Valsalva sinus, where it remains (fig.6.6, c-d).  This expands during the closing 
phase, moving from the sinus cavity towards the centre of the aortic root and 
promoting the leaflets’ closure (fig.6.6, e). A vortex is also generated above the 
stent-commissure, which moves far from the valve during the late closing 
phase (fig.6.6).   
The measured maximum velocity is around 2.9 m/s, and the fast forward jet 
width results equal to 1.1 cm. In terms of hydrodynamic performances, the 
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valve produces a ΔP of 10.91 mmHg and an EOA of 1.41 cm2, corresponding 
to 29% of the root cross section and about 41% of the internal stent diameter.  
The total energy loss is equal to 87.24 mJ, with a regurgitated closing volume 
of 0.16 ml. 
 
 
 
6.3.5 Stentless 25mm mock root (native configuration) 
All described tests are related to configurations achievable with 
bioprosthetic stented valves, rather than an idealised physiological 
configuration. In fact, the stent thickness necessitates the use of leaflets of 
smaller size than the native ones, which occupy a smaller portion of the 
sinuses during opening. Moreover, the stent thickness is likely to enhance the 
swirling structures observed in all tests above the stent (and along the wall) 
(section 6.3.1 to 6.3.4). In order to reduce the influence of the valve stent, a 
final test was performed using an aortic root identical to the one used in 
sections 6.3.2 (25 mm at the sino-tubular junction), with the exception of an 
encasing designed to host the stent thickness of an identical valve of larger 
size (29 mm), characterised by an inner stent size similar to the root size at the 
sino-tubular junction (25 mm). This configuration provides physiological leaflet 
matching.  
The velocity maps and streamlines for the stentless-like configuration are 
represented in fig.6.7. At the maximum gradient of flow, the map shows a 
divergent main vertical jet, with a positive vortex inside the sinus (fig.6.7, a). In 
the fully open state, at the peak of the flow, the valve leaflets, now larger than 
the previous ones, expand closer to the sinus wall, demonstrating a more 
physiological geometric ratio (fig.6.7, b). The main forward jet develops in all 
the acceleration phase without any lateral obstruction (maximum velocity 
around 1.7 m/s, width of 1.92 cm), and is still uniform and wide after the flow 
peak, with minor vortical effects visible at the root wall (fig.6.7, a-b-c). Before 
the velocity peak, a positive vortex forms in the Valsalva sinus, and during the 
maximum negative gradient this is clearly developed inside the sinus (fig.6.7, 
b-c). The positive vortex is still visible in the sinus and at the leaflet edge at 234 
ms (fig.6.7, d), when another vortical structure forms at the right side, above 
the commissure, which is reduced in profile but still partially evident. Closure is 
characterised by the permanence of the positive vortex inside the sinus, and a 
slow flow velocity region close to the leaflet edges (fig.6.7, e).  
In terms of hydrodynamic performances, the valve produces a ΔP of 3.29 
mmHg and a computed EOA of 2.99 cm2, equating to 61% of the root cross 
section. The closing regurgitant volume is much higher than in previous cases 
(3.20 ml), due to the larger leaflets, but the associated energy losses are 
significantly smaller (29.62 mJ) than the gain in terms of systolic performance. 
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Fig.6.7 Velocity maps and streamlines for stentless configuration. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6.8 a) plot of EOA and transaortic pressure drop for each configuration; 
b) plots of transaortic enegry losses and valve regurgitation for each 
configuration. 
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Table1. Hydrodynamic data for all configurations. 
 
6.4 Discussion about the flow dynamic patters in 
integrated valve-root aortic system 
One of the most interesting ongoing issues with the flow dynamics of 
prosthetic valves is the recreation of an experimental setup able to closely 
mimic the physiological flow behaviour. In this context, the local flow behaviour 
in the human aortic root appears to be still unclear, with reports of different 
vortical structures within the Valsalva. This study focused on different 
experimental combinations of mock aortic roots and porcine valves, in order to 
identify the closest physiological condition and offer an explanation for the 
different fluid dynamics observed in the sinuses and reported in literature. 
 
The repeated formation and migration of vortices observed in the sinusless 
configuration corroborates the hypothesis that the development of the vortices 
depending upon the root geometry (fig.6.9) (Bellhouse & Bellhouse, 1968; 
Peskin, 1982; Van Steenhoven et al., 1982; Peacock, 1990). Comparison 
between the 25 mm physiological root and the 25 mm straight root suggest that 
the presence of Valsalva sinuses act as chambers, which host the vortical rings 
formed during systolic ejection, enabling the main jet to reattach to the wall just 
after the sino-tubular junction (fig.6.9, i-ii). It also suggests that presence of the 
Valsalva sinuses is sufficient to substantially enhance the hydrodynamic 
performance of the valve. In both cases a strong stable vortex above the 
commissure (fig.6.3, a-d; fig.6.4, a-d) was observed. However, as described 
above, other operative modes have been observed, which are characterised by 
a mixed behaviour. The alternative dynamics reported in the literature often 
resulted from investigations where there was geometric mismatch between the 
valve and the testing root (which is commonly larger than the ideal 
physiological root, in order to host valves of various dimensions), or the axial 
position of the valve, which is often housed between the ventricular and the 
aortic chamber, was below the physiological position. Hence both conditions 
were simulated, in order to verify how they affect the flow and if they can justify 
the reported inconsistencies. 
The valve mismatch (e.g. due to undersizing), represented here by placing 
a 25 mm valve into a 29 mm physiological root, results in intermediate flow 
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patterns: the systolic vortex ring expands into the sinuses but, due to the large 
cross-section at the sino-tubular junction, it escapes into the ascending aorta, 
resulting in a narrowing of the high velocity blood stream (fig.6.9, iii). This 
mechanism increases the transvalvular pressure drop. Interestingly, despite an 
aortic root cross section 35% larger than in the other tests, the effect of the jet 
contraction results in a significant reduction in EOA, which is similar to the case 
study with no sinuses.  Closing regurgitant fractions and global energy losses 
are intermediate between the ideal surgical and the cylindrical configurations.  
This testing configuration, common in in vitro tests due to the need for 
universal roots fitting the different valve sizes, also describes the case of 
under-dimensioned valves or dilated aortic roots, providing an idea of the 
change in performance associated with geometric changes occurring in 
pathologic scenarios (Leo et al., 2006; Dasi et al., 2009; Saikrishnan et al., 
2012; Moore et al., 2014). 
In the low position valve experiment, the vortex-escaping phenomenon was 
accompanied by a positive entrapped vortex in the Valsalva sinus (fig.6.9, iv). 
As a result, the forward main jet is rapidly confined on one side by the escaped 
vortical structure, producing a narrower vena contracta. Whilst the formation of 
a large positive vortex in the Valsalva chamber supports early coaptation of the 
leaflets, reducing the closing regurgitant volume, the global energy loss 
performance is diminished.  The resulting mixed mechanism (escaping and 
trapped vortices) appears similar to the one reported in different in vitro 
studies, and demonstrates how the valve housing design is crucial (Lim et al., 
1997; Lim et al., 1998; Lim et al., 2001).  This experiment suggests that current 
supra-annular implantation approach, recently preferred to infra-annular 
implantation, may result in enhanced performance with both a more favourable 
geometric orifice area and improved hemodynamics. 
The ideal surgical configuration, with matching valve and root sizes, 
produces hydrodynamic performance superior to all other stented cases 
(fig.6.9, ii).  Removing the sinuses, which describes the case of a valve 
implanted into a tubular aortic graft, results in the vortices that form during 
systole to cause repeated contractions of the jet. This results in an increase of 
the transvalvular pressure drop greater than 25%, and a 5% reduction in the 
EOA, as well as a reduction in closing efficiency, characterised by a regurgitant 
volume more than twice that of the ideal surgical configuration. This may be 
due to the absence of radial flows, which can develop in the sinuses and 
promote coaptation of the leaflets. Globally, the energy losses due to the 
absence of sinuses are estimated to be more than 50% higher than for the 
physiological root. Our results confirm the finding from Pisani (Pisani et al., 
2013), and the hypothesis developed from in vivo study (Schoenhoff et al., 
2013), providing a justification via fluid dynamics for the reduction in EOA. 
The most efficient valve configuration, as expected, is the stentless-like 
arrangement (or native configuration), which has the largest annulus orifice 
area and more closely replicates physiological conditions, due to leaflet 
matching and an embedded valve stent (fig.6.9, v). This is associated with a 
transvalvular pressure drop 62% lower than that of the stent-matching surgical 
idealised set up, and 70% lower than with the worst performing configuration 
(straight root). This stentless configuration is characterised by a positive 
entrapped vortex present during almost all the cycle in the Valsalva sinus, and 
for the restricted presence of the recirculation region above the commissure.  
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Fig.6.9 Sketch characterisation of flow patterns in all configurations. 
	
6.5 Study abstract 
The in vitro behaviour of the local flow downstream of a prosthetic heart 
valve is a widely discussed topic, since the ‘60s. The physiological flow 
dynamics in the Valsalva sinuses, in terms of global and local parameters, is 
still controversial. This study attempts to identify the physiological conditions as 
closely as possible, and give an explanation of the different and contradictory 
results in literature. To better understand in details the flow patterns inside the 
aortic district an in vitro approach to test different mock aortic roots, coupled 
with two different surgical porcine bio-prosthetic valves (stent matching and 
leaflets matching), were developed.  The global and local flow performances 
were carried out in vitro, on a pulse duplicator, using a 2D particle image 
velocimetry technique. All tests were performed under physiological pressure 
and flow condition, following the ISO 5840:2009. 
The obtained results show how the stentless-like aortic root provided the 
physiological reference system, and characterised by the best hemodynamic 
performance. Tests on other root-valve configurations also evidence that the 
shape and the dimension of the root play an essential role in assessing the 
hydrodynamic performance of the valve. In particular, these outcomes show 
how a stent mismatch, leaflet mismatch, or different positioning of the valve 
could produce significantly different flow patterns and velocity fields in the 
Valvsalva sinuses, as well as the importance of the sinuses in leaflet closure. It 
is opinion of the authors that these tests give an explanation for the different 
vortical structures found in literature, but also raises new considerations, 
reinforcing how difficult could be to accurately describe and assess the 
performance of a prosthetic heart valve, even if only considering the ΔP and 
EOA parameters. 
In conclusion, this study should provide a new answer for the vortical 
structures normally seen downstream of flexible leaflet heart valves. Different 
combinations of flows reported in the literature have been reproduced, 
identifying the optimum physiological fluid dynamics and the perturbations 
introduced by geometric mismatches. This works shows that the valve and 
aortic root act as a system, greatly affecting valve dynamics and hemodynamic 
performance, and therefore must be considered relative to each other in order 
to assess performance. It is therefore suggested that an objective assessment 
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of the device should be carried out on specifically designed aortic root systems. 
These observations strengthen the importance of a new global definition for 
“valve” performances. 
As last, this experimental induction technique could provide an interesting 
base to design and develop new higher performance bioprosthesis. 
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Chapter 7 
Coupling PIV measurements and numerical 
modelling of RBCs to predict thrombogenicity of 
mechanical prosthetic heart valves 
 
 
7.1 Introduction: haemolysis problem for a mechanical 
prosthetic aortic valve 
The principal aim of this study was to approach the haemolysis problem in 
a different way respect to the usual non-physical based studies founded in 
literature (Sutera et al., 1975; Heusen et al., 1980; Paul et al., 2003; 
Goubergrits et al., 2004). Moreover, this research gives the chance to 
approach the numerical studies and the mechanical modelling of small bodies, 
working in couple with a numerical physicist researcher: Giuseppe Fadda, from 
the Mathematical Dept. of the University of Padua. 
In this context, the present chapter and the described research focused on: 
1) estimation of the damage supported by a cardiovascular prosthesis, via 
numerical analysis, starting from velocity fields from in vitro data; 
2) determination of the haemolysis index and the “damage trajectories” for a 
cloud of red blood cells flowing through a mechanical prosthetic valve (MPV), 
placed in aortic position.  
The valve data were obtained from a previous study (Toninato MSc thesis, 
2012), and consist of in vitro velocity maps of the aortic region downstream a 
MPV. Eulerian maps were measured via particle image velocimetry technique 
(PIV), and are here used as a flow velocity reference to direct the red blood 
cells (RBCs) as passive bodies through the measured field. Every single RBC 
was modelled using a specific 2D shape, adopting a mechanical model for the 
shell, and then injected upstream the valve and followed during the time 
needed to leave the region of interest. A haemolysis index (HI) law was 
developed and computed using the obtained data, and compared with others 
literature work, enhancing the importance of a physical based approach 
instead of a mathematical heuristic path (Wurzinger et al., 1986).  
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Before going in deep on the technical description of the cell model,it is 
useful to give some information using the literature view about the haemolysis 
problem, the power law used strategies to computed the damage, and the idea 
of a in vitro-numerical merged strategy. 
 
7.1.1 Haemolysis phenomena: overview 
Since the first implant of prosthetic valves, around the ‘60s, surgeons 
understood the crucial importance of how a good interaction between non-self 
materials, body fluids and organs could determine the implant success 
(Wootton et al., 1999; Yoganathan et al., 2003). 
This characteristic, which was called biocompatibility, is a multi face 
concept that plays a fundamental role in the choice of the materials, chemical 
surface treatments, and design of the prosthetic devices. This study doesn’t 
touch any specific problem about the chemical composition of the prosthetic 
materials however it should give an idea of how a foreign element can modify 
the body equilibrium, finding the impact of the prosthetic device on the blood 
damage. As for cardiovascular implants, it was soon clear that the main 
complications related to the failure of the treatments with mechanical devices 
were strongly linked on thrombosis and thromboembolism and anticoagulant-
related haemorrhage, even far from the device. Events, these latter, that 
lashed lots of patients during the years after the implantation (Katircioglu et al., 
1999; Yin et al., 2006; Sezai et al., 2009).  
The thrombosis is directly correlated to a damage suffered from blood 
particle and it could be defined as the formation of a blood clot inside a blood 
vessel, free to scatter in the circulatory system. Even when a blood vessel is 
not injured, blood clots may form in the body under certain conditions. In 
particular, if the shear stresses suffered by the RBCs flowing through a heart 
valve are high enough, they can tear up the cell membrane. This causes the 
disaggregation of the cell, the beckon of the platelets, and the formation of a 
mass of biologic material. Thromboembolism is the combination of thrombosis 
and its main complication, embolism. 
Now it is easy to understand why the cardiovascular prosthetic devices 
(e.g. mechanical valves, TAH-t, VADs) exhibit a non-negligible haemolytic 
potential. For prosthetic valves, the observations of these phenomena arise 
from far in time, since the first monoleaflet Bjork-Shiley was developed and 
commercialized during the ‘70s. The idea was always to maintain high 
reliability and improve the hemodynamic performance of these prostheses. So, 
the technological trend was to convert an industrially derived device (a simple 
hydraulic pipe valve), into a device more and more alike to the biological native 
structure. Despite a noticeable improvement in performance, the problem of 
thrombus growth and red blood cells damage still remains one of the main 
concerns for mechanical heart valves (MHVs). Their design did not 
substantially change from the early bileaflet valves in the ‘90s. The 
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technological trend is to use more and more biological devices, but a sizeable 
share of market is still held by MHVs. 
Therefore, the problem of blood damage remains quite important from an 
engineering point of view. During the last two decades there were mainly 
“variations on the same theme” (fig.7.1) for discovering and making the best 
bileaflet mechanical heart valve (BMHV). The results of this strategy was  a 
large range of devices such as the ones illustrated in Figure 7.1 were the 
structural materials are almost the same, and the changes are in the leaflets 
design, hinge position, housing height and shape. From these models two main 
design criterion have been used for BMHVs: i) reduction of stagnation in the 
hinge area, to avoid deposition and tissue overgrowth, and ii) lowering the flow 
shear stresses on the leaflets, to preserve RBCs and platelets (PLs). But, up to 
now, a correct evaluation of the risk in term of damage on particles has not 
been done using a mechanical-biological model. 
So, the presence of trombogenesis and damage processes, due to an 
incorrect matching of biological request and prosthetic solutions, in terms of 
biocompatibility and fluid mechanics, beckons the attention on the need to 
evaluate a physically based hemolysis index. 
 
 
 
Fig. 7.1: Different BMHVs: a) Sorin Bicabon slimline, b) Sorin Bicarbon 
overline, c) St. Jude Medical, d) CarboMedics Standard, e) CarboMedics 
Tophat. 
 
7.1.2 Structure and function of a red blood cell (RBC) 
Before talking about the mathematical and mechanical sides of the 
problem, a brief introduction about the red blood cell biology, structure and 
function seems useful. This section is intended to be fundamental to better 
understand the adopted choices in the formulation of the model.		
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The human erythrocytes (from the greek erythròs, «red» e cytos, «cell»), or 
red blood cells, express a fundamental carrier function: they transport the 
oxygen around the body. They are without nucleus, or other internal 
organelles, so they have a very simple structure. The cytoplasm is a solution 
composed by hemoglobin (Hb), a red molecule. Each cell contains about 
270·106 of them, for an internal medium weight of about 26-32 pg. The typical 
RBC shape is a biconcave profile with a diameter of 6.2-8.2 µm, and a variable 
thickness: 2-2.5 µm at the edges, 0,8-1 µm in the center (fig.7.2). This shape, 
as it will be clear in the next section, is the best to allow great deformation in 
shape, without changing the superficial area. The RBCs formation process is 
called erythropoiesis, and it takes 4-5 days. An averaged population man has 
about 2-3·1013 RBCs flowing into the organism, so these cells are the most 
common in the human body. Because of the absence of a nucleus they totally 
depends on the production by the red bone marrow. A mature cell lives about 
100-120 days, after that it will be erase by the depicted cells. During their life 
the RBC shell becomes stiff, so the elastic properties drastically change, 
increasing the probability of a damage and hemolysis.  
 
Characteristic	 Value	
Disk	diameter	 6.2-8.2	μm	
Maximum	thickness	 2-2.5	μm	
Minimum	thickness	(at	the	centre)	 0.8-1	μm	
Area	 140	μm2	
Cell	medium	volume	(MCV)	 90	fl		
Cell	medium	Hb	(MCH)	 26-32	pg		
Medium	life	 100-120	days	
 
Table 7.1: Geometric and biological data for red blood cells.  
 
The main function of the RBCs is to carry the oxygen (O2) from lungs the all 
the organs and tissues, and bring back the CO2 to the lungs: this circle is 
normally completed in 20 seconds. To express their function, the cell 
cytoplasm of RBCs encloses a specific protein: the hemoglobin (Hb).  The 
hemoglobin is a globular protein with a quaternaries structure. It is composed 
by 4 sub units (α e β chains) that contain the EME GROUP, which is a 
protoporfirine molecule linked to an iron ion (fig.7.3). The presence of these 
ions allows the RBC gas exchange through the membrane.  
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The hemoglobin is important in this study because the most used strategies 
to measure or quantify the hemolysis index, and the prosthesis potential 
dangerousness, are referred to the released Hb from the cell lysis. 
 
 
 
 
 
 
 
 
Fig. 7.2: Side and top view of a typical red blood cell. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.3: Hemoglobin polypeptide chains and chemical structure of Heme 
group. 
7.1.3 Clinical and engineering views 
From a mechanical and fatigue point of view the prosthetic valve devices 
satisfy the main fluid dynamic needs but, looking locally in the aortic root region 
(Valsalva sinuses and sinotubular junction) the hematic conditions tend to 
diverge from the physiological (Yoganathan et al., 1995; Chandran et al., 2006; 
Dasi et al., 2007; Dasi et al., 2009; Shariari et al., 2012). Consequences of that 
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are high stresses regions that provide great problems of lysis on the 
curposcolate part of the blood, and recirculation region with very low velocity, 
where the clotting of particles is favourite. In the first case the damage is called 
induced haemolysis and causes the spillage of haemoglobin in the vessel 
(aorta). Hemolysis is to be avoided for two reasons. First, hemoglobyn 
molecule can’t flow free in the organism, due to its toxicity to the other cells 
(oxidation processes). Second, the fragments of RBC are normally blocked by 
platelets and other cells, forming big aggregates, which are potentially very 
dangerous also far from the aorta (ischemic episodes).  
Starting from these considerations, in the last decades different theories 
were developed to face this task, and this study start from the idea that the 
literature is still incomplete with respect to the physical interpretation of the 
problem, and unclear in terms of what really is the haemolysis index and what 
determines the damage on the cells (Heuser et al., 1980; Wurzinger et al., 
1986; Paul et al., 2003; Goubergrits et al., 2004; Arora et al., 2004; Grigioni et 
al., 2005; Chandran et al. 2006; Zhang et al., 2011; Taskin et al., 2012). 
In particular, to better understand the model proposed in the next session, 
here are reported the main ways adopted in literature to quantify the damage 
supported by the RBCs. The clinical measurement of the haemolysis comes 
directly from physiological parameters. The estimation derives from the levels 
of free haemoglobin in the whole blood (Hbfree). The basal value, in absence of 
damage effects is about 0.02-0.05 mg/L, whereas the warning threshold is set 
at 0.3-0.6 g/L (Lippi et al., 2009). 
In the engineering scenario the haemolysis index is mostly derived from the 
variation of the free haemoglobin in the blood (ΔHb) after the cells lysis, 
compared to the whole haemoglobin quantity in the body (HbTOT).  
 𝐻𝐼(%) = ∆𝐻𝑏𝐻𝑏!"! 	
The warning threshold normally adopted is 0.5-1.0% (Lippi et al., 2004). 
In literature are collected lots of studies that try to explain the experimental 
results making use of empiric laws or direct in vitro measurements on the cells 
(Rand, 1964; Blackshear, 1972; Skalak et al., 1973; Evans et al., 1876; 
Hochmouth et al., 1979; Wurzinger et al., 1986; Bronkhorst et al., 1995; Paul et 
al., 2003). One of the first evidence in the past was the dependence of the shell 
damage on the value of the force and of the time interval in which the stress is 
applied. To better understand the correlation between these two parameters in 
vitro tests were carried out, where different strain were imposed to a RBC for 
different times, until the complete lysis of the cell (Sutera et al., 1975). The 
technological limits, due to the difficulties of testing such small bodies, were 
overcome in the last 15 years and a well-known and still used important strain 
threshold is 150-200 Pa (Giersiepen et al., 1990; Paul et al., 2003). Under 
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these values the stress and the time express the same weight in the 
computation of the blood damage, over that threshold the time becomes less 
important to have a lysis of the RBC, (as described in Sutera et al., 1975; Paul 
et al., 2003; Goubergritz et al., 2004). But this approach seems to be too rough 
and other strategies were persecuted recently.  
To better correlate the shear stress (t) to the exposition time (τ),damage 
laws, called blood damage index (BDI) laws, were formulated. They are usually 
written in the form:  
HI	=	f(t,	τ	,	α,	β,	A)	
where t is the exposition time to the dynamic field, τ is the shear stress on 
the cell, and a, b and A are experimental derived parameters (from Couette 
viscosimeter tests) (Heuser et al. 1980; Giersiepen et al., 1990; Paul et al., 
2003; Goubergrits et al., 2004; Zhang et al., 2011). From this general form, 
different specific formulas were derived. The first example is the all-or-none 
law, defined as: 
 𝐻𝐼 = 𝜏!"𝑡!" 	
Here, the hemolysis is computed using the critical values for strain and time 
variables, over that limits the total lysis is instantaneously (Goubergrits et al., 
2004). Other studies have improved that idea developing the “power laws”, 
where HI is computed as:  𝐻𝐼 = 𝐴𝜏!𝑡! 
where stress and time values are weighted through two parameters, a and 
b, and also linearly with the scalar A. The literature founded values, via empiric 
strategy, normally follow the differentiation: α < 1 e β > 1, and are summarized 
in Table 7.3 (Heuser et al., 1980; Wurzinger et al., 1986; Giersiepen et al., 
1990; Zhang et al., 2011). Recent comparison studies focused attention on the 
limitations of these laws, which don’t take in account physical characteristics of 
the system, where the measured data are collected under particular flow 
conditions, and are not representative of a set of cells (Taskin et al., 2012).       
A numerical alternative to these empiric-derived laws is the “strain-based” 
approach (Arora et al., 2004; De Tullio et al., 2012). Here the flows, the 
geometry of the cell, and the stresses, are completely numerically modelled. 
The RBC is followed during his path into the fluid, and the stresses at its shell 
are used to compute HI, still using a power law strategy. In particular, De Tullio 
used a droplet model to simulate a RBC, as a fluid immersed in another liquid 
with different density.Authors obtained the shear stress from the 
instantaneously deformation of the drop shape as 
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𝜑𝒊 = 𝐿! − 𝐵!𝐿! + 𝐵! 
 
where Li is the longer axis and Bi the shorter of the drop. The shear stress 
is computed as: 
 𝜏 = 𝜇 2𝜑𝒊𝑓!1 − 𝜑𝒊𝟐 𝑓! 
 
With f1 = 5.0 s-1 e f2 = 4.2298*10-4, calibrated parameters of the model to 
reproduce the mechanical behaviour of a RBC (f1 depends by the relaxation 
time of the membrane, and f2 incorporates the tank trading effect and the ratio 
between the standard RBC and the area after haemolysis). To finally compute 
the HI, De Tullio puts the shear stress values into a classic power law equation: 
  HI = Aτ!t! 
 
with, α = 0.785, β = 2.416 e A = 3.62. This approach takes in account some 
aspects related to the physiology and in particular to the geometry of RBCs, 
but is still a process driven by power law equation, with two non-physically 
based parameters (f1 and f2). 
The illustrated models from literature overview don’t include the load history 
experienced by RBCs . The cells are idealized as newborn, and the membrane 
expresses the same properties for every RBC. These hypothesis are strongly 
far from a realistic scenario. In attempt to consider the load history into the 
model, some accumulation models were developed, which give the blood 
damage index (BDI) as an integral over time of the different HI computed for 
each instant along a RBC streamline. This is usually done using a rude 
integration of the power laws equation: 
 d BDI = Aτ!t! 
BDI = Aτ ϕ ! dϕ !!!!  
Or considering, as infinitesimal contribution, the time derivative of the 
power law: 
 d BDI =  βAτ t !t!!!dt 
	 147	
BDI = βAτ ϕ !ϕ!!!dϕ!!!  
These approaches (Grigioni et al., 2002; Grigioni et al.,2004) are still quite 
rude. A more sophisticated integration model was proposed still by Grigioni 
(Grigioni et al., 2005). In this case, starting from the definition of dose, as the 
contribution of the instantaneous strains on the RBC shell:  D = t ∙ τ!! 
the BDI is: BDI = A ∙ D! 
 dDdt = ∂D∂t + ∂D∂τ ∙ dτdt 
After some passages, considering dτ/dt > 0 and a constant strain for 
infinitesimal time steps is possible to obtain dD = τ!!dϕ D t − D t! = τ ϕ ! !!!! dϕ 
that, in an infinitesimal time increment, integrate from t0 and t gives the BDI 
at the present time d BDI = d AD! = Ad D! = AβD!!!dD
= Aβ τ ξ ! !!!! dξ + D t!
!!! τ t ! !dt 
BDI = Aβ τ ξ ! !!!! dξ + D t!
!!! τ ϕ ! !!!! dϕ 
The term 
τ ξ ! !!!! dξ + D t!
!!!
 
represents the whole mechanical dose that affect a single RBC, obtained 
as sum of the single doses acting for each time step. 
 
The illustrated literature works are useful to better understand the proposed 
model in the next session, for some reasons. The first is that these laws seem 
not able to express the real connection with the physics of the problem; they 
are simple algebraic forms usually collected in non-physiological flow fields, in 
terms of geometric, spatial context, velocity and pressure fields (Zhang et al. 
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2011; Taskin et al., 2012; Kim et al. 2012). Moreover, the idea of an 
incremental damage is still too poor to justify a real fatigue behavior of the cell, 
that has to live for more than 100 days in the human body, and experiences 
more and more passages through a prosthetic device. To overcome these 
limits a new mechanical physically based model was developed, and tested 
using experimental data from physiologically in vitro flow field. 
 
 
Table 7.3: Costant values ued in power model equations (A, α e β). GW: 
Giersiepen and Wurzinger; HO: Heuser e Opitz; ZT: Zhang e Taskin. 
 
7.2 Rupture model: the ingredients 
The mathematical model presented is an approximation of the reality, but it 
is able to catch a number of aspects of the problem that were not taken in 
account before. To give an easier overview it will be described in three 
separate sections; now some general considerations are introduced.  
Blood is assumed to behave as a homogeneous, isotropic, and Newtonian 
fluid with a constant and uniform dynamic viscosity (Rand et al., 1964). Red 
blood cells are essentially thin (of the order of 1/800 the overall size of the 
RBC) membranes of phospholipids surrounding the liquid cytoplasm. Because 
of the porous nature of the membrane, the internal pressure is nearly equal to 
the external pressure at all times (Rand et al.,1964; Evans, 1983): the inner-
outre pressure difference was hence assumed to be equal to zero for 
simplicity. The action of the fluid on the cell is thus reduced to the viscous part 
2µD, where D is the strain rate tensor, i.e. the symmetric part of the fluid 
velocity gradient. Moreover, as bending is generally negligible for small 
changes of curvature (Evans, 1983; Tan et al., 2010), the membrane theory of 
thin shells was used. Consider a shell of revolution (axis Oz), and a point M on 
its mid-surface; let ξ and η be its principal directions of curvature, and rξ, rη the 
corresponding radii of curvature (as shown in fig. 7.4). 
The internal stress (also called traction in the following) can be 
decomposed into two components Tξ, Tη along the principal directions of 
curvature and a shear component S (see fig.7.4). In the framework of 
membrane theory, the equations determining the principal tractions at point M 
are given by (see Flügge, 1973; Ventesel et al., 2001)  
Model	 α	 β	 A	
GW	 0.7850	 2.4160	 3.620*10-5	
HO	 0.7650	 1.9910	 1.800*10-6	
ZT	 0.6606	 1.9918	 1.228*10-5	
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where rc is the principal radius of curvature at point M and p the external 
loading; pn is the component along the outward unit normal 𝑒! to the tangent 
plane to the shell at point M. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.4: The elements of reduction of the traction on an infinitesimal 
element of the mid-surface of a shell having ξ and η as principal directions of 
curvature. The external loading is given by the vector 𝑝. 
 
7.2.1 Geometrical model 
Erythrocytes are specialized cells without nucleous, composed of two very 
different parts: the cytoplasm, which is a liquid, and the membrane, which is 
essentially a thin layer of phospholipids. In the presented model a single RBC 
is modelled as an ellipsoid, as can be seen in fig.7.5: a and b are the semi 
axes on the flow plane (a along the flow, b transverse to it), and c orthogonal to 
both; the cytoplasm is modelled as incompressible and without motion. The 2D 
ellipse is placed and held in the streamwise plane. RBCs injected in the flow 
field are described by different geometrical parameters according to cell age, 
following in vitro experiments (Tran-Son Tay et al, 1987). These characteristics 
are summarized in Table 7.4.; By symmetry, only 1/4 of the ellipsoid is 
considered. 
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Fig. 7.5: The adopted model for red blood cell geometry: an ellipsoid of 
semi-axes a along Ox, b along Oy, and c along Oz. The plane of the flow is 
Oxy. 
 
Mean	Geometrical	Parameters	(µm)	
Young	 Old	
a	 b	 c	 a	 b	 c	
7.410	 1.175	 2.677	 5.822	 1.357	 2.537	
 
Table 7.4: Geometrical parameters for the RBC in function of the age. 
 
The following analysis is based on the assumption that RBCs do not alter 
the flow while moving; the load on their surfaces is therefore directly equal to 
the jump of stress across the membrane.  
 𝜎 ∙ 𝑒! = (𝜎!"# − 𝜎!"#) ∙ 𝑒!  
 
Hence, in Cartesian coordinates, the traction exerted by both internal and 
external fluids on the surface of the RBC (i.e. the load) is given by  
 𝑝 = 𝑝!  𝑒!  
 𝑝! = 𝜎 ∙ 𝑒! ∙  𝑒!  
 
where 𝑒!  is the unit vector along direction i: here and in the following, the 
implicit summation over repeated indices is used. For simplicity, the RBC is 
represented by a triaxial ellipsoid of centre O (see fig.7.5). Let M(x, y, z) be a 
point at the surface of the ellipsoid; we have the natural parameterization  
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𝑥 = 𝑎𝑠𝑖𝑛𝛼 cos𝜔 , 𝑦 = 𝑏𝑠𝑖𝑛𝛼 sin𝜔 , 𝑧 = 𝑐𝑐𝑜𝑠𝛼;   
 
α and ω correspond to ξ and η are related to the colatitude θ and the 
longitude ϕ through 
 ϕ = arctan 𝑏𝑎 𝑡𝑎𝑛ω ,   θ = arccos 𝑐𝑟 𝑐𝑜𝑠𝛼  
 
with r = 𝑂𝑀! =  𝑠𝑖𝑛!𝛼 𝛼!𝑐𝑜𝑠!𝜔 + 𝑏!𝑠𝑖𝑛!𝜔 + 𝑐!𝑐𝑜𝑠!𝛼 
 
as 𝑥 = 𝑟𝑠𝑖𝑛𝜃 cos𝜑 , 𝑦 = 𝑟𝑠𝑖𝑛𝜃 sin𝜑 , 𝑧 = 𝑐𝑐𝑜𝑠𝜃.   
 
Now only a brief account of the computations is given; for details, see 
(Novozhilov, 1964; Tran Son Tay et al., 1987; Flügge, 1973). In order to find 
the principal tractions at the surface of the triaxial ellipsoid (which is not a solid 
of revolution), we use a linear transformation mapping the ellipsoid into a 
sphere of radius a. For a sphere of radius a (hence rc = rξ = rη = a), the 
equations that describe the principal tractions simplify into 
 
 
 
 
 
 
 
 
Starting from here is possible to follow the procedure described in (Flügge, 
1973), namely to develop the solutions into Fourier series of the variable ω; as 
seen in the principal tractions equation, the load has actually only terms of 
order 0 and 2: consequently, the same holds for the tractions. The following 
expressions for the tractions on the sphere are then obtained 
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The principal tractions (T1, T2) are then the eigenvalues of the matrix 
 𝑇! 𝑆𝑆 𝑇!  
 
Using this method is possible to obtain the main tractions on every little 
area of the RBC shell and then, coupling the rheological model for the cell, 
compute the deformations. 
 
7.2.2 Mechanical model 
The fact that the membrane is thin allows us to use a shell model for the 
red blood cell; the latter is expected to undergo large deformations before 
breaking. The hypothesis of small strains cannot thus hold here, implying the 
necessity of a general constitutive law. 
Starting from Jeffery’s theory (Jeffery, 1922) the condition of non-
perturbation on the flow field was imposed, that is to say the RBC are passive 
particles. Although the velocity gradient is not uniform, the previous assumption 
allows a direct solution of membrane equations (provided that a linear 
transformation is used, i.e. ellipsoid to sphere and back). This strategy enables 
the computation of the principal tractions on the 2D membrane surface. 
To compute the direct deformation on dA due to the external flow fields the 
viscoelastic equivalent of the Skalak model -2D hyper-elastic behaviour- was 
retained (see Skalak et al., 1973; Evans et al., 1976; Dao et al., 2003), which 
explicitly includes the resistance to area changes, and is given by:  𝑇! =  1𝜆!𝜆!  𝐺𝜆!! 𝜆!! − 1 + 𝐵 𝜆!𝜆! !(( 𝜆!𝜆! ! − 1)  
 𝑇! =  1𝜆!𝜆!  𝐺𝜆!! 𝜆!! − 1 + 𝐵 𝜆!𝜆! !(( 𝜆!𝜆! ! − 1)  
 
where (λ1, λ2) are the principal stretches, G the shear modulus (actually a 
tension as the membrane is very thin), and B the bulk modulus (actually a 
tension). Viscous behaviour of RBC si taken into account by by adding to the 
principal tensions the terms: 
 𝜇!𝜆! 𝑑𝜆!𝑑𝑡    ,   𝜇!𝜆! 𝑑𝜆!𝑑𝑡  
 
where M is the viscoelastic modulus of the membrane (actually a tension 
multiplied by a characteristic time of relaxation - T). The adopted parameters 
values are shown in Table 7.5-7.6. The implemented rupture criterion is directly 
linked to global (i.e. for the whole shell) and local (i.e. on each single dA) 
deformation. At this work step, a fragile rupture was assumed: below a specific 
threshold no damage is done. Once the principal tractions are known, the 
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differential equations can be integrated and the principal stretches determined 
for each element depicted in fig.1. 
 
	 Parameters	
	 Shear	Modulus	–	G	
[N/m]	
Bulk	Modulus	–	B	
[N/m]	
Relaxing	Time	–	
T	[s]	
Literature	
span	
(*choosed)	
5÷10·10-6	
(Rand,	Sutera,	
Skalak,	Blackshear)	
5·10-3	
(Skalak)	
	
0.1÷0.2	
(Skalak)	
(T2=5	s	–not	
implemented)	
	
Table. 7.5: The visco-hyper-elastic model parameter, the red highlighted 
values are the chosen one. 
 
7.2.3 Haemolysis index 
To quantify the haemolysis phenomena, a haemolysis index (HI), directly 
correlated to the real shear history experienced by the RBC, was computed. 
This approach does not refer to an analytical formula (e.g. power laws), but 
actually merges a physical in vitro flow field with a direct computation of stress 
phenomena on the immersed particles by means of a shell model. 
Again for simplicity, RBCs are supposed to exhibit fragile rupture: above a 
certain threshold of one-dimensional elongation (given either by λ1 or λ2) or 
area change (given by the product λ1 λ2), the surface element is supposed to 
break and to release haemoglobin in the blood stream (HbRBC); the amount 
released is calculated as the ratio of the ruptured surface over the total surface 
of the membrane multiplied by the total content of haemoglobin of a single 
RBC. This enables the computation of the HI directly from the ruptured area for 
all RBCs present in the blood stream. Thus: 
 𝐻𝐼 =  Δ𝐻𝑏𝐻𝑏!"!   ,       𝑤ℎ𝑒𝑟𝑒  𝐻𝑏!"! =  𝐻𝑏!"#𝑉!"! ⋅ 𝑉!"# + 𝐻𝑏!"# ⋅ 𝑁 Δ𝐻𝑏 = 𝐻𝑏!"##!"# (𝑖)!!!!  
 
where ΔHb is the sum of the 𝐻𝑏!"##!"#  over the M damaged cells. Hbtot is the 
total haemoglobin contained in the N healthy cells observed during the cycle, 
plus the Hb related to the blood flowing in the region of interest, with a 𝐻𝑏!"# and a volume (total = 𝑉!"!, and reference = 𝑉!"#). 
Data literatures on the limit values for rupture are lacking: according to 
(Skalak et al., 1973; Rand, 1964), rupture for isotropic tension occurs at 
λ≈1.08, whereas the limit is between 1.4 and 1.6 for uniaxial tests. Tran Son 
Tay (1987) gives values around 2 as being “reasonable”. Area changes, 
according to Rand (Rand et al., 1964), are of the order of 1.4. Other works 
consider also the plastic phase in the mechanical cell response (Kuypers et al., 
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1998). Values for the mechanical parameters were chosen in order to obtain 
reasonable values of these critical quantities, comparing our computations with 
experimental results on Couette flows (see Taskin et al., 2012). In particular 
the recent work by Zhang (Zhang et al., 2011), and the interpolated power law 
for the Hemolysis Index  
 HI(%) = Cτ!t! 
 
where C, α, and β are constants, t is the exposure time and τ the shear 
stress in Couette flow. This comparison, plus the obtained results for the in 
vitro flow field data are illustrated in the next session, and gave us the help to 
better direct the model behaviour. 
 
 
	 Rupture	Parameters		
	 𝜆g	[lf/li]	 𝜆l	[lf/li]	
Literature	span	
(*choosed)	
1.2÷1.3	
Uniaxial	
(Skalak)		
1.04	
Isotropic	
(Rand)	
2.0÷2.35÷2.5	
(Tran	Son	Tay)	
	
 
Table. 7.6: The rupture parameters, the red highlighted values are the 
adopted in the rupture model. 
 
7.3 Results: power law approach vs. the rupture model; 
from in vitro velocity fields to RBCs damage 
7.3.1 In vitro PIV results 
Phase average velocity field in the transvalvular region was previously 
obtained by in vitro experiments that replicated physiological conditions in both 
flow and pressure waves for prescribed heart rate and stroke volume (Fortini et 
al., 2013). Figure 7.6 illustrates the measured 2D velocity field here adopted for 
HI calculations (SV=64 ml, T=2.4 s; the instant of peak systole is shown). The 
adopted experimental setup is made up of an aortic deformable root, with three 
sinuses, and a bileaflet aortic valve. The prosthesis is oriented with one leaflet 
completely aligned with a sinus (left side of fig.7.6), and the camera is 
perpendicular to the open flat leaflets sides.   
It is easy to observe the typical three-jets mid-plane structure for a 
mechanical prosthetic valve, in which the central jet is wider, compared to the 
external two. The right one is longer, and develops fast along the side, over the 
sinotubular junction. This asymmetry of the flow field reflects the geometrical 
asymmetry of the valve-root coupled system.   
In fig.7.7, the 2D viscous shear stresses at the peak of the systole are 
shown. The maximum stresses are located close to the leaflets, and remain 
high along the boundary layer. 
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These data were used as a starting point to compute, first of all, the 
trajectories of the passive particles (mimicking RBCs injected downstream the 
valve), then the forces applied on cell surfaces, and finally the relative 
elongations following the mechanical model implemented for the shell. Before 
appling the rupture model, another test was performed: using the in vitro flow 
field, the Grigioni dose model was adopted to see how a power law strategy is 
able to describe the damage phenomena in a realistic semi-physiological 
scenario. 
 
 
Fig. 7.6: Coloured vector maps of the 2D in vitro velocity flow field at the 
peak of systole. The valve is positioned following the Grigioni orientation. 
 
 
Looking at theses maps and following what described before, the 
haemolysis is a phenomena strongly related to the spatial component (i.e. it 
depends on the local orientation of the shear forces, and also projects a 
specific fingerprint of the tested device) and to the environment in which it 
develops. This aspect is not taken in account in the power laws based literature 
studies, which decouple the geometry and the damage. This is a clear 
advantage of the rupture model strategy compared to the conventional 
heuristic analysis. To better understand if the spatial component is effectively 
fundamental a comparative test was performed. 
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Fig. 7.7: Coloured vector maps of the 2D shear stresses at the peak of 
systole. The red and blue are enanche the difference in terms of orientation of 
the stress. 
 
 
7.3.2 Importance of the spatial information in integrated approach 
As first experiment, using the described in vitro flow field, N particles were 
injected and an estimation of the HI for each particle was determined using a 
power law equation (so without coupling a mechanical model but thinking at a 
particle only as a geometric entity that support stresses along a pathway). A 
multiple passage strategy was adopted. Cumulate damage was quantified 
using the Grigioni dose model, obtaining a total cumulate damage, at each 
iteration. For this test were identifies: the trajectories in which the damage is 
higher in terms of single passage through the valve and 10 damage classes for 
the trajectories, for cumulate damage after multiple passages through the 
BMHV. 
The results, resumed in fig.7.8 and fig.7.9, allow some considerations: 
- The behaviour of the distribution of the number of trajectories in terms 
of single HI and in function of the belonging class (fig.7.8), seems to 
suggest that the most dangerous trajectories are located in the 
distribution tails, and are very few (4 orders of magnitude less). This 
gap remarks as the frequentation of the dangerous trajectories (red 
areas) could be discouraged by the local flow dynamic, resulting in a 
containment of the HI. The Index grows principally as integration of little 
damages along the preferred trajectories (green area). 
- Looking at the cumulated HI in function of the HI for single RBC, 
divided by the pertaining class, it is evident how the damage is almost 
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totally product (90%) by the passage along the less damaging 
trajectories (fig.7.9). 
- The most damaging trajectories produce a haemolysis contribution that 
is 10 times bigger than the less dangerous. This aspect should have 
resonance in the design of prosthetic devices, and it can be appreciate 
only by a spatial investigation. 
- The cumulated index in 8 days results about 0.01%, , i.e. much smaller 
than clinical warning threshold equal to 0.5%. This level is theoretically 
achieved after a number of passages over the averaged RBC life time.     
 
The above analysis suggests that the power law approach, used in a non-
well defined spatial context, could produce a large different span of results. The 
importance of a correct experimental environment, and an integrated approach, 
help to better understand how, bounding the power law strategy with more 
physical contextualized information, is possible to obtain a detailed response.  
 
 
Fig. 7.8: The distribution of the number of trajectories in terms of single HI 
and in function of the belonging class. The right scale describes the percentage 
of the total number of trajectories. 
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Fig. 7.9: The hoarded HI in function of the HI for single RBC, divided by the 
belonged class. The right scale shows the percentage of the total hoarded 
haemolysis index. 
 
7.3.3 The computed trajectories 
The second numerical experiment uses the in vitro data and the rupture 
model described in the section 7.2 to study if (and how) the haemolysis is 
characteristic of specific area inside the investigated flow region. In fig.7.10 it is 
possible to observe the calculated trajectories of the RBCs during one single 
cycle. In particular, N=1000 RBCs were examinated. Trajectories of the 
damaged RBCs (i.e. path lines along which shell damage is occurred) are 
highlighted in red. It is easy to see how the region of recirculation and vortices 
formation –in the Valsava sinus-, but in particular the area between the right 
leaflet and the wall, are the principal areas suspected for the growth of 
damage. This is due to the relevant shear stresses and to the long resident 
time for the RBCs ending up in these buckets. Damage also occurs in proximity 
of the boundary layer between the lateral jets and the two sinuses regions 
(high velocity gradients). 
Full-integrated approach seems able to illustrate using a physical 
description the damage process suffered by each cell. Moreover, the obtained 
maps reproduce in detail the main features of the phenomena: the high 
gradient of the flow, the vorticity regions, and the effect of the boundary layer 
on the RBCs. Moreover, one of the most important results of the study is the 
ability of the model to give spatial (and not only temporal) information of the 
damage process at work. The results show in fig. 7.10 are robust with respect 
to changes of the simulation parameters (i.e. the number of RBCs injected, the 
perturbation of the flow with a ε in the velocity maps, the number of multiple 
passages). In particular, the areas where damage is accumulated remain the 
same, reinforcing the reliability of the rupture model. 
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All these effects couldn’t be take in account by a heuristic non-rigorous 
approaches, as are pre upower law or derivate Grigioni cumulate damage. 
 
 
 
Fig. 7.10: The calculated trajectories of the 1000 RBCs during one single 
cycle, using the rupture model to describe the damaged and non-injured cells. 
 
7.3.4 The model parameters sensitivity analysis 
As last test, a sensitivity analysis of the model parameters was performed. 
The effect of the variation on the membrane local deformation was first 
investigated. Then, a comparison with the most recent literature results 
obtained by Zang (via experimental investigations using a viscometer and real 
RBCs) was achieved. 
The fig.7.11 shows the change of HI with respect to λloc. This parameter is 
the finest to describe the local strength of the membrane, subdivided in the little 
dAs. The adopted value (λloc=2.35) was proposed by Tran Son Tay. Starting 
from this, little variations were introduced to understand the weight of this 
parameter on the solution. In particular, fig.7.11 illustrates the computed time 
necessary to reach the clinically relevant threshold of 0.5% (Lippi et al, 2009). 
Those “damage times” vary exponentially (from 30s to no damage) while 
related to a linear increment of λloc. The shape is the same for all the models, 
and depends strongly on T: the time scale of the damage is T due to the 
viscosity of the RBC membrane (and it should not be different, because the 
viscous term depends only by a single relaxation time in the model). The 
influence of λloc is evident, and the relative simplicity of the rupture mechanism 
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insert into the mechanical model shows here all its limitations. The main 
problem is to assert and justify the real value of a functional parameter as the 
local deformation limit, for a such small body as a RBC is, without modifying 
the mechanical answer of it (for example with micropipette aspiration, Chien et 
al. 1978; Rand 1964). Probably a much complex mathematical relation has to 
be used to surpass the gap between the numerical simulation and the reality. 
This observation is important as the fact that the rupture model in its entirety 
seems to express a more physically based behaviour if compared with pure 
mathematical strategies, also in this preliminary version. To improve the model 
few strategies should be adopted, in particular: insert a second relaxation time 
in the formulation (T2 ≈ 5 s, following Skalak), and introduce a non-fragile 
rupture mechanism. Both of this additions impose an important additional 
computational cost, and a reformulation of the model with data (that are still 
misty in literature), that are not acceptable with the current possibilities. 
A confirmation of the goodness of the rupture model is shown in fig.7.12. 
Here are compared in vitro results obtained in Couette viscosimeters, and the 
numerical results of the rupture model. It is clear that for small changes in λloc, 
quite different damage times can be obtained. This result wants only to show 
how the model is robust and able to mimic quoted literature data. A comparison 
like this can also be useful to retrieve the unknown parameters from the 
literature, in relation to in vitro experiments (as because in vivo data are 
scarce). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.11: The sensitivity analysis on λloc, how it changes the rupture model 
answer fixing the computed haemolysis index at 0.5%. The values of λloc were 
varying using a literature span reference. 
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Fig. 7.12: The comparison analysis on in vitro results obtained in Couette 
viscosimeters, and the numerical results of the rupture model, for two different 
values of λloc. 
 
In conclusion, the model seems to give a good description of the 
physiological damage occurring to RBCs, described in a more physical way, 
with specific spatial information compared to an heuristic approach. Moreover, 
the integrated approach could be a good strategy to overcame the limit given 
by the pure numerical or non-physiological experiments, coupling a semi 
physiologic in vitro behaviour for the reference flow field (pressure and 
stresses) with a mechanical model for the corpuscolate part.   
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7.4 Study abstract 
In this study, the deformation and collapse of RBCs in a physiological flow 
through a bileaflet MHV, coupling 2D flow velocity fields obtained from previous 
in vitro experiments, and numerical simulations performed adopting a “passive 
immerged particle” technique, was investigated developing and running a self-
made parallel Fortran code.  
First, the RBCs trajectories were computed, highlighting the related fluid 
patterns. Since experimental velocities are known on a 50x51-node grid, this 
step was carried out using a bi-cubic interpolation of the known flow field. In 
turn, the knowledge of particle trajectories allows the reconstruction of the 
history of shear stresses and pressure experienced by the single RBC while 
moving in the investigated flow field. 
Using the membrane theory, and developing a rheological model with 
visco-hyper-elastic behaviour, the global RBC deformations were computed. 
The global information was obtained by the local evaluation of the deformation 
for small areas dA of the cell surface, taking advantage of a specific symmetric 
geometry (ellipsoid) of the idealized red blood cell. 
If the deformation exceeds a specific (a priori fixed) threshold, a quantity of 
haemoglobin (Hb) proportional to dA is released from the RBC. The coupling of 
the mechanical model and fragile damage behaviour is defined as “rupture 
model”. Then, relating this free Hb to the total Hb carried by blood, a damage 
index for RBCs was obtained. This method was simultaneously applied to N 
particles randomly injected just upstream the valve, along a cross-section, 
orthogonally to the flow. 
The results of the tests suggest that an integrated approach is able to carry 
both the spatial and global haemolysis information about the damaging process 
suffered by the cells, promoting a new more physical based strategy to 
investigate the dangerousness of cardiovascular prosthetic device. 
Indeed, although the rupture model still is at its first step into this approach, 
nevertheless it seems a smart way to describe the problem, trying to keep the 
driving factors and excluding the minor contributions. In conclusion, this study 
provides a new way to perform a RBCs damage investigation due to the 
passage through a BMHV, stimulating the literature attention to describe the 
whole phenomena with more physical details, trying to condensate the more 
relevant mechanical variables in few global parameters. It’s trivial to observe 
that the proposed approach can be applied to any othet cardiovascular device, 
provided that a robust velocity field ‘around the device is given. 
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Chapter 8 
Conclusions & developments 
 
 
8.1 Overview of the present research 
During this PhD numerous studies were carried out, ranging from pure 
experimental to numerical investigation. All the conducted researches have a 
common theme that is the assessment of haemodynamic performances for 
cardiovascular prosthetic devices. This central path was covered from 
numerous sides, as seen along the different chapters. 
From an experimental point of view the principal goal has been the 
complete realization of a pulse duplicator, able to simulate the systemic 
circulation. This, from a mechanical design and realization, motion software 
implementation, and data analysis points of view. After a sensitivity analysis, 
the workbench demonstrates an excellent ability to mimic the physiological 
pressure and flow trends. A comparison against a common commercial 
alternative shows a good capability to assess fluid dynamic performance of 
aortic valves. A deformable silicone prototype aortic arch technique was 
described, representing an innovative strategy to product specific copy of 
vascular parts.  
Other experimental activities were conduit with the specific interest of study 
local flow configurations inside the aortic root. In particular, particle image 
velocimetry was adopted to study the flow characteristics in terms of local 
velocity, streamlines and vorticity downstream aortic bio-prosthetic valves, in 
London. Different valve-root setups were varied to inspect the relation between 
the root geometry, for sinuses shape and dimension, and sinotubular junction 
diameter variation. A theory of integrated system able to justify the observed 
flow patterns was developed. 
The aortic root local flow was also investigated from a numerical point of 
view. Using in vitro data of velocity fields for a mechanical bileaflet valve, and 
developing a mechanical model for red blood cells, the haemolysis index was 
studied. The adoption of a physically based approach that take in account the 
visco-iperelastic characteristics of the cell membrane -based on experimental 
analysis- allowed the development of a rupture model. The application to a real 
flow field consents spatial information extraction, as the damaging trajectories, 
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and the computation of a cumulate damage index parameter. This is a new 
way respect to the usual literature perspective based on power laws equations.  
 
In conclusion, after three years seems acceptable to say that the HeR Lab 
is on a good way for provide profitable international research results and 
prototypes development. From a personal point of view, during this PhD 
experience has been expounded transversal skills, which starts from the 
design of mechanic-hydraulic circuit and ability to provide in vitro reliable 
results of devices performance, passing through the purchase and organization 
of the lab materials and instrumentations, and reach aspects as the team 
activities planning and logistic issues solving. Part of the time was also 
depicted to public and private founding survey. A relevant result has been the 
ability of realize a self-founding event with a sailing race and a gala dinner in 
Venice, that saw the participation of two hundreds of clinicians and engineers. 
 
8.2 Further directions for the HeR Lab 
As described before, the HeR Lab is a new born reality in the University of 
Padua context. It grown quite fast in terms of employed people and research 
projects, collecting numerous good feedbacks from national and international 
research groups, and also by some companies. These interesting gave the 
possibility to start fruitful collaboration and open an exchange path for young 
researchers.  
 
To fill the workbench disadvantages mentioned along the thesis (Chapter 3-
4), little mechanical improvements are in development. In particular: a new 
deformable rubber-silicone valve housing system is in construction, which will 
provide higher energy dissipation at valve closure, to avoiding bumps effects 
on sensors measurement. Moreover, a reduction of the fluid mass -redesigning 
the atrial tank and ventricle chamber- plus a new phantom silicone “ventricle” 
will also help to limit the system inertia, avoid energy loss, and limit spike 
pressure waves and backflow from the aortic chamber to the ventricular, in 
particular during the initial phase of diastole. The “ventricle” silicone mold will 
be inserted between the inflow and outflow tracts (mitral to aortic derivations), 
with the aim of reduce the inertia forces to pump the fluid in the aortic branch 
and the rigidity of the actual system. The silicone part will be obtained by 
repetitive dipping of an ABS mold, obtained via fast prototype technique. Even 
though these are important but quite immediate mechanical changes, seems 
important to give a more wide scenario on the future possibly ways for the 
experimental research. 
The developed pulse duplicator is now an efficient and reliable workbench 
for in vitro tests, and the next works will focus on the performance 
characterization of bio-prosthetic, mechanical valves and the flow investigation 
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inside the silicone aortic arch. Indeed, after the publication of the adopted 
casting technique for vessels prototypes production, the idea is to start a study 
campaign to examine and describe the flow inside a healthy and pathologic 
aortic root. This will involve fluid velocimetry techniques and the study of local 
characteristics of the flow field. A local induction is a not cheap way, normally 
conducted with particle image velocimetry and laser instrumentation, or via 
eco-color Doppler machine. Already now is in development a preliminary mixed 
experimental-numerical research that tries to understand which are the 
replicable main characteristics of the flow when a endovascular stented 
prosthesis is inserted in an aneurismatic aortic arch. In particular, a pattern 
recognition and tracking technique is in progress, with the aim of obtain a 
LabView tool for the fine motion characterization of the stent migration, under 
specific flow conditions. In a realistic view, under the right economic support, 
this could be the experimental Lab prospective for the next years. 
The long term idea is to be able to make and test different vessel parts, 
healthy as pathologic, with the aim of a fluid dynamic characterisation in 
presence of external devices or to develop new prosthetic solutions. 
 
The necessary investment to cover the described instrumentations for local 
induction (TSI Inc. 2D PIV System, 90 KEuro, or EcoColor Doppler System, 70 
KEuro) and 2D pattern tracking analysis (LabView Visual, 10 KEuro), plus new 
catheter pressure transducers (Millar MicroTip, 3 KEuro) and a second 
flowmeter and probe (Transonic, 12 KEuro), an industrial hoven (500 Euro), 
two fast prototype printers (ABS and resin materials, Formlabs, 10 KEuro), a 
vacuum chamber, a fridge, new ABS moulds and silicone prototypes (7 KEuro), 
is about 110.000 Euro. Public and private founding strategies are now sifting 
through to fill this gap. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 170	
 
		
 
Acknowledgements 
 
 
It is difficult for me to make an acknowledgements wall, because a value of 
someone is not expressed by its position in a list. 
 
I want to start with Francesca, my professor of cardio vascular fluid 
dynamics, MS thesis supervisor, and finally PhD supervisor. Thanks for your 
constant attention on my research needs, for your unshakable faith in the 
neighbour, and for teach me that there are not bad results when we do the best 
of us. P&L. 
Thanks to Gaetano and Andrea, to teach, improve and strengthen me 
during the fantastic period at UCL (and also for the beers together). I am in 
debt with you. 
 
In particular, thanks to Luigi, Roberto and Giorgio, for help me since the 
beginning of the pulse duplicator realization, and to support me every day in 
the lab. Thanks also to Andrea B., for your support in the biomaterials field. 
I have to mention my favourite sail-man and enthusiastic physician Stefano. 
He spent itself in the Lab growth and support with very concrete actions our 
ideas. 
 
Thanks for the amazing friends, colleagues, and people that I met from all 
parts of the world during the doctorate. In particular, Luigi, Mattia, Lorenzo, 
Silvia, Matteo, Paolo P. & Paolo B., Federico, Pietro, Stefano. Guys in London: 
my “brother” Jacob, Ben, Selim, Wembo, Peter and Lee. You gave me more 
than I expected, it has been a great period. 
 
Last but not least, thanks to my family, you are my backbone; and thanks to 
my best friends Francesco, Marco, Diego, Davide, Nicola, Enrico. Thanks 
Marta, you have been close to me for an important part of my life, although 
now we have taken different ways. 
 
 
--- 
  
		 2	
 
